







Giant cell formation by 
macrophages and lung epithelial 
cells: A unique method of cell-cell 




A thesis submitted in part fulfillment of the requirements 











Department of Infection, Immunity & Cardiovascular 
Disease 
Medical School 





The work presented in this thesis is the work of the candidate, with the 
following exceptions: 
The B. thailandensis E264-ΔtssK was produced by Dr. Jamie Hall (University 
of Sheffield) as a part of his doctoral work. 
The over-expression of CD9 in the J774.2 mouse cell line was performed by 
Dr. Fawwaz Ali (University of Sheffield) as a part of his doctoral work.  
The anti-Tspan-2 antibody and the A549 cells over-expressing Tspan-2 were 
produced by Dr. Ibrahim Yaseen (University of Sheffield) as a part of his 
doctoral work.   
The A549 cells with knockouts of Tspan-15, ADAM10 and the anti-Tspan-15 
antibody were produced by Dr. Mike Tomlinson, University of Birmingham. 
The A549 cells with knockout of CD9 were produced by Dr. David J. Blake at 
Department of Biology, Fort Lewis College, Durango, Colorado. 
This work was funded by the Ministry of Higher Education and Scientific 





I would like to express my deepest gratitude to my supervisors Prof. Peter N 
Monk and Dr. Mark Thomas, whose exceptional discussions and constructive 
criticism. They have enabled me to improve an understanding of the topic and 
achieve this thesis. Without your valuable support and commitment, this 
thesis would not have been possible. Pete, with you, I will never walk alone. 
Mark, you are one of the best microbiologists. I would also like to introduce 
my sincere appreciation and thanks to, Dr Lynda Partridge for her interesting 
encouragement, and theoretical and practical assistance throughout the work. 
She was positive all the time.  
To all the wonderful friends around me, from the bottom of my heart, I 
appreciate your assistance. Rahaf Issa, for her support and her inducing. 
Shaimaa Abbas, for her pleasant conversation. Mohmmad Al-Shamrti, for his 
support to come to Sheffield. Sarmad Al-Sahaf, for his smile and wise talk and 
making me happy all the time. Chris Banyard and Aaron Butt, for their 
assistance in the tagged bacteria. Dr. Ahmed Al-Obaidy, Mahendra Raut and 
Luke Green, for their excellent advice. Ibrahim Yassin, for his assistance. Tom 
Champion, Atiga Elgawidi and Fawwaz Ali, for their real support at this 
project. Nathen Wong for the delicious cakes. Mohammed Moamin and 
Haider Aljanabi, for giving me wise talk. Fawzyah Albaldi, for her friendship 
that gives me the support for my next experiment. Ryawda Al-Hamd, for her 
help and her advice. Many thanks to all of my friends, including Basheer Al-
Waely, Ameer Aljboori, Nawfal Aldulaimi, Dheyaa Alkhanfar, Naer Alkaabawi, 
Ali Al-Saraf, and Haider Amer, for their support. Especially, thanks to Dr. 
Shuang Ma for her encouragement. 
I also much appreciate Dr Sue Clark, Julie Swales, and Kay Hopkinson (flow 
cytometry facility) for the technical assistance.  
Special thanks to University of Kufa and Ministry of Higher Education and 
Scientific Research (Iraq) for their scholarship. 
Finally, from my heart, big thanks to Mum, Dad, Brothers, and Sisters. I 
swear, my thesis would not have been finished without your encouragement. 
III 
 
List of Presentations 
 Poster: 7th European conference on tetraspanin, September 2016, 
Sheffield, UK. 
 Poster presentation presented to the Yorkshire Immunology group, May 
2017 at University of Leeds, Leeds, UK. 
 Oral presentation presented to the combating infectious disease, 4 
December 2017 at the University of York, UK. 
 Poster: 9th International tetraspanin as targets and markers of cancer and 
infectious disease, April 2018 at Tucson -Arizona, USA. 
 Oral presentation presented to the EMC-2018 European microbiology 





Burkholderia thailandensis is widely used as a non-pathogenic model of 
Burkholderia pseudomallei, the causative agent of melioidosis, a disease with 
a 90% mortality rate if untreated. One of the histopathological features of 
melioidosis is the presence of multinucleate giant cells (MGC). MGC 
formation occurs when the plasma membrane of infected cells become 
closely positioned with other cells, which then become attached and fuse 
together. Many studies have described how effector systems of B. 
thailandensis can induce the formation of MGC. It seems that these bacterial 
effectors can regulate this process by affecting the expression of mammalian 
membrane proteins, including the tetraspanins (Tspans) superfamily. Tspans 
are a large family of membrane proteins that bind partner proteins to form 
Tspan-enriched microdomains (TEM) that have many biological roles, 
including cell fusion, adhesion, and bacterial infection. Mammalian cells 
express 33 Tspans, but their specific functions during MGC formation and 
pathogen infection are not fully understood. Here, we have attempted to 
define the roles of all Tspans and some Tspan-partner proteins in B. 
thailandensis infection and/or MGC formation. We found that 5 Tspans are 
specifically involved in MGC formation induced by B. thailandensis: Tspan-2, 
Tspan-5, Tspan-13, CD81, and CD9. 3 Tspan-partner proteins are also 
specifically involved: ADAM10, CD98, and CD172α. 
Using antibodies, an inhibitory peptide derived from CD9 and knockouts and 
knockdowns of Tspans and their partners, we attempted to elucidate the roles 
of these molecules in MGC formation. It was observed that CD9, CD81, 
CD172α, and ADAM10 have negative roles in MGC formation induced by B. 
thailandensis whereas Tspan-2 and Tspan-13 play positive roles and could 
also be required for B. thailandensis infection. CD98 also has a positive role in 
MGC formation but has no role in B. thailandensis infection. It was also found 
that the peptide derived from CD9 could reduce the total number of bacteria of 
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Chapter 1 Introduction 
1.1 Overview 
Lower respiratory tract pathogens result in a wide range of human diseases 
such as melioidosis, tuberculosis and pneumonia (Marrie, 1994, Brett and 
Woods, 2000). Melioidosis is a chronic endemic disease, which is distributed 
through the tropical zone, and is caused by B. pseudomallei, an opportunistic 
pathogen in the human lower respiratory tract and on the skin. Annually, there 
are many recorded cases in southeast Asia, specifically Thailand, Malaysia 
and Vietnam, and it has also been recorded in northern Australia (Brett and 
Woods, 2000).  
B. pseudomallei and B. thailandensis (see sections 1.3 and 1.4) are related 
Gram-negative bacteria (Yu et al., 2006, Atkins et al., 2002). Stagnant water 
and moist soil are considered the main reservoirs for both of these pathogens 
(Wiersinga et al., 2008). Both provoke a similar immune response, and have a 
similar mechanism of immune response (Yu et al., 2006, Haraga et al., 2008). 
Laboratory researchers use B. thailandensis in animal models because it has 
little effect on humans compared to B. pseudomallei (West et al., 2012). The 
ability of B. pseudomallei to bind and invade epithelial cells in the human lung 
is an important part of the process of colonization. Bacterial surface proteins, 
called trimeric autotransporter adhesions (TAA), may achieve the binding. 
These outer membrane proteins have a cooperative role in bacterial 
pathogenesis and adhesion at the host cell surface (Edwards et al., 2010). 
Pili, lipopolysaccharide (LPS) and flagella can help bacteria attach to the cell 
surface as well (DeShazer et al., 1997, Essex-Lopresti et al., 2005, Burtnick et 
al., 2002, DeShazer et al., 1999).  
B. pseudomallei can also invade mammalian cells and stimulate them to form 
a complex structure known as a multinucleate giant cell (MGC) (Wiersinga et 
al., 2006, Kespichayawattana et al., 2000, Harley et al., 1998). There is 
insufficient understanding of how MGC formation is induced in 
monocyte/macrophages and other cells. A good understanding of the 
mechanisms of formation would be helpful in determining the role of MGC in 
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chronic disease to avoid B. pseudomallei infection. Tetraspanins (Tspans) are 
a large family of mammalian cell surface proteins known to be involved in 
MGC formation induced by B. thailandensis (Elgawidi, 2016). An important 
feature of Tspan molecules is their ability to form multiplexes of membrane 
proteins called Tspan-enriched microdomains (TEM) (Maecker et al., 1997). 
Tspan molecules can bind together or with partner proteins, such as 
immunoglobulin superfamily members and CD46, to make TEM. There are 
many functions facilitated by TEM, including cell fusion, signalling and the 
adhesive attaching of leukocytes to endothelial and epithelial cells (Maecker 
et al., 1997). Pathogens can also attach to TEM on the plasma membrane 
(Green et al., 2011). 
 Melioidosis 
Melioidosis has been an emerging infection over the past two decades, more 
frequently recognized in endemic areas (southeast Asia and northern 
Australia) (Currie, 2003). However, melioidosis is now being seen in many 
additional countries since people travel more and the microorganism may 
spread through new environmental conditions, although, as yet, there is no 
evidence to fully substantiate this (Dance, 1991, Dance, 2000). B. 
pseudomallei is also possibly spread by contaminated soil and water imported 
from an endemic area (Kaestli et al., 2007). After exposure to B. 
pseudomallei, the range of incubation times of melioidosis is between 1 and 
10 days, although much longer periods (up to 62 years) are possible before 
the occurrence of clinical symptoms (Ngauy et al., 2005). Twenty percent of 
all community-acquired septicaemias and 40% of sepsis-related mortality in 
northern Thailand is from melioidosis. There is no vaccination to prevent this 
disease, and the causative agent of the disease is highly resistant to 
antibiotics (Häußler et al., 1999).  
 Route of infection  
The causative agent of melioidosis can infect host cells at different sites (Brett 
and Woods, 2000). The most common route is inhalation of aerosolised 
bacteria (Zueter et al., 2016). Also, burn or wound infection may commonly 
occur (Limmathurotsakul et al., 2016). Furthermore, infection can also occur 
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by drinking contaminated water (Limmathurotsakul et al., 2016). Dendritic 
cells can facilitate the dissemination of pathogens in these different sites of 
infection (Williams et al., 2014). 
 Symptoms and diagnosis 
Melioidosis is a very serious disease that can present itself with different 
symptoms such as skin lesions, pneumonia and septicaemia (Gibney et al., 
2008, Reissig et al., 2012). Infection by B. pseudomallei can be classified into 
asymptomatic, localised, chronic and systemic septicaemia. Symptomatic 
infections normally occur via the respiratory tract, and can result in high 
mortality. The patients usually suffer with headache, myalgia, and high fevers, 
followed by rigors and chest pain. The bacterium also has the ability to persist 
for more than one decade asymptomatically. In a case in Texas, the 
bacterium was dormant for more than 60 years until a cut in the man's thumb 
became ulcerated (Ngauy et al., 2005). Septicaemia infection is much more 
serious than other categories; the case mortality rate is about 90%. However, 
the mortality rates have decreased in recent years because of newer more 
effective antibiotics such as the third-generation cephalosporin, ceftazidime.  
There are many diagnoses that confuse melioidosis with chronic pneumonia 
and tuberculosis (Wiersinga et al., 2006). The current clinical diagnosis of the 
melioidosis agent is culture on Ashdown's agar (Limmathurotsakul et al., 
2010). Also, B. pseudomallei can be diagnosed using the latex agglutination 
assay (Ekpo et al., 2007). Another technique that is sometimes used is an 
immunofluorescence assay (IFA) to diagnose melioidosis disease by using a 
fluorescently labelled antibody specific to the bacterium (Puah, 2014).  
 Global distribution of B. pseudomallei and melioidosis 
The first observation of melioidosis was in Myanmar in 1912 (Whitmore and 
Krishnaswami, 1912, Whitmore, 1913). Recently, many countries and regions 
have reported that melioidosis is endemic, such as southeast Asia, northern 
Australia, Brazil, India, southern China, Bangladesh (Jilani et al., 2016) and 
Malawi (Currie et al., 2008, Katangwe et al., 2013). Fig 1.1 shows the global 
distribution of melioidosis.  
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Lack of awareness is one of the factors that make diagnosis difficult and gives 
an opportunity for the global distribution of B. pseudomallei and an increasing 
number of melioidosis cases (Schweizer et al., 2014). Another factor is the 
absence of coherent strategies to detect B. pseudomallei in the soil (Potisap 
et al., 2018). However, human activities and their impact on the environment 
could increase the suitability of areas for B. pseudomallei colonisation (Shams 
et al., 2007). For instance, farming and waste disposal can be classified as 
‘anthrosol’, which is related with human activities, including partial removal, 
filling and cutting, waste disposal and irrigated agriculture (Limmathurotsakul 
et al., 2016). 
 
Figure 1.1 Distribution of melioidosis.  
The different colour means countries according to epidemic area that present the causative 
agent of melioidosis. Black dots indicate a recorded case of melioidosis. Reproduced with 
permission (Limmathurotsakul et al., 2016). 
 Treatment and prevention 
Ceftazidime is the most effective treatment of melioidosis. It can reduce 
mortality by 50% compared to other antibiotic treatments. However, the rates 
of mortality are still high (Wiersinga et al., 2012). Treatment with ceftazidime 
is usually followed by a regime of co-trimoxazole to destroy B. pseudomallei 
(Limmathurotsakul and Peacock, 2011, Dance, 2014).  
Several vaccines have been tested in animal models (Phuong et al., 2008). 
Some of them have attempted to use live bacteria attenuated by the mutation 
of genes (Phuong et al., 2008) and virulence factors (Stevens and Galyov, 
2004). A whole killed B. pseudomallei has been tested as an inactivated 
vaccine (Gilmore et al., 2007, Barnes and Ketheesan, 2007). In addition, other 
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researchers have used B. pseudomallei proteins including type III and type VI 
secretion system proteins as antigens (Druar et al., 2008, Burtnick et al., 
2008). To date, no vaccine has offered complete protection from infection 
(Silva and Dow, 2013, Fertitta et al., 2018). However, it was reported recently 
that an attenuated vaccine of B. pseudomallei PBK001 could activate the 
immune response and offer full protection against aerosol infection by B. 
pseudomallei (Khakhum et al., 2019).  
 B. pseudomallei 
B. pseudomallei is a Gram-negative, motile, lactose non-fermenting, oxidase 
positive, non-spore forming aerobic bacillus (Hemarajata et al., 2016). 
Ashdown’s medium is a selective medium used to identify Burkholderia 
species (Ashdown, 1979).  
 Virulence factors of B. pseudomallei 
B. pseudomallei has many virulence factors, including pili, flagella, capsule, 
bacterial lipopolysaccharide (LPS) and the type III and type VI secretion 
systems (T3SS and T6SS) (Estrada-De Los Santos et al., 2016, Adler, 2011, 




Table 1.1 Virulence factors of B. pseudomallei. 
Virulence factors  Role  References  
Capsular 
polysaccharide 
Adhesion to host cells; 
defense against complement 
(Reckseidler-Zenteno 
et al., 2005) 
Flagella  Movement  (DeShazer et al., 1997) 
Fimbriae and pili  Adhesion to host cells (Essex-Lopresti et al., 
2005) 
Quorum sensing  
 
Stationary phase gene 
regulation, including secreted 
enzymes and oxidative stress 
protein 
(Lumjiaktase et al., 
2006, Song et al., 
2005) 
LPS  Resistance to complement 
and defenses against native 
immune response.  
(DeShazer et al., 1999, 
Burtnick et al., 2002) 
Type I, II, III, V and 
VI secretion 
systems 
To invade and escape from 
host cells;  
Secretion of effector proteins 
for example BopA, BopE 
phospholipase C, protease, 
and lipase required for 
interaction with host cells. 
(Stevens and Galyov, 
2004, Stevens et al., 
2002, Burtnick et al., 
2008) 
  
 Flagella and pili 
The flagellum plays a role in the invasion of human lung epithelial cells (Chua 
et al., 2003). Wikraiphat and co-workers have shown that the flagellum can 
protect bacteria from human polymorphonuclear cells (PMNs) and 
macrophages (Wikraiphat et al., 2009). Chua and co-workers have shown that 
the flagellum has a role in the pathogenesis of B. pseudomallei. However, an 
in vitro study that used A549 cells showed that there were no significant 
differences between wild type and flagella mutant strains of B. pseudomallei 
(Chua et al., 2003). A second important virulence factor is the type IV pilus, 
which has two subclasses (IVA and IVB). A putative pilus protein of IVA is 
used as an adhesive factor to attach to epithelial cells. Some studies showed 
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that the percentage of adhesion to epithelial cells is reduced in pili mutant 
strains (Essex-Lopresti et al., 2005). 
 Quorum sensing 
Burkholderia. spp can produce N-acyl-homoserine lactone (AHL or N-AHL) 
signal molecules, which are involved in cell to cell communication (Chan et 
al., 2015). Many species of bacteria use quorum sensing to coordinate gene 
expression according to the density of their local populations (Keller and 
Surette, 2006). The signal is controlled by gene regulators, which can change 
gene expression, switching between flagella and pili genes during biofilm 
production (Antunes et al., 2010, LaSarre and Federle, 2013). The luxR gene 
family is responsible for the synthesis of AHLs (Subramoni and Venturi, 
2009). There are some data showing that AHL synthase has negative effects 
on the formation of MGC (Horton et al., 2013). The absence of all three AHL 
synthases in B. pseudomallei strongly promotes MGC formation in RAW264 
mouse macrophages. However, when  murine models were infected with the 
AHL null mutant, there was no effect on virulence in mice (Horton et al., 
2013). 
 Capsule 
The capsule has a key role in bacterial attachment and infection (Wiersinga et 
al., 2006). Perry and co-workers have observed that the bacterial capsule is 
composed of 3-2-O-acetyl-6-deoxy-β-ᴅ-manno-heptopyranose-1 (Perry et al., 
1995). The capsule also is important to prevent the binding between bacteria 
and components of innate immunity such as complement C3b, an opsonin 
that promotes phagocytosis (Reckseidler-Zenteno et al., 2005). Deletion of 
genes encoding capsule components has been shown to affect bacterial 
infection in a mouse model (Atkins et al., 2002). Wikraiphat and co-workers 
have shown that mutation of capsule components reduces the ability for 
internalisation and replication inside macrophages (Wikraiphat et al., 2009).  
 Lipopolysaccharide 
LPS is the major component of the outer membrane of Gram negative 
bacteria (Whitfield and Trent, 2014). It is considered the key marker for 
recognition by the innate immune system (Yoon et al., 2009, Brennan et al., 
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2013). LPS consists of 3 components, which are lipid A, O-antigen and core-
oligosaccharide (Nikaido, 2003). The LPS of B. pseudomallei is a type II O-
antigen, and is required for pathogenesis in guinea pigs, mice and infant 
diabetic rats (Wikraiphat et al., 2009, Brett et al., 1998). In addition, LPS of B. 
pseudomallei is also not capable of stimulating inducible nitric oxide synthase, 
which is a part of host defence (Utaisincharoen et al., 2003). 
 Type III secretion system 
Most Gram-negative pathogens secrete proteins important for virulence. The 
type III secretion system (T3SS) is one of the secretion systems that are 
important for the invasion of host cells (Coburn et al., 2007). The T3SS is 
composed of more than 20 proteins (Moraes et al., 2008). These include 
proteins that assemble the T3SS secretion machine, and two or three 
additional proteins known as translocator proteins that insert into the 
membrane of the target eukaryotic cell and are responsible for delivering 
effector proteins into target eukaryotic cells. The translocator proteins are 
responsible for delivering effector proteins into target eukaryotic cells. 
Although of course the other components of the T3SS are required for this, 
otherwise the effectors would not be secreted (Marlovits and Stebbins, 2010).  
Three T3SSs are encoded in the genome of B. pseudomallei (T3SS-1 and -3) 
(Vander Broek and Stevens, 2017). T3SS-1 and -2 are not well defined 
(Vander Broek and Stevens, 2017). T3SS-3 is also known as the Burkholderia 
secretion apparatus (Bsa) (Pumirat et al., 2010). This system is similar to the 
T3SS of Salmonella enterica with regard to virulence characteristics and 
structure (Stevens et al., 2002). The deletion of the translocator gene of the 
Bsa could reduce virulence in a mouse infection model (Stevens et al., 2004). 
The effect of T3SS-3 on the HeLa cell line has also been investigated 
(Stevens et al., 2002). Stevens et al. have found that the inactivation of bopE 
(effector protein of T3SS-3) could reduce bacterial invasion, but not reduce 
bacterial replication in a mouse macrophage-like cell line (Stevens et al., 
2002). However, knockout of bsaZ (effector protein of T3SS-3) leads to the 
reduction of the number of intracellular bacteria (Stevens et al., 2002). 
Interestingly, a device called ‘photothermal nanoblade’ has been used to 
deliver a B. thailandensis mutant lacking a functioning T3SS-3 and wild type 
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(WT) directly to the cytosol of HEK293 cells (French et al., 2011). It was 
noticed that MGC were formed normally with the WT but not with the mutant 
strain using the regular mode of infection, however, there were no differences 
between MGC formation induced by WT and mutant bacteria that were 
delivered by photothermal nanoblade. This may suggest that this secretion 
system could play a role in the initial infection of bacteria, perhaps in the 
escape from endosomes (French et al., 2011). Their results also suggest that 
the B. thailandensis might transfer between cells to others through membrane 
protrusion formation into neighbouring cells resulting in the formation of 
vacuoles. 
 Type VI secretion system 
T6SS is a specific macromolecular machine that is able to deliver proteins into 
host cells. The genes of T6SS have been identified in roughly a quarter of all 
Gram-negative bacterial genomes (Bingle et al., 2008). The genome of B. 
pseudomallei is predicted to encode six T6SSs known as T6SS-1 to T6SS-6, 
as shown in Table 1.2 (Shalom et al., 2007).  
Table 1.2 T6SS gene clusters in B. pseudomallei K96243 and B. 
thailandensis E264.  
T6SS gene cluster a B. pseudomallei K96243  B. thailandensis E264 
1 BPSL3097-BPSL3111 BTH_I294-BTH_I2968 
2 BPSS0095-BPSS0116 BTH_II0119-BTH_II0140 
3 BPSS0167-BPSS0185 Absent 
4 BPSS0515-BPSS0532 BTH_II1885-BTH_II1902 
5 BPSS1493-BPSS1511) BTH_II0873-BTH_II0854 
6 BPSS2093-BPSS2109 BTH_II0249-BTH_II0265 
a According to the nomenclature of Shalom et al., 2007 
Interestingly, only T6SS-5 has a known role in bacterial pathogenesis 
(Shalom et al., 2007). T6SS-5 has a major role for MGC formation (Schwarz 
et al., 2010). Shalom and colleagues have used in vivo expression technology 
(IVET) to identify upregulated genes within bacteria during infection (Shalom 
et al., 2007). They showed that the gene expression of T6SS-5 components 
increased during macrophage infection (Shalom et al., 2007). Furthermore, 
the deletion of the T6SS-5 subunit gene vgrG-5 (tssI-5) in B. pseudomallei 
confirmed the role of T6SS-5 in bacterial pathogenesis in a hamster model of 




French et al. performed the nanoblade experiment using double mutants of 
T3SS-3 and T6SS-5 of B. thailandensis (French et al., 2011). It was 
demonstrated that the mutant strain was incapable of inducing MGC formation 
when delivered directly to the cytosol of a host cell line (French et al., 2011). 
This suggests that MGC formation is mediated specifically by T6SS-5. This 
could support the argument that demonstrates the role of MGC formation in 
facilitating intercellular spreading, as explained in section 1.3.1.5.  
The precise mechanism by which T6SS-5 can facilitate MGC formation by B. 
pseudomallei and B. thailandensis is unclear. Two studies have demonstrated 
a vital role for the C-terminal domain (CTD) of VgrG-5 (TssI-5) in MGC 
formation (Toesca et al., 2014, Schwarz et al., 2014). VgrG (TssI) proteins are 
components of the T6SS that are secreted along with (TssD) Hcp and PAAR 
and their presence in culture supernatants is considered a ‘hallmark’ of a 
functional T6SS as shown in (Fig 1.2). Some VgrG subunits contain a C-
terminal extension that serves as an effector protein (Coulthurst, 2019). VgrG-
5 also appears to have a C-terminal extension. The deletion of the CTD of 
VgrG-5 (TssI-5) in B. pseudomallei and B. thailandensis can abolish their 
ability to induce the formation of MGC (Toesca et al., 2014, Schwarz et al., 
2014). In addition, Toesca and colleagues have demonstrated that the 
deletion of the CTD of VgrG-5  has no effect on the secretion of TssD-5 
(Toesca et al., 2014). Although the CTD of VgrG-5 is important for MGC 





Figure 1.2 Type VI secretion system structure.  
The T6SS is a protein secretion machine containing 14 different subunits (TssA-TssM and the 
PAAR protein) that injects effector proteins into target cells (either other bacteria or eukaryotic 
cells). It is required for pathogenicity in some bacteria. The T6SS-5 is used by B. 
pseudomallei and B. thailandensis to induce MGC formation. C: Cytoplasm, PG: 
peptidoglycan, IM: inner membrane and OM: outer membrane.   
 Mechanism of pathogenesis of B. pseudomallei 
 Bacterial attachment to the host plasma membrane 
B. pseudomallei can adhere to the host cell surface (Brown et al., 2002). 
There are some proteins on the host cell surface that play a role in bacterial 
adhesion and signalling, such as Toll-like receptor (TLR), which is activated 
by B. pseudomallei LPS and flagella, which tend to activate types of innate 
immune cells such as neutrophils, macrophages and natural killer cells. 
Proinflammatory cytokines are released, as shown in Fig 1.3 (Lazar Adler et 
al., 2009). 
Gori et al. suggest that the asialoganglioside aGM1–aGM2 receptor complex 
is one of the receptors to bind B. pseudomallei (Gori et al., 1999). 
Furthermore, there is study that shows P. aeruginosa attachment to host cells 




Figure 1.3 The mechanism of pathogenesis by B. pseudomallei inside the 
mammalian cells. 
It is likely that B. pseudomallei initiates attachment to host cells using specific virulence 
factors such as capsule or pili. Invasion of the epithelial cells uses T3SS3 effector subunit 
proteins. TLR2 and TLR4 are activated by LPS of B. pseudomallei, activating innate immune 
cells including neutrophils, natural killer cells (NK) and macrophages. These activated cells 
produce pro-inflammatory cytokines that cause host tissue damage in acute cases of 
melioidosis. B. pseudomallei can replicate inside macrophages. The number of bacteria 
produced is determined by regulatory factors, for example, RpoS and QS. Bacteria can also 
escape via activation of apoptosis (section 1.3.2.3). Lymphatic vessels can facilitate the 
spreading of B. pseudomallei possibly carried within macrophages. B. pseudomallei infection 
can induce the host adaptive immunity by inducing IFN-γ production, recruiting T cells and 
causing antibody production by B cells. With permission from Lazar Adler et al., 2009. 
 Survival of B. pseudomallei inside host cells 
B. pseudomallei can escape from the membrane-bound phagosome into the 
cytoplasm in infected macrophages or other mammalian cells 
(Kespichayawattana et al., 2000). B. pseudomallei is able to propel itself 
within infected host cells using actin polymerisation, resulting in distinctive 
‘comet tails’ (Kespichayawattana et al., 2000). The mechanism of actin 
polymerisation, which can be induced by B. pseudomallei to achieve 
intracellular motility, is different from mechanisms of actin motility used by 
other intracellular pathogens (Breitbach et al., 2003). BimA is a trimeric 
autotransporter protein and each subunit contains three WASP homology 2 
(WH2) motifs, two of them are required for actin polymerisation activity 
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(Benanti et al., 2015, Sitthidet et al., 2011). B. pseudomallei can use bimA 
protein for inducing actin polymerisation. B. pseudomallei bimA mutants are 
unable to form actin tails in vitro (Stevens et al., 2005). 
There is evidence that this pathogen can invade macrophages without 
activating a key enzyme in the antimicrobial activity of the macrophages, 
known as inducible nitric oxide synthase (iNOS). B. pseudomallei could be 
surviving and replicating inside the phagocytic cells, due to lack of induction of 
iNOS expression (Utaisincharoen et al., 2006). The reason for repression of 
iNOS might be the overexpression of Suppressor of Cytokine Signalling 3 
(SOCS3) and Cytokine-Inducible SRC Homology 2-containing protein (CIS) 
inside the macrophage (Baral and Utaisincharoen, 2012). These proteins are 
negative regulators of cytokine production (Ekchariyawat et al., 2005). The 
activation of these negative regulators is not well defined (Ekchariyawat et al., 
2007). Furthermore, Burtnick and co-workers have shown that T3SS-1 and 
T3SS-2 have no role in bacterial escaping from phagosome in RAW264.7 
cells but have observed that T3SS-3 is involved in delayed phagosomal 
escape in RAW 264.7 cells (Burtnick et al., 2011). However, Adler has found 
that the T3SS-1 ATPase mutant shows reduced intracellular replication in 
RAW 264.7 macrophage-like cells, suggesting that the T3SS-1 plays a role in 
the intracellular replication of B. pseudomallei (Adler, 2011). 
In addition, B. pseudomallei can invade the A549 lung epithelial cell line and 
activate nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
κB), leading to the generation of IL-8 (Hengge-Aronis, 2002). Interestingly, B. 
pseudomallei invasion does not require NF-κB activation or IL-8 production 
(Hengge-Aronis, 2002). B. pseudomallei adhesion to the surface membrane 
of the epithelial cells causes signalling (Adler, 2011). The mitogen-activated 
protein (MAP) kinases are essential to many signalling pathways in the host 
cells (Utaisincharoen et al., 2001). It has been reported that signalling proteins 
may be involved in many immune responses in the host against the bacterial 
invasion (Krachler et al., 2011). There are specific inhibitors which can inhibit 
MAP kinase so that the activation of cells is significantly decreased and 
cytokine production from infected cells is also reduced (Utaisincharoen et al., 
2001). There are some findings which implicate MAP kinases in bacterial 
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internalisation. When a MAP kinase inhibitor is added to epithelial cells, 
Listeria monocytogenes invasion can be inhibited (Nickerson and Curtiss, 
1997, Frederiksen and Leisner, 2015). However, this inhibitor has no effect on 
S. enterica serova typhimurium (S. typhimurium) invasion (Utaisincharoen et 
al., 2006). One of the most important MAP kinase proteins is p38, which has a 
vital role in immune responses against a bacterial infections (Zhang et al., 
2007). To illustrate this, p38 MAP kinases can be activated in S. typhimurium-
infected epithelial cell lines, so that it leads not only to NF-κB activation but 
also induces activator protein 1 (AP-1), which has a role in a number of 
cellular processes (Mynott et al., 2002). Cytokine (such as IL-8) expression is 
switched off by inhibition of p38 MAP kinase with epithelial cells infected by S. 
typhimurium (Mynott et al., 2002). 
 Activation of cell death by B. pseudomallei  
Pathogen clearance induces cell death in innate phagocytes (Haase et al., 
2003). There are different types of cell death in phagocytes including 
apoptosis, pyroptosis, necroptosis and necrosis (Fink and Cookson, 2005). 
There are two pathways that can trigger apoptosis: extrinsic or intrinsic (Wali 
et al., 2013), involving death receptors and mitochondrial damage, 
respectively. The induction of apoptosis in infected cells depends on 
proteolytic enzymes caspase-7 and caspase-3, while pyroptosis depends on 
caspase-1 and caspase-11 (Lamkanfi and Dixit, 2010). Neutrophil apoptosis 
can be induced by intracellular bacteria and the oxidative burst (González-
Cortés et al., 2009). B. pseudomallei can delay the spontaneous apoptosis of 
human neutrophils via LPS and proinflammatory cytokines (Chanchamroen et 
al., 2009).  
In contrast, pyroptosis is another form of lytic cell death which can be 
activated by caspase-1 or caspase-11 (Mathur et al., 2018). Human 
macrophages and mouse macrophages infected by B. pseudomallei can die 
due to caspase-1-dependent pyroptosis (Chanchamroen et al., 2009, Miao et 
al., 2010). However, a small number of cells also succumb by necrosis 
(Chanchamroen et al., 2009). The knockout of caspase-1 in mice increases 
susceptibility to B. pseudomallei infection (Ceballos-Olvera et al., 2011). 
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However, pyroptosis does not occur during the death of neutrophils 
(Chanchamroen et al., 2009).  
 Role of cell signalling molecules in B. pseudomallei infection and MGC 
formation 
 p38 
p38 plays a vital role in skeletal muscle biology, myoblast differentiation and 
myofibrillogenesis (Gardner et al., 2015). Recently, a study has reported that 
p38, ERK, and mitogen-activated protein kinases play a role during B. 
pseudomallei infections (D’elia et al., 2017). However, during infection, no 
modulation of the anti-or pro-inflammatory cytokines was shown (D’elia et al., 
2017). p38 activation could be controlled by M-CSF and can induce the 
receptor activator of NF-ĸB ligand (RANKL) that enhances cell fusion in 
osteoclast (Baek et al., 2015). It was suggested that p38 could regulate 
NFATc1 expression and activity that regulates DC-STAMP expression. 
NFATc1 plays a positive role in osteoclast (Song et al., 2009). 
 p53 
p53 is a transcription factor that controls programmed cell death (Crighton et 
al., 2007). p53 is known also to prevent tumorigenesis induced through the 
apoptosis process (Deng and Wu, 2000). p53 plays a role in many cell 
functions including tissue homeostasis, metabolism, aging and stem cell state 
(Jackson et al., 2012). It has been shown that the role of p53 in HPV infection 
(Levine, 2009). It can regulate many immune molecules via NF-κB and STAT 
pathways, such as IL-6 and inducible nitric oxide synthase (iNOS), which are 
important during bacterial infection (Levine, 2009). Recently, a study has 
reported that p53 regulates MGC formation in cancer cell lines (Fu et al., 
2013). Mirzayans and co-workers have observed that the deletion of p53 led 
to the induction of MGC formation (Mirzayans et al., 2018). Gauster et al. 
have also demonstrated the positive involvement of p53 in the production of 
syncytia (Gauster et al., 2018). The deletion of p53 induced autophagy, which 
could ensure survival in times of moderate nutrient depletion and/or oxidative 
stress (Humpton and Vousden, 2016).  
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 B. thailandensis as an alternative model for B. pseudomallei 
B. thailandensis is a saprophytic bacterium and is a non-pathogenic species 
for humans, although having a similar mechanism to B. pseudomallei in 
respect of immune response and cell attachment (Chen et al., 2006, Yu et al., 
2006, Brett et al., 1997, Wongprompitak et al., 2009).  
Both species have the same ability to invade and replicate inside 
macrophages or monocytes and A549 human lung epithelial cells (a 
carcinoma cell line) (Kespichayawattana et al., 2004, Charoensap et al., 
2009). B. pseudomallei is more efficient than B. thailandensis in invasion, 
adherence and inducing cellular damage in A549 cells (Kespichayawattana et 
al., 2004, Charoensap et al., 2009). There is another difference between 
these two species, which is that B. thailandensis can assimilate L-arabinose, 
but B. pseudomallei cannot (Thibault et al., 2004). 
Although B. thailandensis is non-pathogenic to humans, severe infections can 
be caused by an inhalation challenge on mice with B. thailandensis, which 
possibly depends on virulence factors shared with B. pseudomallei (Yu et al., 
2006). In spite of B. pseudomallei being more virulent than B. thailandensis, 
doses of more than 10000 colony forming unit (CFU) of B. thailandensis killed 
mice (West et al., 2008). Because B. thailandensis is less virulent but causes 
similar immune response to B. pseudomallei, B. thailandensis has been used 
as an alternative infection model (West et al., 2012). 
 Multinucleate giant cells 
MGCs are fused cells that are formed in some pathological states (Möst et al., 
1997, Milde et al., 2015). These include melioidosis, tuberculosis, and the 
presence of foreign bodies (Möst et al., 1997). The mechanisms of formation 
and pathological roles of MGC are not fully understood yet. 
In vitro studies showed that monocytes can be induced to form MGC by using 
different conditioned media or by mixtures of cytokines (Möst et al., 1990, 
Postlethwaite et al., 1982). Some studies used lectins alone or in combination 
with IFN-γ, others used phorbol myristate acetate (PMA) to induce cell fusion 
(Takashima et al., 1993, Hassan et al., 1989). Moreover, cytokines can play a 
role in monocyte fusion to inhibit or enhance MGC formation (Möst et al., 
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1990). Fais et al. have shown that Interleukin-4 (IL-4) has the ability to inhibit 
MGC formation (Fais et al., 1994). 
 Types of MGC 
MGC can be classified depending on morphology into several types of cells: 
Langhan’s giant cells (LGC), which occur during granulomatous inflammation 
and depend on epithelioid macrophages; the number of nuclei in this type of 
MGC is usually less than 20 (Okamoto et al., 2003). Foreign-body giant cells 
(FBGC) occur in chronic disease and during responses to foreign bodies such 
as prostheses (Anderson, 2000); they can occur in epithelioid macrophages 
as well but the number of nuclei is typically more than 20 (Anderson, 2000). 
 LGC 
LGC have been identified in granulomatous diseases, for example, 
tuberculosis (TB), a serious lung disease caused by Mycobacterium 
tuberculosis (Sandor et al., 2003). LGC have also been observed in 
sarcoidosis, a granulomatous disorder of unknown causes (Anderson, 2000). 
M. tuberculosis can induce LGC by stimulating cytokine and chemokine 
production (Saunders and Britton, 2007). LGC are formed by macrophages, 
lymphocytes and dendritic cells aggregated together in a granuloma 
(Saunders and Britton, 2007). The main features of LGC are the number of 
nuclei (around 20 nuclei per cell), in a circular or horseshoe-shape within giant 
cells (Okamoto et al., 2003a). The mycobacterial envelope induces the 
macrophages to produce proinflammatory cytokines that are important in 
cellular aggregation and cell-cell fusion (Gasser and Möst, 1999). For 
example, interferon-γ (IFN-γ) is induced by monocytes and macrophages to 
form LGC (Gasser and Möst, 1999). Toll-like Receptor 2, metalloproteinase 
domain-containing protein 9 (ADAM9) and integrin β1-mediated pathways are 
also important during bacterial stimulation of LGC formation (Puissegur et al., 
2007). M. tuberculosis can penetrate into cells and tissues and can remain for 
decades before activation to form LGC (Parrish et al., 1998). Parrish et al. 
also reported that DC-STAMP was increased during LGC formation and that 
the DC-STAMPKD reduced LGC formation (Parrish et al., 1998). 
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 Foreign body giant cells 
Medical devices implanted in tissues cause the formation of FBGC, which are 
observed at the tissue-material interface in vivo, and are thought to remain 
there for the lifetime of the device. FBGCs have been involved in 
biodegradation of such medical devices (Anderson, 2000). The number of 
nuclei in FBGC is typically more than 20, and the shape of these giant cells 
are irregular and have a variety of shapes. FBGC formation is dependent on 
the surface area and the nature of the biomaterial used in the devices 
(Anderson, 2000).  
McNally and colleagues used human IL4 to induce FBGC formation (McNally 
and Anderson, 2005). It was observed that IL4 could induce macrophages 
and monocytes to form very large FBGC. It has also been reported that Type 
2 T helper lymphocytes (Th2) have a role in inducing cell fusion at the tissue-
material interface in macrophages, due to the secretion of a high level of IL4 
and IL13 (DeFife et al., 1997). McNally and colleagues have demonstrated 
that during the adhesion process, the β1 and β2 integrin receptor families 
have a positive role in FBGC formation induced by IL4 (McNally and 
Anderson, 2002). Other integrins have been implicated in FBGC formation 
such as αMβ2, αXβ2, α5β1>αVβ1>α3β1, and α2β1 (McNally et al., 2007). In 
addition, several studies have reported that matrix metalloproteinase MMP-9 
and DC-STAMP have a role in FBGC formation (MacLauchlan et al., 2009, 
Yagi et al., 2005).  
 Osteoclasts 
Osteoclasts play important roles in the physiological bone remodelling 
process, bone development and regeneration (Hernández-Gil et al., 2006, 
Charles and Aliprantis, 2014). The lack of osteoclasts leads to bone disorders 
such as osteoporosis (Segovia-Silvestre et al., 2009, Jones et al., 2011) 
whereas the increased activity of osteoclasts leads to disorders such as 
osteoporosis (Boyle et al., 2003, Segovia-Silvestre et al., 2009). The number 
of nuclei in this type of MGC is around 5-10. The osteoclast is formed from 
tissue-specific macrophages and myeloid precursor cells at or near the bone 
surface (Vignery, 2005). Osteoclasts can be induced by cytokines such as 
receptor activator of NF-kB ligand (RANKL) and macrophage colony-
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stimulating factor (MCSF) (Aubin and Bonnelye, 2000). Osteoblasts produce 
osteoprotegerin (OPG) which can interact with RANKL, and RANKL also can 
interact with its RANKL receptor (Teitelbaum et al., 2006). Simonet and 
colleagues have shown that OPG can reduce osteoclast formation in vitro and 
block bone resorption in vivo (Simonet et al., 1997). Osteoclast-stimulating 
agents such as TNF-α can enhance RANKL production (Teitelbaum, 2005). 
Many cell surface molecules are involved in the formation of these giant cells 
(Yagi et al., 2005). However, the pathway of how these osteoclasts form is still 
unclear. For example, DC-STAMP is implicated in osteoclast formation (Chiu 
and Ritchlin, 2016). Yagi and co-workers have used knock-out of DC-STAMP 
to investigate mice osteoclast formation and found that osteoclast formation 
was completely abrogated, leading to osteoporosis (Yagi et al., 2005). Tspan-
29 (CD9) has a positive involvement in osteoclast formation stimulated by 
RANKL in the RAW264.7 macrophage cell line (Ishii et al., 2006). They also 
noticed that the CD9KD reduced osteoclast formation. In addition, it was 
noticed that CD9 distributed into lipid raft microdomains in RANKL-treated 
cells but not in untreated cells (Ishii et al., 2006). This would suggest that the 
distribution of CD9 in microdomains plays a role during osteoclastogenesis 
(Ishii et al., 2006). 
 MGC in cancer 
Cell-cell fusion may occur between somatic and tumour cells, leading to 
cancer (Wang et al., 2012). There are several types of fusogenic cancers 
such as melanoma, in which malignant melanocytes can fuse with 
macrophages (Rachkovsky et al., 1998). In breast cancer, cancerous cells 
can fuse with endothelial cells, and tumour cells can fuse each other 
(Mortensen et al., 2004). Tumour cells also can fuse with somatic cells like 
monocytes, enhancing metastasis, epigenetic regulation and chromosomal 
aberration (Duelli and Lazebnik, 2003). 
 Mechanism of macrophage fusion 
Cytokines IL-4 and RANKL can induce the formation of different types of 
MGC, such as osteoclasts, FBGC and LGC (Jeganathan et al., 2014). 
However, the specific mechanism of the MGC formation process is not well 
defined. Several studies have demonstrated that many surface molecules and 
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proteins play roles in macrophage fusion such as CD44, CD47, CD98, 
P2X₇CD9, CD81, CD63, DC-STAMP, ADAMs and integrins (Shuster et al., 
2000, Yagi et al., 2005, Chakraborty et al., 2001, Takeda et al., 2003). A study 
has reported that the cytoplasmic protein tyrosine phosphatase PTP-PEST 
(also known as PTPN12) plays a negative role in vivo and in vitro in 
macrophage fusion (Martinez et al., 2009). Rhee and co-workers have 
demonstrated that the lack of PTP-PEST leads to hyperphosphorylation of the 
protein tyrosine kinase Pyk2, and then in response to cytokines, the ability of 
macrophages to migrate is increased whereas cell-cell adhesion and the 
rearrangement of the cytoskeleton was suppressed (Rhee et al., 2013). 
Another pathway was demonstrated by Martinez and others who showed that 
transmembrane protein signalling adaptor protein DAP12 is crucial for 
cytokine-stimulated macrophage fusion (Martinez et al., 2009). The depletion 
of DAP12 reduced MGC formation both in vivo and in vitro (Martinez et al., 
2009). The over-expression of DAP12 could also induce MGC formation by 
regulation of surface protein expression such as DC-STAMP, MMP9 and 
cadherin (Martinez et al., 2009, Brown, 2011). Actin cytoskeleton 
rearrangement is important in MGC formation and it has been reported that it 
acts as the driving force for MGC formation by establishing membrane 
protrusions (Shilagardi et al., 2013). These membrane protrusions are 
required to control the fusion process promoted by fusogenic proteins 
(Shilagardi et al., 2013).  
Moreover, it has been proposed that the mechanism of MGC formation is 
similar to phagocytosis (Vignery, 2005). Briefly, macrophages adhere to, and 
internalise, each other, then aggregated macrophages coated by two cell 
membranes. These two membranes are recycled, and host cells become 
integrated (Vignery, 2005).  
This mechanism of macrophage fusion was also supported by other 
researchers. McNally et al. have shown that endoplasmic reticulum (ER) 
promoted cell fusion, with some markers of ER such as calregulin and 
calnexin co-localized at interfaces of cell fusion on cell surfaces during FBGC 
formation induced by IL4 (McNally and Anderson, 2005, McNally et al., 1996). 
They also proposed that the FBGC formation could be reduced by inhibition of 
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ER components or by blockade of mannose receptor expression, a known 
regulator of FBGC formation (McNally and Anderson, 2005, McNally et al., 
1996).  
As shown in Fig 1.4, the different stages of osteoclast formation in RAW264.7 
EGFP cells stimulated by RANKL have been demonstrated using confocal 
microscopy (Takito et al., 2012, Takito et al., 2015). Two macrophages 
attached together show a delay before cell fusion occurs, which is required for 
a temporary actin superstructure formation, a zipper-like structure, at the 
contact site. This structure disappeared during the initial stage of cell fusion. A 
gap was formed between the parallel plasma membranes, and then 
membranes were fused, due to the podosome belts of distinct osteoclasts. 
Podosome is actin-rich structures found on the outer surface of the cell 
membrane of host cells (Takito et al., 2012). 
 
Figure 1.4 The mechanism of macrophage fusion.  
A: Confocal microscopy images of RAW 264 mouse macrophages forming osteoclasts, the 
cells were stained with actin (red), plasma membrane (green) and nuclei stained DAPI (blue). 
Scale bar: 50μm. B: The site of connection between cell:cell in A. Scale bar 10μm. C: 
Confocal microscopy images at different time points show mouse macrophages, cell 
transfected with EGFP–actin. The grey images are phase contrast. With permission from 
(Takito et al., 2012). 
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 MGC formation induced by B. pseudomallei 
The induction of MGC formation in host cells could enhance the ability of B. 
pseudomallei to survive and replicate inside host cells (Benanti et al., 2015, 
Stevens et al., 2005, French et al., 2011, Kespichayawattana et al., 2000). 
MGC are observed in some tissues of melioidosis cases including the lung, 
spleen and kidney (Wong et al., 1995). B. pseudomallei also induces 
phagocytic and non-phagocytic cells to form MGC in tissue models (Franco et 
al., 2018). B. pseudomallei, B. mallei and B. thailandensis employ the T6SS-5 
to induce cell membrane fusion between the cell in which they are present 
and an adjacent host cell. This process leads to MGC formation and facilitates 
bacterial access to other uninfected cells (Chen et al., 2011, Schwarz et al., 
2014, Toesca et al., 2014, Whiteley et al., 2017). 
It has been shown that peripheral membrane protrusions form in both 
phagocytic and non-phagocytic cells after infection by B. pseudomallei, which 
are closely related to the protrusions that created in infected cells by L. 
monocytogenes and Shigella flexneri (Stevens and Galyov, 2004, de 
Chastellier and Berche, 1994, Kespichayawattana et al., 2000). B. 
pseudomallei can escape from endosomes and can replicate in the cytoplasm 
of the cell to induce cell fusion (Ray et al., 2009, Kespichayawattana et al., 
2004).  
Another bacterial factor involved in MGC formation is (T6SS-5), as discussed 
above (Schell et al., 2007, Shalom et al., 2007). Shalom and co-workers 
showed that T6SS-5 expression was  increased at the mRNA level following 
infection (Shalom et al., 2007). Burtnick and colleagues have also shown the 
role of TssI-5 in MGC formation (Burtnick et al., 2011).  
In terms of the molecular mechanisms of MGC formation, Boddey et al. found 
that B. pseudomallei infection significantly increased the expression of 
NFATc1 nuclear factor of activated T‐cells cytoplasmic 1, calcitonin receptor 
(CTR), tartrate-resistant acid phosphatase (TRAP), cathepsin K (CTSK). This 
data suggested that B. pseudomallei is able to induce many host cells factors 
involved in membrane fusion processes (Boddey et al., 2007). However, 
these osteoclast markers did not change after B. thailandensis infection. 
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Boddey et al also showed that the expression of lfpA mRNA (lactonase family 
protein A) in B. pseudomallei is massively increased during infection of the 
RAW264.7 cell line compared to bacteria growing in the absence of 
RAW264.7 cells. Interestingly, the lack of lfpA dramatically decreased the 
expression of these host genes compared to the wild type B. pseudomallei 
(Boddey et al., 2007). 
Furthermore, bacterial infection can induce epigenetic changes such as 
histone modification, and chromatin regulation that have effects on small 
signalling molecules either increase or decrease host defence (Bierne et al., 
2012). Pegoraro et al investigated 43 epigenetic regulation compounds on 
MGC formation induced by B. pseudomallei. These epigenetic regulation 
compounds are Histone Deacetylase (HDAC) inhibitors. Interestingly, one of 
them called M-344 has a negative effect on MGC formation induced by B. 
pseudomallei (Pegoraro et al., 2014). 
Interestingly, Whiteley et al demonstrated that cholesterol depletion and 
proteins exposed on the host cell surface affected MGC formation induced 
by B. thailandensis. The ratio of MGC formation and the number of nuclei per 
MGC were reduced when infected cells were treated with trypsin compared 
with not treated. Furthermore, the modulation of cholesterol on the surface of 
host cells by methyl-β-cyclodextrin treatment or exogenous addition of 
cholesterol reduced the ability of B. thailandensis to induce MGC formation. 
Methyl-β-cyclodextrin (MβCD) is an oligosaccharide with a hydrophobic cavity 
and a low ability to cross membranes. These findings suggested that the 
organization of the lipid bilayer in the cell membrane is involved in MGC 
formation (Whiteley et al., 2017). 
In addition, MGC formation induced by B. pseudomallei could be controlled by 
several host cell surface proteins including E-cadherin (CD324), fusion 
regulatory protein (CD98), E-selectin (CD62E), integrin-associated protein 
(CD47), and CD172α (Suparak et al., 2011). Anti-CD98, CD47, CD62E and 
CD324 antibodies completely blocked MGC formation induced by B. 
Pseudomallei in U937 human monocytic cells while anti-ICAM-1 (CD54) and 
LFA-1 antibodies only partly blocked the cell fusion (Suparak et al., 2011). 
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The mechanism of fusion induced by B. pseudomallei and B. thailandensis is 
shown in Fig 1.5. 
 
Figure 1.5 The cell fusion process induced by B. pseudomallei.  
Host cells can be stimulated to form MGC by B. pseudomallei which can travel between cell 
and replicate inside the host cells. Bacteria can form actin mediated and deliver several 
proteins inside the host cells such as T3SS and T6SS, in regards its requirements to survive 
and spread. T3SS-3 proteins are involved in invasion and replication, rarely in cell fusion. 
T6SS-5 plays a major role in MGC formation by creating a hemi fusion zone that facilitates 
the membrane fusion process. Adapted from Toesca et al., 2014. 
1.6 Tetraspanins overview 
Tspan molecules are a superfamily of membrane proteins with distinctive 
properties. Tspan molecules are expressed in different organisms ranging 
from invertebrates, including sponges, to the higher vertebrates, including 
mammals (Garcia-España et al., 2008). 37 Tspans have found in insects 
(Drosophila sp.), 23 Tspans in sea anemones (Nematostella sp.) and 17 
Tspans in plant (Arabidopsis sp.) (Todres et al., 2000, Garcia-España et al., 
2008, Huang et al., 2005). Their diversity of expression and specific roles in 
several biological processes have encouraged scientists to focus and shed 
light on the structure and function of Tspans since their discovery more than 
two decades ago (Oren et al., 1990).  
Recently, our group has demonstrated the role of Tspan molecules in MGC 
formation induced by B. thailandensis. It has been observed that CD9, CD63 
and CD81 play a role in mouse macrophage cell fusion induced by B. 
thailandensis (Elgawidi, 2016). CD9 and CD81 are known to be involved in 
the MGC formation (Elgawidi, 2016). 33 human Tspan molecules have been 
identified (Todres et al., 2000, DeSalle et al., 2010, Charrin et al., 2014). 
These proteins can also be expressed on cell organelles, for instance, the 
endosome and lysosome (Hemler, 2005, Hemler, 2003, Garcia-España et al., 
2006, Lakkaraju and Rodriguez-Boulan, 2008). Some Tspan molecules, for 
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example, CD9 are universally expressed, while others are only expressed in 
certain cells (Leung et al., 2011). 
Tspans are distinguished from other proteins by several motifs in the large 
extracellular loop (Seigneuret et al., 2001). Fig 1.6 shows simple Tspan 
structure (Seigneuret et al., 2001). There are two extracellular loops: a small 
and large extracellular loop (EC1 and EC2), containing 20–28 and 76–131 
amino acids, respectively (Seigneuret et al., 2001). The intracellular termini 
consist of a short N terminal and a typically longer C-terminal cytoplasmic 
domain (Boucheix and Rubinstein, 2001). The EC2 can be divided into two 
regions: the variable and the constant region. The constant region of EC2 
loop has 3 helices (A, B and E).  
 
Figure 1.6 Tspan protein structure. 
Tspan proteins are made of 4 transmembrane domains (TM), two extra-loops (large and 
small), and two intracellular domains (N-terminus NH2) and (C-terminus COOH). Adapted 
from Hemler, 2005. 
1.6.1 Extracellular loops of Tspans 
The EC2 is a variable domain that has a highly conserved Cys-Cys-Gly motif. 
The stability of Tspan structure is dependent on the formation of disulphide 
bridges by these Cys residues and others elsewhere in the EC2 
(Parthasarathy et al., 2009, Hemler, 2001). EC2 is considered an essential 
part of the protein for binding or association with partner proteins. For 
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example, Kazarov and co-workers have shown that CD151 can associate with 
α3β1 and α6β1, which plays a role in cell migration (Kazarov et al., 2002). 
Deletion of Gln-Arg-Asp 194–196 residues in the EC2 of CD151 leads to the 
blocking of cell migration. In another example, studies have shown that the 
deletion of Ser-Phe-Gln 173-175 residues from EC2 of CD9 in oocytes of the 
mouse leads to the blocking of sperm-egg fusion (Ha, 2004, Ellerman et al., 
2003). Furthermore, soluble recombinant EC2 domains of Tspans have also 
been used to interfere with interactions with other proteins (Takeda et al., 
2003, Parthasarathy et al., 2009, Yáñez-Mó et al., 2001). 
Masciopinto and co-workers have revealed the function of the EC1 region 
(Masciopinto et al., 2001). The deletion of EC1 of CD81 leads to a failure in 
the CD81 trafficking in the Golgi, and then decreased expression of CD81 on 
the cell surface (Masciopinto et al., 2001).  
1.6.2 Transmembrane domains of Tspans 
All Tspan molecules have 4 helices in the transmembrane domain (Hemler, 
2005). These helices are important for the facilitation of the Tspans interaction 
with their partner proteins in Tspan enriched microdomains (TEM) (Kashef et 
al., 2013). It has been demonstrated that the deletion of CD151EC2 did not 
inhibit co-localisation with other Tspans, including CD9, CD63 and CD8, 
suggesting that there is intramembrane interaction (Berditchevski, 2001).  
1.6.3 Palmitoylation sites 
The hydrophobicity of Tspan proteins is enhanced by palmitoylation (Hemler, 
2005). The intracellular side of all Tspan proteins have palmitic acid covalently 
linked to Cys residues during post-translational modification (Hemler, 2005). 
Many Tspan molecules have six conserved Cys that act as palmitoylation 
sites (Berditchevski, 2001, Kraus, 1991, Yang et al., 2002, Zhou et al., 2004, 
Seehafer et al., 1988). This modification is important to stabilise the Tspan 
structure (Yang et al., 2002). It has been demonstrated that palmitoylation can 
also contribute to the Tspan-Tspan interactions in the TEM and important in 
the rigidity of the protein (Charrin et al., 2002, Yang et al., 2004). Yang and 
colleagues have also shown that the deletion of palmitoylation sites from 
CD151 led to the reduction of the interaction between CD151, CD9 and 
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CD63, but not with α3β1 integrin (Yang et al., 2002). In another example, 
Charrin and co-workers demonstrated that the mutation of palmitoylation sites 
in CD9 reduced the association between CD9 and CD81 (Charrin et al., 
2002). 
1.6.4 Tspan enriched microdomains  
One of the main features of Tspan molecules is their capacity for interaction 
with other Tspan molecules and with other transmembrane proteins such as 
integrins, thereby acting as molecular coordinators to modulate the functional 
clustering of proteins in TEMs (Levy and Shoham, 2005, Charrin et al., 2002, 
Hemler, 2008). It has been shown that Tspans can bind with other proteins 
such as immunoglobulin superfamily members to form TEMs (Maecker et al., 
1997, Seigneuret et al., 2001). Furthermore, Suzuki et al have shown that 
Tspans can bind with other proteins in lipid rafts such as CD14 and TLR4 
proteins (Suzuki et al., 2009), as described in Fig 1.7. 
 
Figure 1.7 Interactions of Tspans with partner proteins. 
It simply shows the Tspan-Tspan and Tspan-partner interaction with different regions of 
Tspan. The red colour shows Tspans, partner immunoglobulin (orange) and integrin (pale 
blue) family members. Tspan-partner interactions (blue interactions). Adapted from Levy and 
Shoham, 2005.  
In addition, Hemler and Stipp have shown that many Tspans can bind with 
partners (Hemler, 2008, Stipp, 2010). It has been shown that Tspans can also 
co-localise with other Tspan molecules (Nydegger et al., 2006, Andreu and 
Yáñez-Mó, 2014). However, Zuidscherwoude and colleagues have used 
stimulated emission depletion microscopy, to show that CD37, CD81, CD82 
and CD53 are localised in separate clusters (Zuidscherwoude et al., 2015). 
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Tspan-partner protein interactions can be categorized into different groups 
depending on the strength of interaction (Yauch and Hemler, 2000, Kovalenko 
et al., 2007). Primary interactions are a direct interaction which is stable in 
strong detergents such as TritonX-100 (Kovalenko et al., 2007). Secondary 
interactions are indirect interactions, which lose stability in strong detergent 
(Charrin et al., 2002, Hemler, 2005).  
Tertiary interactions are likely to be indirect interactions which display stability 
only in some weak detergents such [3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulfonate] (CHAPS) (Tarrant et al., 2003). van 
Spriel and Figdor have shown that Tspans can modulate the function of 
pathogen recognition receptors (PRRs) and signalling of specific PRRs by 
their recruitment into TEMs, hence leading to immune activation or tolerance 
(van Spriel and Figdor, 2010).  
1.6.5 Other membrane proteins involved in MGC formation 
1.6.5.1 CD172α 
Signal regulator protein α (SIRPα or CD172α) plays a role in cell fusion 
(Galson and Roodman, 2011, Suparak et al., 2011). It is also known as 
macrophage fusion receptor (MFR) (Vignery, 2008). CD172α is a membrane 
glycoprotein that contains immunoglobulin superfamily domains (Gautam and 
Acharya, 2014). CD172α interacts with CD47 and CD44, other 
transmembrane glycoproteins (Saginario et al., 1998). Many studies have 
reported that these two membrane proteins have a role in the macrophage 
fusion process (Saginario et al., 1998, Suparak et al., 2011). The interaction 
between CD47 and CD172α is due to the variable IgV loop of an 
immunoglobulin domain that plays a role in the stabilisation of the plasma 
membrane (Beare et al., 2008). 
In addition, a role for CD172α has been demonstrated in osteoclast formation 
due to its interaction with CD47 (Koskinen et al., 2013). It has also been 
reported that the deletion of CD47 could inhibit CD172α signalling, blocking 




CD98 is a type 2 transmembrane protein, having a large glycosylated 
extracellular domain a short transmembrane domain and a cytoplasmic tail 
(Campbell and Ginsberg, 2004). CD98 is also called a fusion regulatory 
protein-1 that plays a role in humoral immunity and cancer progression, as 
reviewed by (Cantor and Ginsberg, 2012). Anti-CD98 antibody can enhance 
MGC formation in vitro without any other trigger (Okamoto et al., 2003b, 
Ohgimoto et al., 1995). The role of CD98 could be related to its interaction 
with other proteins (Higuchi et al., 1998, Ohgimoto et al., 1995). It has been 
shown that TEM on the surface of eggs includes ADAM3, integrins, CD9 and 
CD81, which are positive regulators of sperm-egg fusion (Takahashi et al., 
2001). 
1.6.5.3 ADAMs 
The disintegrin and metalloprotease domain (ADAM) membrane protein family 
have a role in ectodomain shedding, myoblast fusion, bacterial infection and 
inflammation (Huovila et al., 1996, Gonzales et al., 2004, Von et al., 2016). 
Several distinct protein domains are contained in ADAMs proteins. The 
prodomain, a domain with a similar sequence to snake venom 
metalloproteases; the transmembrane domain with a Cys-rich region which 
promotes membrane fusion and a disintegrin like domain (Huovila et al., 
1996). It has been reported that the fertilin-α fusion peptide from the 
transmembrane Cys-rich domain could induce myoblast fusion (Huovila et al., 
1996). Furthermore, it has been reported that ADAM9 and ADAM11 also have 
a potential role in fusion in monkey and mouse cell fusion induced by RANKL 
and anti-CD98 antibody (Namba et al., 2001).  
ADAM10 is expressed in many cell types and several tissues and is 
considered as a key regulator of cellular processes including shedding 
extracellular domains of transmembrane proteins, lymphocyte development 
reviewed in (Chaimowitz et al., 2012). Many studies have been reported that 
ADAM10 has a role in bacterial infection and MGC formation. For example, a 
role for ADAM10 in Staphylococcus aureus and P. aeruginosa infection has 
been demonstrated (Von et al., 2016, Reboud et al., 2017). It was observed 
that ADAM10 has a role in the control of the cytosolic Ca2+ concentration in 
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host cells, which is important to activate ExlA from P. aeruginosa on host cell-
cell junctions (Reboud et al., 2017). ExlA (Exolysin) is a pore-forming toxin in 
this bacterial species (Boukerb et al., 2015).  
Due to the liberation of the ectodomain from ADAM10 by the γ-secretase 
complex, the Notch Intracellular Domain (NICD) was released by this enzyme 
complex (Groot et al., 2014). Interestingly, due to ADAM10 interactions with 
other partners, several different human diseases and pathological processes 
are associated with ADAM10 dysregulation (Seals and Courtneidge, 2003, 
Haining et al., 2012, Ichiro et al., 2011, Von et al., 2016). For example, 
ADAM10 interacts with SAP97 and the clathrin adaptor molecule AP2, and 
these interactions are thought to regulate plasma membrane transport and 
internalisation (Elena et al., 2007).  
1.6.6 Functions of Tspans 
1.6.6.1 Tspans in adhesion and motility 
The role of many Tspans in cell-cell adhesion has been reported. For 
example, Yáñez-Mó et al have demonstrated that Tspan molecules are 
engaged in the adhesion between neighbouring skin cells (Yáñez-Mó et al., 
2001). Peter et al, and Dominguez-Bello and co-workers have demonstrated a 
role for Tspans in embryonic implantation (Peter, 2009), (Dominguez-Bello et 
al., 2010). Barreiro and colleagues have also observed the role of Tspans in 
adhesion and extravasation of leukocytes (Barreiro et al., 2005). In addition, 
the role of Tspans in membrane adhesion has been reported in a case with 
syncytia formation (Gordón-Alonso et al., 2006), and the same role in 
myotubes formation (Hemler, 2003). Tspan interactions with other proteins 
such as integrins could promote the control of cell motility and cell migration. 
These complex processes involve extracellular proteins, signalling molecules, 
the components of cytoskeletal and adhesion receptors (Boucheix and 
Rubinstein, 2001).  
1.6.6.2 Tspans in signalling 
Some studies have shown that TEMs play a role in intracellular signalling 
pathways. Delaguillaumie et al demonstrated that Tspan-28 (CD82) links the 
Rho-GTPase with the cytoskeleton (Delaguillaumie et al., 2002). Furthermore, 
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integrin partner Tspans including CD9, CD81, CD151 can interact with 
phosphatidylinositol 4-kinase and protein kinase C (Hemler, 2005). 
Immunoprecipitation tests showed direct associations between CD9, CD53, 
CD81, CD82 and CD151 with phosphatidylinositol 4-kinase protein (P-I4K) 
(Zhang et al., 2001). As shown in Fig 1.8, the role of Tspan molecules in cell 
processes requires interactions mediated by Tspan intra-cytoplasmic regions 
with the PDZ domains of as yet unknown intracellular proteins. For example, 
the intra-cytoplasmic regions of Tspans contribute to the activation of P-I4K to 
produce phosphatidylinositol-4, 5-bisphosphate (PtdIns (4, 5) P2), which is 
important to activate the SHCSRC-homology-2 domain-containing 
transforming protein  (Hemler, 2005). 
 
Figure 1.8 Tspans signalling at the cell membrane. 
It is likely to show the CD9, CD81, CD151 and CD82 are involved with different cell signalling 
pathway such as JNK, MAPK and Akt/PKB pathway. These pathways have a major role in 
cell processes such as cell fusion, apoptosis, cell motility and proliferation. Adapted from 
Hemler, 2005. 
1.6.6.3 Tspans in protein trafficking 
CD81 deletion in mice reduces the expression of CD19 at the B cell surface 
by 50%, and the CD19 glycosylation is also abnormal (Tsipi et al., 2003). 
Furthermore, it has also been shown that a defect in ER to Golgi complex 
trafficking causes the entire loss of CD19 on the surface of cells deficient in 
CD81 (Zelm et al., 2010). EWI-2 could also be controlled by CD81 (Stipp et 
al., 2003). Moreover, uroplakins UPIa and UPIb interact with their partner 
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proteins and are involved in biosynthetic maturation to form complexes. The 
trafficking of UPII and UPIII in ER to cell membrane can be regulated by this 
interaction (Tu et al., 2002). Furthermore, the interaction of CD63 with H+/K+-
ATPase promotes trafficking to the plasma membrane (Juan et al., 2005, Amy 
et al., 2003). 
In addition, the TspanC8 subfamily of Tspans (Tspan 5, Tspan-10, Tspan-14, 
Tspan-15, Tspan-17 and Tspan-33) have been shown to be involved in 
ADAM10 trafficking (Prox et al., 2012, Emmanuel et al., 2012, Haining et al., 
2012). ADAM10 expression is reduced by more than 50% from the surface of 
A549 cells following knock out of Tspan-15 (Haining et al., 2012).  
1.6.6.4 Tspans in bacterial infections 
1.6.6.4.1 Corynebacterium diphtheriae  
C. diphtheriae causes diphtheria and produces a cellular protein synthesis 
inhibitor called diphtheria toxin (DT) (Pappenheimer, 1977). Iwamo and co-
workers have shown that CD9 can indirectly interact with DT (Iwamoto et al., 
1994). CD9 can associate with pro-heparin-binding EGF-like growth factor 
(proHB-EGF), which is the direct receptor of DT (Mitamura et al., 1992). 
1.6.6.4.2 Uropathogenic Escherichia coli (UPEC) 
Tspan-20 and 21 are implicated in E. coli infection and adhesion (Wu et al., 
1996). Tspan-20 and 21 in the urinary tract epithelium can bind with fimbriated 
UPECE. coli (Wu et al., 1996), via FimH, a Type I fimbriae (Zhou et al., 2001, 
Bo et al., 2006). It has been demonstrated that CD63 is important in the 
internalisation of UPEC into vesicles within bladder epithelium cells (Bishop et 
al., 2007).  
1.6.6.4.3 Listeria monocytogenes 
L. monocytogenes is the causative agent of listeriosis (Gray and Killinger, 
1966). There have been studies indicating that Tspan molecules have a 
cooperative role in the attachment of L. monocytogenes to the surface of cells 
(Tham et al., 2010). L. monocytogenes needs CD81 for entry into epithelial 
cells (Tham et al., 2010). It was also observed that CD9, CD63 and CD81 
were recruited to bacterial uptake sites on host cells (Pizarro-Cerdá et al., 
2010). CD81 knockdown (KD) was found to inhibit bacterial uptake and could 
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block the type II phosphatidylinositol-4-kinase activation that is important in 
bacterium uptake (Pizarro-Cerdá et al., 2010).  
1.6.6.4.4 Chlamydia trachomatis 
C. trachomatis is an intracellular bacterium, the causative agent of sexually 
transmitted infections and trachoma (Peeling and Brunham, 1996). CD63 
plays a role in Chlamydia infection (Beatty, 2006). It was found that CD63 can 
mobilise from multi-vesicular bodies and then be recruited into inclusion 
bodies of Chlamydia (Beatty, 2006). CD63KD or anti-CD63 antibody 
treatment affects this trafficking, leading to inhibition of C. trachomatis growth 
in host cells (Beatty, 2006, Beatty and Immunity, 2008). 
1.6.6.4.5 Role of Tspans in other bacterial species  
Green et al. have shown that CD9, CD63 and CD151 are facilitators of 
adhesion of S. pneumoniae, E. coli, Neisseria meningitidis, Neisseria 
lactamica and S. aureus on the host cells (Green et al., 2011). In published 
studies, members of my laboratory group have shown that CD9 and CD81 
have positive effects on invasion and localization of S. typhimurium 
NCTC12023 (Hassuna et al., 2017). Our lab showed that recombinant soluble 
EC2 of CD9, CD81 and CD63 had no effects on B. thailandensis infection, 
while the CD9KO in a mouse cell line reduced B. thailandensis uptake in the 
early stages of infection (Elgawidi, 2016). Ultimately, these studies have 
shown that bacterial colonisation and invasion of host cells can require the 
microdomain of Tspan molecules. However, these cooperative roles of Tspan 
molecules in bacterial infection needs further investigations to understand the 
specific roles of these proteins. 
1.6.6.5 Tspans and MGC formation 
Tspan molecules have a role in some types of cell fusion including MGC, 
myoblast fusion, virus syncytium and sperm-egg fusion. Part of this project will 
be focused on the involvement of Tspan molecules in the formation of MGC in 
response to infection. 
1.6.6.5.1 CD9 
The involvement of CD9 in MGC formation has been widely studied. CD9 in 
mice has a positive role in fertility, demonstrated using CD9KO (Kaji et al., 
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2000, Le Naour et al., 2000). Interestingly, the CD9KO seems to have a 
positive effect on the fusion of myoblasts (Charrin et al., 2013). CD9 antibody 
also have been found to have a positive effect on human monocyte fusion, 
causing an increased number of nuclei in MGC (Charrin et al., 2013). 
CD9 is associated with many membrane proteins linked to fusion, such as 
CD47, CD44, and CD36 scavenger receptor, MMP-9, EWI-2 and DC-STAMP 
(Longhurst et al., 1999, Dirk-Steffen et al., 2004, Yashiro-Ohtani et al., 2000, 
Huang et al., 2011, Herr et al., 2013, Stipp and Kolesnikova, 2001). Garner 
and et al have also found that CD9KD in human kidney cell lines reduced 
80% of E-cadherin protein that has a role in cell fusion (Garner et al., 2016). 
In contrast, Mirkina and colleagues have found that the CD63KD caused the 
up-regulation of E-cadherin, and the down-regulation of β-catenin, which has 
a role in cell fusion (Mirkina et al., 2014). CD9 interaction with other fusion 
molecules makes it difficult to identify the specific role of CD9 in MGC 
formation. In addition, Takeda and co-workers have shown that the 
expression of CD9 is down-regulated when the monocytes are cultured under 
fusogenic conditions, but that CD63 is up-regulated in MGC formation under 
the same condition (Takeda et al., 2003). 
In addition, in previous publications by our group have revealed that soluble 
recombinant EC2 domains can inhibit giant cell formation from human 
monocytes or macrophages (Parthasarathy et al., 2009, Hulme et al., 2014). 
Furthermore, recombinant EC2 of CD9 inhibits MGC formation (Takeda et al., 
2003). In previous publications, members of my laboratory have demonstrated 
that constant regions from the large extracellular loop of CD9 can affect the 
formation of MGC. Recombinant CD9 chimeric EC2 protein and point mutants 
have been used to map the specific regions of the CD9EC2 which have the 
negative effect on MGC formation (Parthasarathy et al., 2009, Hulme et al., 
2014). Interestingly, our research team have observed that CD9KO enhances 
MGC formation in a mouse macrophages cell line infected with B. 
thailandensis (Elgawidi, 2016). It was speculated that the deletion of CD9 




CD81 is also involved in MGC formation (Parthasarathy et al., 2009, Hulme et 
al., 2014). CD81 is also associated with partner proteins such as CD36 (Yount 
et al., 2013) and EWI-2 (Mónica et al., 2006). CD81 is also involved in MGC 
formation and may have a similar role to CD9 in fertility (Eric et al., 2006). 
Wang and Pfenninger demonstrated that CD81 can associate with MFR, 
when bound with CD47 and could generate TEMs (Wang and Pfenninger, 
2006). EWI-2 is also associated with many Tspan molecules such as CD9, 
CD81, CD82 and CD151 (Xin et al., 2003, Charrin et al., 2013).  
1.6.6.5.3 CD151 
Many studies have reported that CD151 is involved in cell fusion. For 
example, Ziyyat and co-workers noted that sperm-egg fusion could be 
reduced by using anti-CD151 antibody (Ziyyat et al., 2006). In addition, 
CD151 is involved in cell regulation processes (Hong et al., 2006). For 
example, overexpression of CD151 can increase MMP-9 production and 
enhance cell motility (Hong et al., 2006). CD151 can also control β1 integrin 
trafficking, demonstrated using deletion of CD151 in mouse embryonic 
fibroblasts that resulted in increased cellular migration due to integrin cycling 
arrest (Li et al., 2007). 
1.6.6.5.4 Other Tspans involved in MGC formation 
Tspan-2 can interact with CD9, CD81 (Hemler, 2008, Nobuo et al., 2002, 
Yaseen et al., 2017). Tspan-2 has a high sequence identity to CD9 and CD81 
(Nobuo et al., 2002). Tspan-5 and Tspan-13 are implicated in many cell 
functions, for example in cell fusion and metastasis of breast cancer (Iwai et 
al., 2007, Arencibia et al., 2009, Sala-Valdés et al., 2012). It has been shown 
that Tspan-13 plays a negative role in osteoclast formation, but that Tspan-5 
has a positive role in osteoclast formation induced by RANKL (Iwai et al., 
2007). Tspan-15 can regulate TspanC8 and ADAM10 expression (Haining et 
al., 2012). Interestingly, it has been shown that ADAM10 expression was 
reduced around 50% in Tspan-15KO A549 cells when compared with WT 
A549 cells (Jouannet et al., 2016, Haining et al., 2012). 
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1.7 The hypothesis and aims of the study 
Previous studies suggest that Tspans are involved in MGC formation and may 
have indirect roles in MGC formation by affecting partner proteins that form 
TEM. B. thailandensis can induce MGC formation and is an alternative model 
of the causative agent of melioidosis, B. pseudomallei. We hypothesise that 
Tspans and Tspan-partner molecules are involved in MGC formation induced 
by B. thailandensis. Secondly, we hypothesise that the disruption of TEM by 
Tspan-related reagents could inhibit the adhesion or invasion of host cells by 
B. thailandensis and/or the formation of MGC, and thus prevent infection and 
fusion. 
Overall aim: to investigate the roles of all human and mouse Tspans in 
infection by B. thailandensis and the resulting MGC formation in macrophages 
and lung epithelial cells. 
Specific aims: 
 To systemically investigate changes in Tspan and Tspan-partner genes 
expression in response to B. thailandensis infection, using real-time 
qPCR. 
 To validate changes in gene expression at the protein level. 
 To validate roles of selected Tspan molecules and partner proteins in 
MGC formation or/and bacterial infection, using KOs and KDs of Tspans 
and Tspan-partners in human lung epithelial cells.  





Chapter 2 Materials and methods 
2.1 Materials 
2.1.1 Reagents and buffers 
The reagents and buffer solutions were prepared according to the 
manufacturers’ instructions and other resources (Roskams and Mellick, 2002, 
Lausted et al., 2004, Wilson and Corlett, 2005). Sterile distilled water (dH2O) 
was used throughout the project unless otherwise stated. Bacteria culture 
media, buffers, glassware, tips and reagents were sterilised by autoclaving at 
121°C for 20min. Stock solutions were autoclave-sterilised, and antibiotics 
were filtered using 0.2µm filter units. The following tables summarise the 
reagents, buffer solutions and other materials used in this project. Buffers and 
reagents used in this study are listed in Table 2.1. 
Table 2.1 Buffers and reagent solutions. 
Buffer/reagent Preparation 
TAE 50X (1l) 57.1ml glacial acetic acid, 242.2g Tris base, and 100ml 
0.5M EDTA pH8 
DNA loading dye 
6X (100ml) 
10mg bromophenol blue and 60g glycerol, 12ml 0.5M 
EDTA pH 8 
RF1  100mM KCl, 61.1mM MnCl2, 30mM CH3CO2K,  
10mM CaCl2, 15% (w/v) glycerol were dissolved in 
distilled water/the pH was 5.8 with 0.2M acetic acid. The 
components were filter sterilised through a 0.22μm 
membrane, and stored at 4°C. 
RF2 Solution A: -0.5 M MOPS (4-morpholinepopanesulfonic 
acid)  
Solution B: 10mM KCl, 75mM CaCl2, 15% (w/v) glycerol, 
RF2 solution was prepared fresh (0.2ml of Solution A to 




400mg SRB sodium salt (Sigma), 100ml 1% acetic acid 
10mM (1X) PBS, 0.26g KH2PO4, 2.17g Na2HPO4-7H20, 8.71g NaCl, 800ml 
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0.1% sodium azide, 0.1% BSA in HBSS with Mg2+ and 
Ca2+ ions. 
Cell lysis buffer 
(mammalian) 
1% TritonX-100 in PBS 
Freezing mixture 
(bacterial cells) 









divalent Mg and 
Ca elements 
5.4mM KCl, 0.3mM Na2HPO4, 0.4mM KH2HPO4, 4.2mM 
NaHCO3, 1.3mM CaCl2, 0.5mM MgCl2, 0.6mM MgSO4, 
137mM NaCl, 5.6mM D-glucose, 0.02% (w/v) phenol red 




10% of Giemsa solution in 1x PBS 
Acid/ethanol  5% acetic acid (v/v), 5% dH₂O, 90% ethanol (v/v) 
Trypsin/EDTA 
solution 10X 
Prepared in sterile HBSS (see above): 0.25% (w/v) 
trypsin, 0.2% (w/v) EDTA (Sigma) 
10x phosphate-
buffered saline 
80g NaCl, 2g KCl, 11.5g Na₂HPO₄, 2g KH₂PO₄ dissolved 
in 1l H2O 
Paraformaldehyd
e solution 4% 
4g paraformaldehyde was added to 50ml of dH20 and 1ml 
1M NaOH. The mixture was placed in a glass beaker, 
then the beaker was placed in a water bath for 1hr at 
60°C, then 10ml of 10x PBS with pH 7.4 was added. 
Finally, the volume was made up to 100ml using dH2O. 
The prepared solution was cooled and filtered and was 







2.1.2 Bacterial growth media 
Table 2.2 Bacterial growth media. 
Medium Preparation 
LB (Lysogeny Broth) 
(1l) 
10g tryptone, 5g yeast extract, 10g NaCl. LB agar 
prepared with the same recipe with an additional 15g 
agar to make up to 1l medium 
SOC (Super optimal 
broth) (1l) 
20g tryptone, 5g yeast extract, 0.5g NaCl, 0.186g KCl, 
0.952g MgCl2 in dH2O 
M9 Minimal Agar 0.5g glucose and 1.5g agar were dissolved in 90ml 
H₂O, autoclaved then 10ml M9 salts, 0.1ml 1M 
MgSO₄7H₂O, 0.1ml 0.1M CaCl₂ (sterile) were added 
Iso-Sensitest Broth 
(IST) 
It was prepared by dissolving 21.4g IST powder in 1l 
dH2O. Agar was added to 1.5% (w/v) 
Brain-Heart Infusion 
Broth (BHI) 
37g of BHI powder in 1l ddH2O 
 
2.1.3 Antibiotics 
Table 2.3 Antibiotics with working concentrations. 
Antibiotic Concentration (µg/ml) 
Amikacin 500  
Kanamycin 500  
Chloramphenicol 34-50  
Neomycin (G418) 250-1000  
Ampicillin 50-100  
Penicillin/Streptomycin 10 units/100  
Tetracycline 12.5  
Hygromycin  250-500 




2.1.4 Bacterial strains 
Table 2.4 Bacterial species and their intended use. 
 
2.1.5 Plasmids 




Human Tspan-2GFP expression construct, OriGene 
MG226288 (CD9GFP) Mouse CD9GFP expression construct, OriGene 
pEGFP-N2 Mammalian GFP expression construct, Clonetech 
pBBR1MCS  Bacterial broad host range cloning vector, (CmR)  
pSHAFT-GFP Containing GFP cloned between HindIII and PstI, 
(AmpR)  
ptetmcCherry_prey-2 Containing mcCherry cloned between HindIII and 
xhoI, (CmR) 
pEX18Tp-pheS -tssk  pEX18Tp-pheS containing tssk cloned between 
Acc65I and BamHI (TmpR) 
pBBR1MCS-mcCherry pBBR1MCS containing mcCherry cloned between 
HindIII and XhoI, (CmR)  
pBBR1MCS-GFP pBBR1MCS containing GFP cloned between HindIII 
and PstI, (CmR)  
Bacterium Description/Source  
E. coli SM10λpir Dr Mark Thomas at the University of Sheffield, UK, 
Department of Infection and immunity and 
Cardiovascular Disease 
E. coli S17λ 
E. coli JM83 
E. coli DH5α  Life technologies 
B. thailandensis E264 Soil isolates obtained from a rice field in central 
Thailand (Brett et al. 1998) 
B. thailandensis  E264-
ΔtssK 
E264 with a markerless in-frame deletion of 




This strain is a clinical isolate and was obtained 
from the patient (Glass et al. 2006) 
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2.1.6 Primers and siRNA 
NCBI Blast (www.ncbi.nlm.nih.gov/tools/primer-blast) was used to design all 
the primers. The parameters, which were used to all primers design, are 
exon-exon junction targeting, length of PCR product between 50 to 150bp and 
GC ratio at least 50% from all primers. All of the primers were purchased from 
Thermofisher. The primers were dissolved in TE buffer at 100μM and stored 
at -20°C. 
2.1.6.1 Tspan primers 
Table 2.6 Primer sequences used to investigate Tspan genes 
expression. 
Tspan Human primers  Mouse Primers  




Tspan-2 F 5’AAGGGGGTAGCTATCCGACA 
R 5’ TGGACCTGTTCGGAGCTTTC 
F CCATCATCTTCGGCGGCATC 
R TACAGCCCCACATAGAAATACTCT 




















































Tspan-16 F GAAATGACAACGGGCCACAC 
R AACAGCCCTTCTGGTGGATG 
not accessible in database 








Tspan-19 F ACGCAGCATTTCAGGGACTG 
RGTCCAAGAACCAAGAAAGCTCC 
not accessible in database  






















CD53 F TTTTACACAAATAGCCCCGGA 
R ATTCTTGCCCTTTTCCAGGCA 
F GTGGCTGAGGGTCTGAATGA  
R ACTGCAGTTGTGTCTGGATGA 









































2.1.6.2 Other transmembrane proteins primer 
Table 2.7 Primer sequences used to investigate Tspan-partner genes 
expression. 
Name  Human Primers Mouse Primers 














































2.1.6.3 Primers of some regulatory proteins 
Table 2.8 Primer sequences used to investigate gene expression. 
 
2.1.6.4 Sequence of Smart Pool Accell siRNA 
Table 2.9 Smart Pool Accell siRNA sequences. 
siRNA Sequence 















Tspan-2 siRNA, Dharmacon 





Non-targeting siRNA, Dharmacon 











































2.1.7 Equipment and apparatus 
Table 2.10 Equipment 
Equipment and apparatus Manufacturer  
Electroporator Bio-Rad (Gene pluserRII) 
Bench centrifuge Sigma (SciQuip)  
Microscopes light Olympus (CK40-SLP) 
Nikon (MAZUREK) 
Nikon A1+ Confocal imaging system 
FACS Attune  Applied Biosystems Inc. (BD) 
FACS LSRII Applied Biosystems Inc (BD) 
Spectrophotometer Bio-Rad (S2000 UV/VIS) Diode-array 
NanoDrop lite  Thermo Scientific (6VDC-18W) 
Sensitive balance Swiss Quality (Precisa 125A) 
Thermocycler G-STORM 
Incubators  BIOHIT 
LTE laboratory thermal equipment 
LTD 
Class I Microbiological Safety 
Cabinet 
WALKER 
Class II Microbiological safety 
Cabinet  
BioMAT² 
LT-4000 Microplate Reader Labtech 
7900HT Fast real-Time PCR Applied Biosystems AbiPrism 
sequence 
 
2.1.8 Analysis software 
Table 2.11Software 
Programme Comment  




Statistical and graphical analysis 
Source:  
http://www.graphpad.com/scientific-software/prism/ 
Image J Calculation of number of nuclei per giant cell; image 
manipulation 
Source: http://imagej.nih.gov/ij/ 
SnapGene Viewer Plasmid gene map viewer 
Source: 
http://www.snapgene.com/products/snapgene_viewer/ 
Cell Quest Pro 
Flow cytometry 
software 
Data acquisition and analysis 




The primary and secondary antibodies and isotype controls used for 
immunofluorescent studies, fusion and infection assays are summarised in 
the following tables. 
2.1.9.1 Primary antibodies and isotypes 
Table 2.12 Primary antibodies and isotypes. 

































Tspan-11 Human 10 Mouse 
IgG1 



















































2.1.9.2 Secondary antibodies 
Table 2.13 Secondary antibodies 
Antibody Target  Specificity  Conc. Source  
anti-mouse IgG Mouse IgG FITC 1:300 Sigma 
anti-rabbit IgG rabbit IgG FITC 1:300 Sigma 
anti-Goat IgG Goat IgG FITC 1:300 Sigma 
 
2.1.10 Mammalian cell lines 
Two cell lines were used, A549 human lung epithelial cells and J774.2 mouse 
macrophage/monocyte cells. Both cells are commonly used as models to 
study the interaction of the bacterium with a host cell. A549 cells were 
obtained from the European Collection of Authenticated Cell Cultures 
(ECACC) and other cell lines from laboratories, as indicated in Table 2.14. All 
of them were grown under same conditions at 37ºC with 5% CO2, and the 
media (from Gibco) were supplemented with 10% FCS with 




Table 2.14 Mammalian cell lines. 
















(4.5g/l) DMEM with 




















(Yaseen,  2017) 
Used for fusion, 
infection and 
functional studies 
as a control 
Human lung 
adenocarcinoma A549 
















Dr David Blake, 
Department of 
Biology at Fort 
Lewis College 





cell line J774.2 
High glucose 
(4.5g/l) DMEM  







CD9 overexpression  
High glucose 
(4.5g/l) DMEM with 
G418 antibiotics 
Dr Fawwaz Ali, 
University of 
Sheffield, made 
in house (Ali, 
2016) 





cell line J774.2-GFP 
High glucose 
(4.5g/l) DMEM with 
G418 antibiotics 
Dr Fawwaz Ali, 
Univ of Sheffield, 
made in house 
(Ali, 2016) 
Used for fusion, 
infection, and 
functional studies 




2.2.1 Bacteriological techniques 
2.2.1.1 Bacterial glycerol stocks 
Bacteria were incubated overnight in LB broth at 37°C in a shaking incubator. 
850µl bacterial culture was added to 150µl of sterile glycerol in a cryovial 
tube. The final concentration of bacteria was about 85%. The mixture was 
transferred into labelled cryovial tubes, and then the bacterial cells were 
mixed gently with glycerol and made aliquots. Finally, tubes were stored at -
80°C. 
2.2.1.2 Estimation of viable bacteria 
The relationship between numbers of living bacteria and optical density 
(OD600) was evaluated using viable count and optical density at different time 
points (0, 2, 4, 6, 8 and 24hr). The number of bacteria were determined 
according to colony-forming units (CFU) and OD600 at different time points (0, 
2, 4, 6 and 8 hr). The number of bacterial cells were approximately 1x108 per 
ml at OD600 0.4. All the following assays in this study were used at OD600 0.4 
to determine multiplicity of infection (MOI). 
2.2.1.3 Preparation of competent cells 
Hanrahans’ method was used to prepare E. coli to take genetic materials 
(Sambrook and Russell, 2006). Briefly, E. coli strains were grown for 24hr and 
a single colony was inoculated in 50ml of appropriate media at 37°C in 
shaking incubator. Typically, bacteria were grown to reach an OD600 0.4-0.5 
and then placed on ice for 20min. The culture was centrifuged at 4000xg for 
10min. The pellet was gently resuspended in 16ml of RF1 and then placed on 
ice for 30min. The cell suspension was centrifuged again at 4000xg for 10min 
and discarded the supernatant. The pellet was gently resuspended with 4ml of 
RF2 solution. The bacteria were placed on ice for 20min and were kept as 
200-400μl aliquots in microcentrifuge tubes. Competent cells were stored 
indefinitely at -80°C, and could be used immediately.  
2.2.1.4 Plasmid extraction and purification 
A miniprep kit from QIAGEN (QIAGEN Plasmid Mini Kit) was used, and the 
protocol was followed as the manufacturer's instructions. Briefly, 10ml LB 
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medium containing antibiotics was inoculated by a single colony of bacteria 
and was grown in shaking incubator for 18hr at 37°C. Bacteria culture was 
centrifuged at 4000xg for 10min at 4°C. The supernatant was discarded, and 
the pellet was re-suspended with 250µl of a resuspension buffer (P1), and 
there were no cells clump in a cell pellet. Lysis buffer (P2) was added and 
mixed thoroughly by inverting the sealed tube 4-6 times. After 3-5min, the 
mixture should be vicious and slightly clear. The neutralization buffer (N3) 
buffer 350µl was added and gently inverted 4-6 times. The mixture was 
centrifuged at 13,000xg for 10min at 4ºC and the supernatant containing the 
plasmid. 800µl of supernatant was taken and put in spin column tube, and 
then spent down 1min 13000xg. 500µl of binding buffer was added and 
centrifuged at 13,000xg for 1min at 4ºC. Then, 750µl of a wash buffer (PE) 
buffer was added to wash the DNA. Finally, the DNA was dissolved using 50µl 
Tris:EDTA (TE) buffer in the collection tube. The yield was quantified using a 
NanoDrop lite (Thermo) UV spectrophotometer at 260nm. 
2.2.1.5 Agarose gel electrophoresis 
This method was used for the separation of DNA molecules based on their 
size. 0.8-1.5g/ml of agarose (Fisher Scientific) was dissolved in tris base, 
acetic acid and EDTA (TAE) buffer by boiling in a microwave. The volume of 
the gel was between 100ml and 200ml according to a number of samples. 
The agarose solution was left in room temperature to allow to cool around 
55°C, and then the GelRed stain was added 5µl per each 100µl of agarose 
gel to stain the DNA fragments in agarose gel. A suitable comb was placed 
into a gel cast before pouring. The comb was removed after 30min to set, and 
the gel was transferred to an electrophoresis tank and the position of wells at 
the cathode end. TAE buffer was covered a gel cast. Typically, 1μl of 6X DNA 
gel loading dye (Thermo) and 5μl of samples were mixed before loading in the 
gel. DNA ladder was loaded with a suitable volume recommended by the 
manufacturer. Depending on the gel size, the gel was electrophoresed at 80-
120V for 45-60min. To visualise the DNA pieces, the UV transilluminator was 
used an EDAS 290 imaging system (Kodak). 
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2.2.1.5.1 Gene cloning strategy  
Gene cloning was used to insert DNA fragments encoding (mCherry and GFP 
proteins) in an appropriate vector for B. thailandensis, pBBR1MCS. The 
ptetmcCherry_prey-2 and pSHAFT-GFP vectors were used to take the 
mCherry and GFP fragments, respectively. These fragments were taken and 
inserted in broad host vector (pBBR1MCS), as shown in Appendix Fig 1. 
2.2.1.5.2 Restriction digestion 
DNA restriction digestion was carried out according to manufacturer’s 
(Promega) instructions in a volume of 30μl. DNA segments were purified by 
either GeneJET PCR purification to remove all contaminating enzymes and 
other molecules, or after separation on agarose gels and using the QIAquick 
Gel Extraction Kit Prior. The restriction digestion components were used as 
following: 
Table 2.15 Restriction digestion components. 
Materials  Sample  
Vector DNA  1µg 
Restriction enzyme 1µl 
An appropriate buffer 10x 6µl 
10x BSA 3µl 
Nuclease-free water To reach 30μl 
 
2.2.1.5.3 Gel extraction 
QIAquick Gel Extraction Kit was used to extract appropriate fragments of 
DNA, according to the manufacturer’s instructions. After DNA electrophoresis, 
the samples were illuminated using UV. Depending on size, DNA fragments 
were taken from the agarose using a sterile scalpel and transferred into a 
microcentrifuge tube for weighing. 3 volumes of buffer QG was added for 
each 1 volume of gel, and then samples were dissolved in a 60°C using a 
heater with vortexing. After dissolving the gel slice, the solution was added to 
a spin column and centrifuged at 13000xg for 1min. 750μl of buffer PE was 
added to the column to wash and then was centrifuged at max speed for 1min 
to remove all debris. The fragment of DNA was eluted using 30μl of water into 
a clean microcentrifuge tube.  
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2.2.1.5.4 Ligation  
After restriction enzyme digestion, the vectors and fragments were quantified 
using a NanoDrop 2000 (Thermo) UV spectrophotometer at 260nm. For 
ligation of DNA fragments, T4 DNA ligase enzyme (purchased from Promega) 
was used as manufacturer’s instructions. The ratio was used around 3 insert 
DNA to 1 vector DNA with a total volume of ligation mixture of 30μl. Two 
negative controls were used to assess the ligation efficiency: a vector control 
with no ligase enzyme, and a ligation control with no insert DNA. Finally, 
these components were incubated overnight at 16°C. The ligation 
components were used as following: 
Table 2.16 Ligation components 
Materials  Sample  no ligase No-insert 
DNA 
Vector DNA  (25ng) (25ng) (25ng) 
Insert DNA  (75ng) (75ng) - 
Ligase buffer 1μl 1μl 1μl 
DNA ligase 1μl - 1μl 




2.2.1.5.5 2 Bacterial transformation 
E. coli SM10 (λpir) and S17λ competent bacteria were used to transform the 
genetic materials into a heat-shock protocol. These bacteria were thawed on 
ice, and 1-2µl of a solution, containing more than 200-300 DNA, was mixed 
gently with 25µl of competent cells. The mixture was chilled on ice for 20-
30min, and then the bacteria were shocked by placing the tube into a 42ºC 
water bath for 80sec. The microcentrifuge tube was placed back on the ice for 
2-5min. 750µl of LB medium was added to the mixture and left in a shaking 
incubator at 37ºC for 2hr. 50µl of the mixture was plated on LB agar which 
has selective antibiotic marker chloramphenicol. 
2.2.1.5.6 Conjugation  
The plasmid DNA was introduced to B. thailandensis using bacterial 
conjugation. This was accomplished using SM10 (λpir) and S17λ competent 
cells with the self-transmissible plasmid RP4 integrated into the chromosome. 
10ml overnight cultures of SM10 (donor) and B. thailandensis (recipient) were 
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prepared. 1ml from each bacterium into microcentrifuge tubes were taken 
from overnight cultures and centrifuged at 13000xg for 5min. The pelleted 
cells were washed by resuspension in 1ml of 0.85% (w/v) normal saline. The 
cells were centrifuged again at 13000xg for 5min, and the supernatant was 
discarded, and then the pellet was re-suspended in 100μl of 0.85% (w/v) 
saline.  
50μl of donor and recipient cells were added to a new microcentrifuge tube 
and mixed gently. 25mm circular nitrocellulose filter membranes with a pore 
size of 0.45μm were placed on LB agar plates with sterile forceps. The cell 
mixture was then dropped onto the nitrocellulose membranes. The plates with 
the inoculated nitrocellulose filters were then incubated at 37°C for 18hr 
before the cells were recovered. The nitrocellulose filters were transferred into 
25ml universal tubes with 4ml of 0.85% saline on the following day. The 
suspension was plated in medium with a selective antibiotic for recipient cells. 
This method was used for the transfer of GFP and mCherry plasmids.  
2.2.1.6 B. thailandensis mutant strain production by allelic replacement 
Jamie Hall at the University of Sheffield, UK, Department of Infection and 
immunity and Cardiovascular Disease, generated B. thailandensis E264-
ΔtssK strain (Hall, 2016) according to Barrett’s method (Barrett et al., 2008). 
The suicide pEX18Tp-pheS plasmid was applied to insert the guide of tssk. 
The first recombination used a trimethoprim resistance gene as a selective 
marker for plasmid delivery into the chromosome. The second recombination 
was detected by growth on plates, which contain p-chlorophenylalanine 
(cPhe). In the presence of cPhe, this plasmid caused cell death in 
B.thailandensis. 
After insertion of the deleted gene of tssk into pEX18Tp-pheS, the plasmid 
was transformed into an E. coli SM10λpir strain and then transferred into B. 
thailandensis E264 by conjugation as mentioned in section 2.2.1.5.5. As 
above, the first recombination was detected using the selection on plates 
containing trimethoprim. Then every single colony was streaked on the agar 
with 0.1% (w/v) cPhe to select cross recombination which confirmed the loss 
of plasmid from mutant and the wild type bacteria. Genomic DNA was 
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prepared from every single colony to confirm the deletion of the allele using 
colony PCR with primers flanking the original cloned region. 
2.2.1.7 DNA sequencing 
Samples of plasmids were purified by the miniprep technique. Plasmid DNA 
concentration was around 100ng/µl and forward and reverse primers. An 
applied Biosystems' 3730 DNA analyser and Big Dye 3.1 sequencing kits 
were used in the DNA sequencing service at Genomics Core Facility, the 
University of Sheffield, UK. All data was analysed by SnapGene viewer 
program. 
2.2.2 Tissue culture techniques 
All experimental work in tissue culture was carried out in Class I and Class II 
laminar flow hoods (BioMAT).  
2.2.2.1 Culturing of J774.2 cells 
The cells were cultured in DMEM with 10% FBS. When the cells were 
confluent, the medium was discarded, and the cells washed in 5ml HBSS. 
The adherent cells were harvested using 25mm a cell scraper with 5ml HBSS, 
then all harvested cell suspensions were placed in 5ml fresh medium. The 
cells were centrifuged at 200xg for 5min, and then the media was discarded, 
and the pellet mixed with 5ml fresh medium. Finally, the cells were split 
1:14ml fresh medium. 
2.2.2.2 Culturing of A549 cells 
The incubation conditions were at 37ºC in 5% CO2. The harvesting of A549 
cells was carried out using trypsinisation. After discarding the medium, the 
cells were washed with 5ml HBSS to remove all traces of serum. Then 3ml 1x 
Trypsin/EDTA (Lonza) was added and incubated for 6-8min. 7ml of DMEM 
medium containing serum was added and re-suspended by gentle aspiration. 
The pellet was centrifuged at 200xg for 5min. 5ml media was added to the 
pellet and re-suspended with complete media. Then cells were counted using 
a haemocytometer, and an appropriate number of cells were used for seeding 
for the next experiments. The cells were split 1ml:14ml fresh medium.  
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2.2.2.3 Cell freezing 
The confluent cells which reached 85-90% density were harvested and 
counted using a haemocytometer. The harvested cells were centrifuged at 
200xg for 5min, then the supernatant was removed and the pellet was re-
suspended with freezing medium (as mentioned in 2.3) at 1-2x106 cells/ml. 
1ml of cells was transferred to each cryovial tube, and then the vials were 
transferred to freezing plug-in liquid nitrogen for 2-3hr. Finally, the vials were 
stored in liquid nitrogen. All vials are labelled with the date of freezing and 
name of cells.  
2.2.2.4 Cell thawing 
The cryovial was taken from a liquid nitrogen dewar and was shaken under 
warm water until the contents became semisolid. To avoid contamination, the 
outside of the cryovial was dried off and wiped with a 70% ethanol solution 
before opening. The cells were transferred quickly to a universal tube with 9ml 
fresh medium, and were centrifuged at 200xg for 5min. The supernatant was 
removed, and the pellet was re-suspended with 10ml complete medium, and 
then placed in a new flask.  
2.2.2.5 Viability of cells 
After harvesting, the cell suspension was transferred to a haemocytometer 
counting chamber. Viability of cells was measured by adding 0.5ml of 0.2% 
trypan blue and 0.5ml of cell suspension to a tube. These were gently mixed 
after standing for 5min, and then loaded into the haemocytometer. Dead cells 
were stained with the blue dye, whereas live cells did not stain with trypan 
blue. 
2.2.2.6 Sulforhodamine B assay 
A549 and J774.2 cells were used to inverstigate the effects of CD9 peptide 
8005 and control on cell numbers in tissue culture 96-well plates. The 
colourimetric sulforhodamine B dye method was carried out according to 
(Vanicha and Kanyawim, 2006). Overnight incubation of 96 well plates with 
1x104 cells per well in 100ul at 37°C in 5% CO2. The plates were washed 3 
times in 1x PBS and fixed with 50μl of trichloroacetic acid (TCA) at 4ºC for 
1hr. The plates were washed thoroughly using water and kept inverted on 
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tissue paper to dry. 100μl 0.4% SRB dye was added to each well for 45min 
with shaking at room temperature. The plates were washed with dH2O and 
then added 1% acetic acid and air-dried. Then 50μl of 10mM unbuffered Tris 
was added per well for the solubilisation of SRB dye, and incubated at room 
temperature with gentle shaking for 5min. A LT-4000 microplate reader at 
570nm was used to measure absorbance.  
2.2.2.7 Cytotoxicity assays–MTT 
Cells were seeded of 1x105 cell/ml in a flat bottomed 96-well tissue culture 
plate in 100μl complete media (DMEM + 10% FBS) per well and incubated at 
37°C, 5% CO2 for 24hr to allow the cells to attach to the wells. The media was 
gently aspirated with a multi-channel pipette and washed 2x with 100μl HBSS. 
The bacteria were prepared at different MOI (1, 3, 5, 10 and 100) in DMEM 
+1% FBS. The cells were infected by adding 100μl from each MOI to 8 
replicate wells. There were also 2 controls: no treatment positive cell death 
(with 1% TritonX-100), and only media without cells. After incubation for 2hr at 
37°C in 5% CO2, the bacteria were removed using a multichannel pipette and 
washed 2x with HBSS. The media was replaced with DMEM +1% FBS with 
500µg/ml kanamycin and amikacin to kill all outside bacterial and incubated 
for 16hr at 37°C in 5% CO2. The cells were washed 2x with HBSS. MTT 
(Sigma M5655) was prepared at 0.5mg/ml in medium without FBS, and 100μl 
added to each well. After 3hr of incubation at 37°C in 5% CO2 in the dark, the 
media was gently aspirated and washed again with HBSS one time. Finally, 
100μl DMSO was added to each well and left at room temperature for 1hr to 
solubilise in the dark. A LT-4000 microplate reader was used to measure 
absorbance at 540nm.  
2.2.2.8 Assessment of protein level by flow cytometry 
Tspans and partner protein expression in J774.2 macrophages and A549 
cells were measured using flow cytometry. WT J774.2 and A549 cells were 
harvested and kept on ice at all times at 4°C to avoid antigen capping. The 
cells were centrifuged at 200xg for 5min, and then the pellet was taken and 
re-suspended with BBN to approximately 0.5x10⁶/ml. Cells were washed 2x 
with cold BBN by centrifugation. Cell pellets were incubated with 30μl of 
primary antibody (with a suitable concentration of antibody around 1-10μg/ml 
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in BBN) on ice for 45min. Cells were then washed 3 times with BBN and 
centrifugation at 500xg for 5min. Then, labelled secondary antibody was 
diluted 1:250 and 30μl added to the cell pellet and incubated on ice in the dark 
for 45min, and then washed 3 times as well. A LSRII flow cytometer used at 
the Medical School Flow Cytometry Facility, University of Sheffield. For 
analysis by flow cytometry, cells were gently resuspended with 0.3ml BBN 
and stored on ice until sampled. The data was manipulated using FlowJo 
software.  
2.2.2.9 Transfection of mammalian cells 
Transfection of mammalian cells was performed by chemical and physical 
techniques.  
2.2.2.9.1 Transfection system using Gene Pulser II 
J774.2 cells were seeded in a tissue culture plate to reach 90% confluency. 
Cells were harvested as mentioned in section 2.2.2.1. 1x107 cells were re-
suspended with 1ml of serum free-DMEM. 10µg of plasmid was mixed with 
cells in a tube and transferred to a chilled electroporation cuvette (Bio-Rad, 
0.2cm gap width), then left on ice for 15min. The cells were pulsed in an 
electroporator at 250V/975µF for 4sec. The cells were placed on ice for 
30min, re-suspended in DMEM+5% FCS, and then incubated overnight. After 
18hr, the medium was replaced by fresh DMEM+10% FCS with a suitable 
concentration of selective antibiotic G418.  
2.2.2.9.2 Transfection system using Turbofect 
Turbofect transfection (Thermo Scientific) was performed according to the 
manufacturer’s instructions. Briefly, 4x105 A549 cells/well were seeded in a 
tissue culture six-well plate. Cells were incubated overnight, and the 
confluency was around 70-85% confluent prior to transfection. 5µg of plasmid 
was added in 500µl of free media. 6µl of Turbofect transfection reagent was 
added to the mixture with vortexing and left at room temperature for 20min. 
After that, 500µl of the diluted DNA mixture was added to each well in a drop-
drop gently, and then was incubated 24hr post-transfection. The media was 




2.2.3 Peptide synthesis 
8005 and control (SCR) peptides were provided by Dr Rahaf Issa at 
Department of Infection and Immunity and Cardiovascular Disease, the 
University of Sheffield, UK. The 8005 peptide is part of the CD9EC2. It was 
synthesised using solid-phase peptide synthesis with Fmoc chemistry by 
GenScript UK (Table 2.17). SCR peptide is randomly synthesized from the 
8005 amino acid sequence. DMSO was used to dissolve the lyophilised stock 
at 2mM and stored at -20°C.  
Table 2.17 8005 and SCR sequences. 






Scrambled control  THDAEKKNPINDLKKEVLERVKQK
TYESTHFADLYQIEYK 
 
2.2.4 Real-time quantitative polymerase chain reaction (RT-qPCR) 
The mRNA levels of Tspans in infected and uninfected cells were measured 
using qPCR.  
2.2.4.1 RNA extraction 
QIAGEN RNeasy Mini Kits were used to extract mRNA from J774.2 and A549 
cells before and after infection by B. thailandensis. J774.2 and A549 cells 
were grown overnight at 8x105 cells in tissue culture 6 well plates. B. 
thailandensis CDC272 or E264 and E264-ΔtssK strains were grown in 
overnight culture. The cells were infected with B. thailandensis CDC272, E264 
and E264-ΔtssK at MOI 3 for J774.2 and at MOI 5 for A549 cells. The medium 
was discarded after 2hr of infection and the cells were washed 2x with HBSS. 
Then medium containing 500μg/ml kanamycin and amikacin was added to kill 
all extracellular bacteria. After 16hr, the infected cells were scraped from the 
plates and centrifuged at 200xg for 5min. Cells were re-suspended in 350μl of 
lysis buffer, and then 350μl of 70% ethanol was added and mixed gently. The 
solution was transferred to RNA kit tubes and centrifuged at 9000xg for 
15sec, then 700μl of RNA washing buffer (RW1) was added to remove 
carbohydrates, proteins and fatty acids and centrifuged at 9000xg for 15sec, 
after that 500μl of RNA precipitating elution buffer (RPE) was added, and then 
centrifuged for 15sec at 9000xg to remove traces of salts. 500μl of RPE was 
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added and centrifuged at 9000xg for 2min. Finally, 50μl of RNA-free water 
was added and centrifuged at 9000xg for 1min to get the RNA sample. The 
total concentration of RNA was measured using the NanoDrop lite 
spectrophotometer.  
2.2.4.2 RNA integrity 
The RNA samples were treated by DNase I to remove genomic DNA 
contamination. The TURBO DNase kit was used according to the 
manufacturer’s instructions. Briefly, 0.1 volume of 10xTURBO DNase buffer 
and 1µl TURBO DNase were added to RNA samples and kept in an incubator 
at 37ºC for 30min. Then, 0.1x volume DNase inactivation reagent was added 
to all samples and the tubes were incubated at room temperature for 5min. 
The RNA samples were centrifuged at 10,000xg for 90sec, and then 
supernatants were collected in other tubes. Finally, the samples were stored 
at -80°C. 
2.2.4.3 cDNA synthesis 
A High-Capacity cDNA Reverse Transcription Kit was used to make 
complementary DNA (cDNA) for the qPCR assay. All RNA samples (infected 
and uninfected) were standardized to a concentration of 75ng/μl. cDNA 
materials were prepared for each reaction as shown in Table 2.18. All 
samples were loaded into the thermal cycler machine. The settings of the 
thermal cycler machine are shown in Table 2.19 and the cDNA samples were 
directly used for qPCR. There are two negative controls: no-RT (no reverse 
transcriptase), and no RNA (no sample, only master mix). 
Table 2.18 cDNA synthesis components. 





no RNA  
10X RT buffer 2.0 2.0 2.0 
10X RT random primer 2.0 2.0 2.0 
25X dNTP mix (100mM) 0.8 0.8 0.8 
Reverse transcriptase  1.0 0 1.0 
Nuclease-free H2O 4.2 5.2 14.2 
RNA samples 10  10  0 





Table 2.19 Thermocycler steps for cDNA generation. 
Thermocycler steps Step 1 Step 2 Step 3 Step 4 
Temperature 25oC 37oC-45oC 85oC 4oC 
Time 10min 120min 5min Hold 
 
2.2.4.4 Quantification of the DNA product 
The SYBR green method was used to quantify PCR product. The reactions 
were prepared (Table 2.20) using 2x qPCR SYBR Green Master Mix (Primer 
Design Precision) according to the manufacturer’s instructions. All samples 
were loaded into a 384 well plate and centrifuged at 200xg for 2min. Then the 
qPCR plate was placed into the 7900HT AbiPrism sequence detection system 
and run according to the following cycles (Table 2.21). In addition, the melting 
point of the primers was added to machine setting to detect primer specificity. 
Table 2.20 2x qPCR mastermix components. 
Materials  Volume (μl) 
2x master mix with SYBR green (with ROX) 5  
Forward primer 0.5 
Reverse primer 0.5 
Nuclease-free H2O 3 
cDNA 1 
A total volume 10 
 
Table 2.21 Parameters of qPCR reaction. 
qPCR reaction x1 cycle x40 cycles 
Reaction step Enzyme activation Denaturation Data collection 
Cycle length 10min 15sec 1min 
Temperature 95oC 95oC 60oC 
 
Equation 2.1 Delta Ct equations to analyse qPCR results 
The threshold cycle (Ct) value were calculated as below: 
ΔCt value (Control) (ΔCtC) = Average control Ct value (test gene) - Average 
experimental Ct value (housekeeping gene) 
ΔCt value experimental (ΔCtE) = Average experimental Ct value (test gene) - 
Average experimental Ct value (housekeeping gene) 
Delta Delta Ct value (ΔΔCt) = Δ CtE – Δ CtC 
The fold change (∆∆Cq) = 2-ΔΔCt 
Percentage of KD was calculated as follows: 
% KD = (1 – ∆∆Cq) × 100 
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2.2.5 Infection assay 
The modified kanamycin-protection assay was used to measure bacterial 
infection, internalised bacteria and intracellular survival. Overnight cultures of 
bacteria were centrifuged, washed and re-suspended in DMEM to prepare 
MOI 0.5, 1 and 3 for J774.2 cells, and MOI 3, 5 and 10 for A549 cells. They 
were incubated with the bacteria at 37°C in 5% CO2 for 2hr and then washed 
2x with HBSS to remove extracellular bacteria that have not adhered to the 
mammalian cells. One group of wells was washed 3x with HBSS and added 
0.1% (v/v) TritonX-100 (lysis solution) for 15min. Serial dilutions of the lysates 
were plated onto LB agar and incubated at 37°C for 48hr. Colonies of bacteria 
were counted and the number of bacteria was calculated using the CFU 
equation as below. Furthermore, to measure internalised bacteria, cells were 
washed 2x with HBSS and incubated in DMEM containing 500μg/ml 
kanamycin and amikacin for 10min, and again washed 2x with HBSS. Then, 
the cells were lysed with 0.2% (v/v) TritonX-100 for 15min. The serial dilution 
and bacterial counting were followed as above. 
Equation 2.2 Total bacteria 
CFU/ml = (no. of colonies x dilution factor) / volume of culture plate 
The total number of bacteria and internalised bacteria were routinely 
measured at 2hr post-infection. However, intracellular survival bacteria were 
routinely measured at 16hr post-infection. 
2.2.6 Fusion assay 
This assay was performed using the infection assay, as mentioned in section 
2.2.5. The fusion index and the number of nuclei per MGC were measured at 
2, 4, 10 and 16 hr post-infection. J774.2 cells were infected with B. 
thailandensis CDC272, E264 and E264-ΔtssK strains at MOI 0.5, 1, and 3. 
A549 cells were infected at MOI 3, 5 and 10. After 2hr of infection, the cells 
were washed 2x with HBSS. The infected cells were incubated for 16hr using 
kanamycin with amikacin at 500μg/ml to kill all extracellular bacteria. Then, 
the cells were washed with HBSS and fixed by absolute ethanol at room 
temperature for 30min. After that, cells were washed 2x with HBSS and 
stained with 20% Giemsa solution at room temperature for 30min. Finally, the 
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cells were washed with dH₂O and allowed to dry. Images were captured with 
a Nikon light microscope using the 40x objective with at least 10 images per 
each well. The fusion index was calculated relative to normal host cells per 
field of view, as demonstrated in Equation 2.3.  
Equation 2.4 Fusion index and number of nuclei per MGC 
 Fusion index =  
number of nuclei in MGC
total number of nuclei counted
 X 100% 
Nuclei per MGC =  
number of nuclei in MGC
number of MGC
 
2.2.7 Effect of Tspans and partner protein antibodies on bacterial 
infection and MGC formation inA549 cells 
1x105 A549 cells were seeded in tissue culture 96-well plates (100µl medium 
per well) overnight to reach 70% confluency. Cells were washed with warm 
HBSS and treated for 1hr with antibodies diluted with BBN (Table 2.12). 
10µg/ml concentration of antibodies was used. Then cells were washed with 
HBSS and infected with B. thailandensis CDC272 and E264 at MOI 5. As 
described in section 2.2.5, the infected cells were incubated for 2hr and then 
washed 2x with HBSS. To determine the total number of bacteria, each well 
was washed 3x with HBSS and added 0.1% TritonX-100 for 15 min. Serial 
dilutions of the cell lysate were performed in HBSS and plated on LB agar at 
48hr, and then the equation of CFU was used to measure bacteria. To 
determine only internalised bacteria, the wells were incubated with medium 
containing kanamycin and amikacin at 500μg/ml for 15min, to kill extracellular 
bacteria. The cells were washed with HBSS, 0.2% (v/v) TritonX-100 added for 
15min, then CFU was quantified as above. To measure the fusion index and 
the number of nuclei per MGC after 2hr of infection, the cells were washed 
and incubated for a further 16hr with medium containing kanamycin and 
amikacin at 500μg/ml to prevent continued bacterial growth. The protocol 
described in section 2.2.6 was then followed. 
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2.2.8 Effect of 8005 peptide derived from human CD9 on B. 
thailandensis infection and MGC formation to A549 cells 
This modified method was performed to investigate the effect of peptides 
derived from human CD9 on bacterial infection and MGC formation. Briefly, 
1x105 A549 cells were seeded in 96-well tissue culture plates (100µl 
medium/well) overnight to reach 70% confluency. Cells were washed with 
warm HBSS and treated with 8005 and SCR for 1hr. The cells were washed 
with warm HBSS and infected with B. thailandensis CDC272 and E264 at MOI 
5:1 bacteria. Then, the protocol mentioned in section 2.2.5 and section 2.2.6 
was carried out for bacterial infection and fusion index.  
2.2.9 Flow cytometric method for measuring bacterial binding to 
host cells 
Binding was measured using flow cytometry (Valdivia, 1998, Pils et al., 2006). 
Bacteria were labelled with two plasmids expressing GFP and mCherry. In 
brief, A549 cells were seeded 1x105/ml in 6 well tissue culture plate overnight 
at 37c in 5% CO2 and bacteria were inoculated overnight culture. Cells were 
washed and infected with B. thailandensis CDC272, E264 and E264-ΔtssK 
labelled with mCherry and GFP at MOI 10, 25 and 50 for 2hr on the following 
day. The infected cells were washed 3 times with HBSS and gently scraped 
using a scraper, and then were washed and centrifuged at 200xg for 5min to 
remove unbound bacteria. Finally, they were fixed with 2% PFA and analysed 
by flow cytometry machine. 
2.2.10 Knockdown 
2.2.10.1 siRNA Smart Pool Accell transfection 
Smart Pool Accell was purchased from Dharmacon company, and the 
transfection method was performed according to the manufacturers’ 
instructions. Briefly, cells were grown overnight with Accell medium plus 2.5% 
FBS to reach 70-90% confluency in 6 well tissue culture plate. 7.5µl of 100nM 
siRNA was mixed with 700µl Accell medium plus serum 2.5% FBS. The 
mixture was added in a dropwise fashion to each well of a 6 well plate. The 
cells were incubated at 37oC in 5% CO2 for 72hr. Cell dissociation solution 
was used to harvest the cells and RNA extracted for measurement of the 
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gene KD efficiency after 72hr using qPCR. After 72hr, protein level changes 
were measured using flow cytometry which was described in section 2.2.7.  
2.2.10.2 Effect of KD on infection and MGC formation induced by B. 
thailandensis 
This method was carried out to investigate the roles of Tspans and ADAM10 
in bacterial infection and MGC formation induced by B. thailandensis. 
Typically, cells were grown overnight in Accell media with 2.5% of FBS 
(Sigma), as mentioned in section 2.2.6.1. After 72hr, the cells were harvested 
and seeded in tissue culture 96 well plates flat bottom. The cells were infected 
with bacteria. The protocol was followed as mentioned in section 2.2.5 for 
infection assay to calculate the total number of bacteria and internalised 
bacteria, and as mentioned in section 2.2.6 for measuring fusion index and a 
number of nuclei per MGC. 
2.2.11 Effect of B. thailandensis infection on the levels of Tspans 
and other surface molecules. 
The levels of cell surface membrane protein levels were measured for 
uninfected and infected A549 cells by flow cytometry. Cells were seeded in 6 
well tissue culture plates at 2x105/well for overnight. Cells were infected for 
2hr with B. thailandensis CDC272, E264 and E264-ΔtssK. Bacteria were 
removed and cells were washed 2x with HBSS. The cells were incubated with 
medium containing 500μg/ml of kanamycin/amikacin antibiotics. For 2, 8 and 
16hr of infection, the cells were harvested and prepared for flow cytometry 
(section 2.2.7) using appropriate concentrations of the primary antibodies, 
matching isotype controls and FITC-labelled secondary antibodies as shown 
in Table 2.12 and Table 2.13. 
2.2.12 Fluorescent imaging of infected mammalian cells by B. 
thailandensis  
On day 1, J774.2CD9GFP cells were grown at 1.5x105 cells/ml on 6mm glass 
coverslips in 24 well tissue culture plates. In addition, B. thailandensis 
CDC272 and E264, labelled with mCherry protein, were grown in overnight 
culture. On day 2, the CD9GFP cells were infected at MOI 3 and incubated at 
37oC in 5% CO2 for 2hr. The infected cells were washed 2x with HBSS and 
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incubated with media containing 500μg/ml kanamycin and amikacin to kill all 
extracellular bacteria. Then they were incubated for 2hr. Finally, they were 
fixed in 2% paraformaldehyde for 10min, followed by washing 2x with HBSS. 
Coverslips were mounted using Vectashield (with DAPI) that was sealed onto 
slides, in darkness. The images are single optical sections and performed 
under identical conditions using immunofluorescence microscopy. 
2.2.13 Statistical analyses 
Statistical analyses were performed using GraphPad Prism.8. Significance 
was determined using an unpaired t-test, two-way or one-way ANOVA using 
Bonferroni post hoc analysis for multiple comparisons. Data are presented as 
mean ±SEM unless otherwise stated. Flow cytometry results were normalized 




Chapter 3 MGC formation following B. thailandensis 
infection 
3.1 Introduction 
B. thailandensis is a non-pathogenic bacterium and is widely used as a model 
of B. pseudomallei, the causative agent of melioidosis. In tissues infected with 
B. pseudomallei, one of the histopathological features is the presence of 
distinctive MGC formation, potentially a protective structure for the bacteria. 
However, the molecular mechanisms of this pathogenic process have not 
been elucidated. The two main features of B. pseudomallei infections are long 
periods of latency, due to the ability to survive intracellularly, and MGC 
formation. B. pseudomallei can infect a range of cell types, is able to avoid 
killing by macrophages and is also able to promote cell fusion and induce 
MGC formation by bacterial effectors (Wong et al., 1995). Previous studies 
have shown that T6SS-5 of B. pseudomallei and B. thailandensis have a 
major role in MGC formation (Toesca et al., 2014, Schwarz et al., 2014, 
French et al., 2011). Interestingly, B. thailandensis was able to induce MGC 
formation in a strain-dependent manner. In particular, B. thailandensis 
CDC272 was most effective at causing MGC formation in J774.1 cells. In 
contrast, B. thailandensis E264 was poor at causing MGC formation in J774.1 
cells (Wand et al., 2011). This chapter will describe how B. thailandensis 
CDC272 and E264 can induce MGC formation in J774.2 mouse macrophages 
and A549 human lung epithelial cells. This chapter will also demonstrate the 
transformation of fluorescent protein expression vectors into two B. 
thailandensis strains. These were generated as such strains could facilitate 
the quantification and characterization of infected mammalian cells. In 
addition, mammalian cells were transfected with CD9GFP to facilitate the 
tracking of this protein during infection and MGC formation.  
3.2 Aims 
In this chapter, tools for subsequent experiments were generated and tested. 
Firstly, the growth characteristics of two strains of B. thailandensis (CDC272 
and E264) were characterized using different counting methods. Secondly, 
two cells lines, A549 human lung epithelial and J774.2 mouse macrophage, 
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were investigated for infection and induction of MGC formation by the two 
strains of B. thailandensis and a non-fusogenic mutant strain (B. thailandensis 
E264-ΔtssK). Thirdly, fluorescent B. thailandensis strains were produced and 
characterised to determine if MGC formation and bacterial infection are the 
same as the wild-type strains. Finally, fluorescently labelled A549 and J774.2 
cells were investigated to determine if they have similar properties to the wild 
type cell lines.  
3.3 Results 
3.3.1 B. thailandensis infection 
3.3.1.1 Estimation of viable bacteria 
Two methods of quantifying the number of bacteria in growth cultures were 
compared to determine the most accurate and convenient method for the 
preparation of MOI for the subsequent experiments: optical density (OD600) or 
colony forming unit (CFU). As described in section 2.2.1.2, bacterial strains 
were grown in LB medium at 37°C, then numbers were estimated by 
measuring both the OD600 and CFU of the culture at 0, 2, 4, 6 and 8hr after 
inoculation. As Fig 3.1 shows, bacterial growth gradually increased over the 
given time. Also, the number of bacteria, calculated by the CFU method, was 
about 1x108 cells per ml when the OD600 was approximately 0.4. This value of 
OD600 was used in all following experiments. 







































Figure 3.1 Growth curves for B. thailandensis strains. 
Both strains of bacteria were cultured and incubated in Luria-Bertani broth and were 
incubated in a shaking incubator at 37ºC. CFU and OD600 methods were used to measure the 
numbers of bacteria at different time points. A: growth curves of B. thailandensis CDC272 
and E264 strains using OD600. B: growth curves of B. thailandensis CDC272 and E264 strains 
using CFU. The results are the means (± SEM) of 2 independent experiments each 
performed in 2 technical replicates.  
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3.3.1.2 Assessment of fluorescent proteins expression in B. thailandensis by 
flow cytometry 
In this work, plasmids encoding mCherry and GFP were used to tag B. 
thailandensis E264 and CDC272, as described in section 2.2.1.5. B. 
thailandensis expressing mCherry was used to detect any co-localisation 
between B. thailandensis and CD9 during infection. B. thailandensis 
expressing GFP were used to detect binding to host cells using flow 
cytometry. Flow cytometry showed that more than 95% of bacteria have 
mCherry and GFP expression (Fig 3.2 and Fig 3.3). According to this result, 
we decided mCherry or GFP-tagged bacteria could be used for bacterial 






Figure 3.2 Flow cytometry analysis of GFP and mCherry expression in B. 
thailandensis CDC272. 
B. thailandensis CDC272 were transformed with mCherry or GFP as described in section 
2.2.1.5. Fluorescent bacteria were detected using BL-1 A530-30 and red 610-20A channels of 
an LSR-II flow cytometer. Untagged bacteria were used as a negative control. A: Negative 
control B. thailandensis CDC272, showing the gating strategy. B: B. thailandensis CDC272 
tagged with GFP. C: B. thailandensis CDC272 tagged with mCherry. D: Percentage of 
positive B. thailandensis CDC272 tagged with mCherry compared with untagged bacteria. E: 
Percentage of positive B. thailandensis CDC272 tagged with GFP compared with untagged 
strain. The results are representative of 2 independent experiments each performed in 2 
technical replicates.  
A: Non-labelled bacteria  B: Bacteria labelled with mCherry 
C: Bacteria labelled with GFP 









Figure 3.3 Flow cytometry analysis of GFP and mCherry expression in B. 
thailandensis E264. 
B. thailandensis E264 were transformed with mCherry or GFP as described in section 
2.2.1.5. Fluorescent bacteria were detected using BL-1 A530-30 and red 610-20A channels of 
an LSR-II flow cytometer. Untagged bacteria were used as a negative control. A: Negative 
control B. thailandensis CDC272, showing the gating strategy. B: B. thailandensis CDC272 
tagged with GFP. C: B. thailandensis CDC272 tagged with mCherry. D: Percentage of 
positive B. thailandensis CDC272 tagged with mCherry compared with untagged strain. E: 
Percentage of positive B. thailandensis CDC272 tagged with GFP compared with untagged 
bacteria. The results are representative of 2 independent experiments each performed in 2 
technical replicates.  
3.3.1.3 B. thailandensis infection of A549 and J774.2 cells 
This section was to determine the number of bacteria that can attach to, and 
be internalised into, two cell lines, J774.2 and A549. These cell lines were 
infected with B. thailandensis CDC272 and E264 for 2hr to measure the total 
number of bacteria and to determine which MOI is the best in the subsequent 
investigations. The CFU equation was used to count the total number of 
bacteria (i.e. adherent and internalised) as described in section 2.2.5. The 
MOI used were 0.5, 1, 3 and 5 bacteria/cell. The data showed that CFU per 
host cells was increased when using a higher MOI (Fig 3.4). For the J774.2 
cells, MOI 3 was the best ratio of infection compared with other MOIs, 
A: Non-labelled bacteria  
C: Bacteria labelled with GFP 
D: Analysis of mCherry bacteria  
 
E: Analysis of GFP bacteria  
B: Bacteria labelled with mCherry  
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because the results were statistically significantly different between MOI 3 and 
other MOIs. However, the best MOI for A549 cells was 5 because the data 




























































































































Figure 3.4 B. thailandensis CDC272 and E264 infection in J774.2 and A549 cells 
at different multiplicities of infection. 
Cells were infected at MOI 0.5, 1, 3 and 5 for J774.2 cells and A549 human lung cells as 
described in section 2.2.5. The total number of bacteria (adhered and internalised bacteria) 
was counted after 2hr of infection using CFU for counting. The black bars are B. thailandensis 
CDC272 infecting cell lines after 2hr, and the grey bars are B. thailandensis E264 infecting 
cell lines after 2hr. The significance of the differences between treatments was tested by two-
way ANOVA, where * p<0.05; *** p<0.001 significant; ns=non-significant. The results are the 
means (± SEM) of 3 independent experiments each performed in 4 technical replicates. 
3.3.1.4 The effect of GFP expression in J774.2 and A549 cells on infection 
with B. thailandensis 
The first study investigated the effect of GFP, which was transfected into both 
cell lines J774.2 and A549, on B. thailandensis infection. Briefly, bacteria 
released from lysed J774.2 and A549 cells 2hr post-infection were 
enumerated on agar plates. The results demonstrated that in regards to the 
total number of bacteria per host cell, there were no significant differences 
between WTA549 and J774.2 cells compared to GFPA549 and J774.2 cells 
(Fig 3.5). It seems that GFP has no effect on the number of bacteria per host 


















































































Figure 3.5 Effect of GFP expression in J774.2 and A549 cells on B. 
thailandensis infection. 
WT and GFP tagged A549, and J774.2 cells were infected with B. thailandensis CDC272 or 
E264 at MOI 5 for 2hr. The graph shows the effect of GFP on the total number of bacteria 
(adhered and internalized bacteria) in both cell lines and both bacteria strains per 20000 for 
J774.2 cells and 10000 for A549 cells. The significance of the differences between treatments 
was tested by two-way ANOVA, ns=non-significant. The results are the means (± SEM) of 3 
biological experiment performed in 3 technical replicates. 
3.3.1.5 Effect of the expression of fluorescent proteins in B. thailandensis 
CDC272 and E264 on the bacterial infection in J774.2 cells 
In this section, we investigated the effect of two fluorescent proteins, mCherry 
and GFP, on the ability of bacteria to infect mammalian cells. The infection 
assay was performed as described in section 2.2.5. In brief, J774.2 cells 
were seeded in a 96 well plate. After 2hr of infection with WT and B. 
thailandensis containing the GFP and mCherry, the wells were washed 3x 
with HBSS and lysed by the addition of 100μl of 1% TritonX-100 for 15min. 
The lysis mixture was serially diluted before 10μl of each dilution was pipetted 
onto LB agar plates. After 48hr of incubation at 37oC, colonies were counted 
and used to calculate bacteria per well. The results demonstrated that the 
presence of fluorescent proteins have no affect on the efficiency of infection of 



























































































Figure 3.6 Effect of fluorescent proteins on B. thailandensis infection in J774.2 
cells. 
Cells were infected by tagged and untagged bacteria at MOI3 for J774.2 cells, as described in 
section 2.2.5. The total number of bacteria (adhered and internalized bacteria) was counted 
after 2hr of infection using CFU for counting. Black bars show the total WT bacteria in J774.2; 
grey bars show the total tagged bacteria with GFP and mCherry in J774.2 at MOI 3 per 20000 
cells. The effects of different treatments were tested by two-way ANOVA, where ns=non-
significant. The results are the means (± SEM) of 3 independent experiments each performed 
in 3 technical replicates. 
3.3.1.6 Effect of the expression of fluorescent proteins in B. thailandensis 
CDC272 and E264 on the infection of A549 cells 
These experiments were performed to ensure that there is no effect of 
fluorescent proteins expressed in B. thailandensis in A549 cells infection. The 
infection assay was performed as described in section 2.2.5. The A549 cells 
were seeded in a 96-well plate and infected with B. thailandensis CDC272 or 
E264 and B. thailandensis containing GFP and mCherry for 2hr. 
Measurement of the bacterial infection was assessed as CFU. As 
demonstrated in Fig 3.7, the presence of fluorescent proteins does not effect 































































































Figure 3.7 Effect of fluorescent proteins on total B. thailandensis infection in 
A549 cells. 
Cells were infected by tagged and untagged bacteria at MOI5 for A549 cells, as described in 
section 2.2.5. The total number of bacteria (adhered and internalised bacteria) was counted 
after 2hr of infection using CFU counting. Black bars show the total untagged bacteria in per 
10000 A549; grey bars show the total bacteria tagged with GFP and mCherry in A549 at MOI 
5 per 10000 cells. The significance of the difference between treatments was tested by two-
way ANOVA, ns=non-significant. The results are the means (± SEM) of 3 independent 
experiments each performed in 4 technical replicates. 
3.3.2 B. thailandensis induces the formation of MGC formation in 
vitro in A549 and J774.2 cells 
3.3.2.1 MGC formation 
Previous studies in our group have described MGC formation in J774.2 cells 
after infection by B. thailandensis (Elgawidi, 2016). Here, we show that B. 
thailandensis has the ability to induce human lung epithelial A549 cells to form 
MGC (Figs 3.8 and 3.11). This is consistent with findings in the literature 
(Micheva-Viteva et al., 2017). In addition, we used a B. thailandensis E264-
ΔtssK mutant strain as a negative control for MGC formation. This strain does 
not induce MGC formation (Hall, 2016, Whiteley et al., 2017). Briefly, J774.2 
and A549 cells were infected at MOI 0.5, 1 and 3 and 5 with B. thailandensis 
CDC272, E264 and E264-ΔtssK for 2hr and added medium containing 
amikacin and kanamycin to kill extracellular bacteria. MGC formation was 
assessed at 18hr post-infection. Cells were stained with Giemsa, and the 
fusion index was calculated relative to normal host cells per field of view. 
MGCs were defined as cells containing 3 or more nuclei. Our results 
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demonstrated that the fusion index for both J774.2 and A549 cells were 














































































































C D C 2 7 2
E 2 6 4
**** *
 
Figure 3.8 The formation of MGC at different MOI of B. thailandensis CDC272 
and E264. 
Cells were infected at MOI 0.5, 1, 3 and 5 for J774.2 cells and A549 human lung cells as 
described in section 2.2.5. The fusion index was measured as described in section 2.2.6. 
Black bars show the fusion index induced by CDC272; grey bars show the fusion index 
induced by E264. The significance of the difference between treatments was tested by two-
way ANOVA, where * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 significant; ns=non-
significant. The results are the means (± SEM) of 3 independent experiments each performed 



























           
 
Figure 3.9 Light micrographs of J774.2 cells infected with B. thailandensis 
E264, CDC272 and E264-ΔtssK. 
J774.2 cells were cultured in 96 well plates overnight and then infected with two fusogenic 
strains B. thailandensis CDC272, E264 and non-fusogenic mutant B. thailandensis E264-
ΔtssK at MOI 3. Cells were fixed and stained at 18hr post-infection. A: Uninfected. B: B. 
thailandensis, ΔtssK-E264. C: WT B. thailandensis E264. D: B. thailandensis CDC272. 
Images are representative of 3 independent experiments each performed in 8 technical 











Figure 3.10 Light micrographs of A549 cells infected with B. thailandensis E264, 
CDC272 and E264-ΔtssK. 
A549 cells were cultured in 96 well plates overnight and then infected with two fusogenic 
strains B. thailandensis CDC272, E264 and non-fusogenic mutant B. thailandensis E264-ΔtssK 
at MOI 5. Cells were fixed and stained at 18hr post infection. A: uninfected. B: B. 
thailandensis, E264-ΔtssK. C: WT B. thailandensis E264. D: WT B. thailandensis CDC272. 
Images are representative of 3 independent experiments each performed in 8 technical 
replicates. Images were taken using a Nikon light microscope 40x objective.  
3.3.2.2 B. thailandensis tssk deletion mutant is incapable of inducing MGC 
formation 
It is known that B. thailandensis has several type VI secretion systems, but 
only one (T6SS-5) is required for inducing MGC formation (Toesca et al., 
2014, Schwarz et al., 2014, Whiteley et al., 2017). Here we intend to use tssK 
mutant to differentiate between mechanisms involved in infection and fusion. 
To do this, four wells of a 96 well plate were infected at MOI 5 for A549 cells, 
MOI 3 for J774.2 cells with both E264-ΔtssK and WT strains. 2hr post-
infection, the DMEM medium was replaced with medium containing 
kanamycin and amikacin to kill extracellular bacteria. At different time points 
after the initial infection, wells were washed 2x with HBSS before fixing with 
100% ethanol for 30min. The ethanol was removed and the wells were 
allowed to dry before immersing in 20% of Giemsa for 30min. The stain was 







and nuclei of J774.2 and A549 cells could be distinguished. The 10x objective 
of a Nikon (MAZUREK) inverted microscope was used to capture five random 
fields of view per well. Nuclei within cells containing three or more nuclei were 
counted, as well as the number of nuclei in the field of view. The fusion index 
in J774.2 and A549 cells infected with E264-ΔtssK was less than 3%, much 
lower than cells infected with two strains of WT B. thailandensis, which 
induced the cells to form MGC with a fusion index of more than 30%. B. 
thailandensis E264-ΔtssK can infect cells normally but can only weakly induce 
fusion (Fig 3.11). As expected from the published literature, T6SS-5 is 
required for MCG formation (Toesca et al., 2014, Schwarz et al., 2014, Hall, 
2016, Whiteley et al., 2017). This is consistent with our findings where there 
was a significant difference in the fusion index between WT and E264-ΔtssK 























































































































Figure 3.11 MGC formation in J774.2 and A549 cells. 
Cells were cultured in 96 well plates overnight and then infected with fusogenic and non-
fusogenic mutant (E264-ΔtssK) of B. thailandensis at MOI 3 and 5 as described in section 
2.2.6. Cells were fixed and stained at 6, 10 and 18hr infection. Upper panel: The bars show 
the fusion index for J774.2 and A549 cells induced bacteria. Lower panel: The bars show the 
number of nuclei per MGC for J774.2 and A549 cells induced by WT and mutant E264-ΔtssK 
bacteria at MOI 3 for J774.2 cells and at MOI 5 for A549 cells. The significance was tested by 
two-way ANOVA, where * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 significant; ns=non-
significant. The results are the means (± SEM) of 3 independent experiments each performed 
in 8 technical replicates.  
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3.3.2.3 The effect of GFP expression in J774.2 and A549 cells on MGC 
formation induced by B. thailandensis 
We performed infection and fusion assay to investigate the effect of GFP on 
MGC formation. As mentioned in section 2.2.2.9, the J774.2 and A549 cells 
were labelled with GFP using transfection assay. The percentage of 
transfection was about 80% of cells (data are shown in Appendix Figs 2 and 
3). The transfected and WT J774.2 and A549 cells were infected by B. 
thailandensis using fusion assay, as mentioned in section 2.2.6. In brief, after 
infection for 18hr, all wells were washed 2x with HBSS before fixing with 
100% ethanol for 30min. The ethanol was removed and the wells were 
allowed to dry before immersing in 20% of Giemsa for 30min. The stain was 
removed before the cells were destained with tap water until the cytoplasm 
and nuclei of J774.2 and A549 cells could be distinguished. A Nikon 
(MAZUREK) inverted microscope was used to capture five random fields of 
view per well. Nuclei within cells containing three or more nuclei were 
counted, as well as the number of nuclei in the field of view. The results 
demonstrated that there were no significant difference between tagged J774.2 
and A549 cells and their WT counterparts regarding MGC formation (Figs 

































































Figure 3.12 Effect of GFP in J774.2 cells on MGC formation induced by both B. 
thailandensis strains. 
Cells were cultured in 96 well plates overnight and then infected with two fusogenic strains B. 
thailandensis CDC272 and E264 at MOI 0.5, 1 and 3 as described in section 2.2.6. Cells 
were fixed and stained at 18hr post-infection. Black bars show the fusion index for WT J774.2 
cells; green bars show the fusion index for GFPJ774.2 cells at MOI 0.5,1 and 3, respectively. 
The significance of the difference between treatments was tested by two-way ANOVA; 
ns=non-significant. The results are the means (± SEM) of 3 independent experiments each 
































































Figure 3.13 Effect of GFP in A549 cells on MGC formation induced by both B. 
thailandensis strains. 
Cells were cultured in 96 well plates overnight and then infected with B. thailandensis 
CDC272 and E264 at MOI 3 as described in section 2.2.6. Cells were fixed and stained at 
18hr post-infection. Black bars show the fusion index for WT A549 cells; green bars show the 
fusion index for GFPA549 cells at MOI 5. The significance of the difference between 
treatments was tested unpaired t-test, ns=non-significant. The results are the means (± SEM) 
of 3 independent experiments each performed in 4 technical replicates. 
3.3.2.4 Effect of mCherry and GFP expression in B. thailandensis on MGC 
formation 
To investigate whether mCherry and GFP have an effect on B. thailandensis-
induced MGC formation in either A549 or J774.2 cells, bacteria were labelled 
with these fluorescent proteins as mentioned in section 2.2.1.5.6. The fusion 
assay was performed to quantify the percentage of fusion caused by either 
WT B. thailandensis or B. thailandensis carrying the mCherry and GFP 
fluorescent markers. The results demonstrated that there were no significant 
differences between labelled bacteria and non-labelled bacteria in regards to 



















































































Figure 3.14 Effect of fluorescent reporter proteins on B. thailandensis-induced 
MGC formation in J774.2 cells. 
Cells were seeded in 96 well plates overnight. The cells were infected by tagged and 
untagged B. thailandensis, GFP and mCherry at MOI 3. Cells were fixed and stained at 18hr 
post-infection. Black bars show the fusion index for WT J774.2 cells infected with untagged 
bacteria; grey bars show the fusion index for J774.2 cells infected with tagged bacteria at MOI 
3. The significance of the difference between treatments was tested by two-way ANOVA, 
where ns=non-significant. The results are the means (± SEM) of 3 independent experiments 
















































































Figure 3.15 Effect of fluorescent reporter proteins on B. thailandensis-induced 
MGC formation in A549 cells. 
Cells were seeded in 96 well plates overnight. The cells were infected by tagged and 
untagged B. thailandensis, GFP and mCherry at MOI 5. Cells were fixed and stained at 18hr 
post-infection. Black bars show the fusion index for WT A549 cells infected with untagged 
bacteria; grey bars show the fusion index for A549 cells infected with tagged bacteria at MOI 
5. The significance of the difference between treatments was tested by two-way ANOVA, 
where ns=non-significant. The results are the means (± SEM) of 3 independent experiments 




3.4.1 B. thailandensis infection 
Many studies have demonstrated that B. pseudomallei and B. thailandensis 
can replicate and survive inside RAW 264.7 and A549 cells following infection 
(Utaisincharoen et al., 2001, Kespichayawattana et al., 2004, Lamothe and 
Valvano, 2008). A previous study found that B. pseudomallei and B. 
thailandensis can infect mouse macrophage cell lines (J774.2 and RAW 264) 
and human monocytes cell lines (THP1 and U937) (Benanti et al., 2015, 
Stevens et al., 2005, French et al., 2011, Kespichayawattana et al., 2000). In 
our lab, a study demonstrated that there was also no difference in the ability 
of clinical and environmental B. thailandensis strains to adhere to, and 
internalise into, mammalian cells (Elgawidi, 2016). Human lung epithelial 
A549 and mouse macrophage J774.2 cells were infected with B. thailandensis 
E264 and CDC272 to measure the total bacterial infection and/or 
internalisation to mammalian cells after 2hr exposure of infection.  
The first aim of this study was to determine which MOI will be used in the next 
investigations. In section 3.3.1.2, our results showed that the infection 
efficiency of J774.2 cells at MOI 3 was significantly higher than MOI 0.5. It 
seems that MOI 3 was the appropriate ratio of infection for J774.2 cells. 
These results with J774.2 were similar to the previous study that used MOI 2 
to infected RAW 264 (Utaisincharoen et al., 2006). Stevens and co-workers 
used MOI 1 for B. pseudomallei infection and MOI 10 for B. thailandensis  to 
study the replication of bacteria inside J774.2 macrophages (Stevens et al., 
2002). We also found that the A549 cells can be infected by B. thailandensis 
CDC272 and E264 at MOI 1,  3 and 5. However, the optimum MOI was 5 with 
both strains for A549 cells, as described in Fig 3.5. The total bacterial 
infection at MOI 5 was significantly larger than at MOI 1. We also compared 
this with another researcher’s findings. For example, Haraga and colleagues 
have noticed that MOI 10 was the best ratio of infection for Hela cells (Haraga 
et al., 2008). 
The second aim was to know if there was any effect of fluorescent protein 
tags in the mammalian cells on the bacterial infection. The findings showed 
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there no significant differences between GFP and WT J774.2 cells after 2hr 
infection. The results also showed non-significant differences between A549 
GFP and WT A549 cells (Fig 3.5 and Fig 3.6). There are no publications 
about the effect of GFP tags in mammalian cells on bacterial infection.  
The third aim was to determine whether there was any effect of two different 
fluorescent protein tags in the infection efficiency of B. thailandensis. Our data 
demonstrated that there were no differences with J774.2 or A549 cells 
infected with tagged or untagged B. thailandensis (Fig 3.6 and Fig 3.7). 
These results were similar to a previous study that used RAW 264.7 
macrophage cells, as they found that GFP had no effect on the total bacterial 
infection (Burtnick et al., 2011, Burtnick et al., 2010). Moreover, our findings 
were also similar to those obtained when GFP was used to tag Pseudomonas 
syringae (Wang et al., 2007). In addition, it has been observed that there is no 
effect of GFP tag on S. typhimurium infection and internalisation (Ma et al., 
2011). 
3.4.2 MGC formation induced by B. thailandensis 
Here, I have characterised B. thailandensis induction of MGC formation. This 
section will discuss 3 aims. The first aim was to detect which MOI will be used 
in the next MGC formation investigations. Both host cell types were infected at 
different MOIs, as described in section 2.2.6. The experiment was optimised 
for the fusion index during different periods.  
In section 3.3.2.1, we observed that the best MOI to induce the cells to form 
MGC is 3 in J774.2 and 5 in A549 cells. These results were similar to previous 
studies which found that the optimaium MOI to infect RAW264.7 and J774.2 
mouse cell lines was 3 (Elgawidi, 2016, Hall, 2016). However, Whiteley et al. 
used MOI 33 in RAW264.7 to induce the cells to form MGC to reach ~40% 
fusion index (Whiteley et al., 2017). We found that the fusion index with A549 
cells infected with B. thailandensis CDC272 at MOI 5 ~32%; however, 
Micheva-Viteva et al. used B. thailandensis CDC272 at MOI 50 to infect A549 
cells (Micheva-Viteva et al., 2017). They found that the MGC fusion index was 
~10% after 24hr of infection. The reasons for this difference are unclear. 
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In section 3.3.2.2, we tested if a tssK mutant  could induce the cells to form 
MGC. Our results showed that ΔtssK could not cause fusion in two types of 
cells, A549 and J774.2, at different time points. This supports data from a 
previous study at University of Sheffield, which showed that E264-ΔtssK 
cannot induce RAW cells to form MGC (Hall, 2016). This is also in support of 
results that show that T6SS-5 is required in MGC formation induced by B. 
thailandensis E264-ΔtssK and ΔtssI-5 (Schwarz et al., 2014,Toesca et al., 
2014, Whiteley et al., 2017) . 
The results shown in this chapter indicate that the J774.2 cells fused within 
6hr of infection and A549 cells fused within 10hr of infection. Whiteley et al. 
showed that RAW264.7 macrophages could also fuse to form MGC after 6hr 
of infection (Whiteley et al., 2017). These results were in agreement with our 
study that reported that the start point of fusion is 6hr post-infection. However, 
these were not in agreement with our finding with A549 cells, which can fuse 
10hr post-infection. It might be because these cells are human lung epithelial 
cells, which are not professional phagocytes like macrophages. 
The second aim was to know if the fluorescent protein tags in mammalian 
cells have any effect on MGC formation. There are no published studies about 
the effect of GFP tag protein on MGC formation. These investigations were 
necessary to confirm that the fusion index did not change because of the 
protein tag. Our results in Fig 3.12 and Fig 3.13 suggested that there was no 
effect of GFP expression in A549 and J774.2 cells. The third aim was to know 
if there was any effect of fluorescent protein tags in the bacteria on MGC 
formation. In section 3.3.2.4, our results demonstrated clearly that there was 
no effect of bacterially-expressed GFP and mCherry proteins on MGC 
formation. There are no publications about the effect of GFP and mCherry 





Chapter 4 Strategy to discriminate the role of 
Tspans and partner proteins involved in MGC 
formation and/or bacterial infection 
4.1 Introduction 
It was demonstrated in chapter 3 that A549 and J774.2 cells can be induced 
to form MGC by B. thailandensis. In fact MGC formation is involved in 
pathogenesis and important in melioidosis. For example, MGCs have been 
found in the tissues of patients with melioidosis (Wong et al., 1995). B. 
pseudomallei can survive intracellularly, and also induce phagocytic and non-
phagocytic cells to form MGC in tissue models (Franco et al., 2018). MGC 
formation is also a means of B. pseudomallei spreading from cell to cell 
(Kespichayawattana et al., 2000). Using actin-associated plasma membrane 
protrusions, the bacteria co-localise and spread directly from cell to cell 
(Kespichayawattana et al., 2000). However, the mechanism of MGC formation 
is not fully understood. It is likely that host cell factors are involved. 
Previous studies showed that cell fusion and bacterial infection could be 
regulated by host membrane proteins. Helming and Gordon have observed 
that CD36 might contribute to cell fusion of macrophages stimulated by the 
cytokines IL-4 and GM-CSF. Anti-CD36 antibody can also inhibit macrophage 
fusion (Helming and Gordon, 2009). It was also observed that CD47 integrin-
associated protein could participate in cell fusion, Hobolt et al. have used 
monoclonal antibody against CD47, which strongly inhibited cell fusion in a 
murine osteoclast culture system (Hobolt-Pedersen et al., 2014). CD98 
protein can also regulate cell fusion (Yoshiki and Boyd, 2004). DC-STAMP 
plays an essential role in cell fusion (Yagi et al., 2005). Suparak et al. 
observed MGC formation induced by B. pseudomallei and found that it could 
be significantly inhibited when antibodies against CD47 and CD98 were used 
on U937 macrophages, whereas antibodies against CD44 and CD14 (LPS 
receptor) had no effect on MGC formation in U937 macrophages (Suparak et 
al., 2011). Borisova et al. found that integrin β3 mRNA was raised after 
Staphylococcus infection (Borisova et al., 2013).  
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Tspan molecules have been implicated in regulating cell:cell fusion and 
virus:cell fusion. Previous studies have indicated roles for Tspan molecules in 
mononuclear phagocyte fusion, including osteoclast formation and the 
formation of MGC associated with chronic inflammation (Iwai et al., 2007). It 
has been observed that antibodies against CD9 and CD81 can enhance the 
fusion of peripheral blood monocytes stimulated by Con A, and the deletion of 
CD9 and CD81 can also enhance MGC formation in vivo and in vitro (Takeda 
et al., 2003). Recently, a previous PhD student from University of Sheffield 
has shown roles for Tspan molecules in cell fusion in mouse macrophages 
induced by B. thailandensis (Elgawidi, 2016). Here the role of Tspan 
molecules in bacterial infection and/or MGC formation induced by B. 
thailandensis was investigated. 
4.2 Aims 
This work aims to investigate the role of Tspan molecules in MGC formation 
during B. thailandensis infection using mouse macrophage J774.2 cells and 
human lung epithelial A549 cells, as they are commonly used as models to 
study the interaction of the bacterium with host cells. We used a B. 
thailandensis  T6SS mutant strain (ΔtssK, which can infect cells without 
stimulating MGC formation) to distinguish between Tspans involved in 
infection from those with a role in MGC formation and B. thailandensis 
infection 
The first aim was to investigate if Tspans and Tspan-partner genes 
expression are changed in response to B. thailandensis infection, using real-
time qPCR. Three criteria were used to discriminate a role for Tspans and 
Tspan-partner proteins in MGC formation and/or infection. Firstly, the levels of 
Tspans and partner proteins mRNA should show consistent changes in both 
host cell types (A549, J774.2) regarding MGC formation and/or bacterial 
infection. Secondly, the levels of Tspans mRNA should show consistent 
changes with two fusogenic bacterial strains (E264, CDC272) regarding MGC 
formation and/or bacterial infection. Thirdly, there should be no change with 
the non-fusogenic E264-ΔtssK mutant for a gene involved only in MGC 
formation. The second aim was to use flow cytometry to validate the data on 




4.3.1 Tspan genes expression at the mRNA level in A549 and 
J774.2 cells 
This study was to investigate the gene expression of Tspans at the mRNA 
level in the J774.2 and the A549 cells. According to the criteria for primer 
design for real-time qPCR, we designed 33 human Tspan primers and 31 
mouse Tspan primers (there are two mouse Tspan genes that do not appear 
in the NCBI database, Tspan-16 and Tspan-19). The study used the qPCR 
assay, as described in section 2.2.4. The expression of mRNA is determined 
by the accumulation of a fluorescent signal, using SYBR green fluorescent 
dye. The number of PCR cycles required for the fluorescent signal to cross 
the threshold is the cycle threshold (Ct). The Ct value was used to calculate 
the relative amount of RNA. The relative expression of Tspans mRNA is 
calculated against a suitable housekeeping gene, ribosomal protein 13α 
(RpL13α) for mouse J774.2 cells and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) for human A549 cells.  
As described in section 2.2.4, RNA was extracted and treated with DNaseI to 
avoid genomic DNA contamination. As shown in Fig 4.1A, there was no 
genomic DNA after treatment with DNaseI. cDNA was prepared using a 
thermocycler machine. cDNA samples and all reverse and forward primers for 
Tspans (human and mouse) were prepared and tested in a real-time PCR 
machine. The primer specificity was checked using melting curves as an extra 
step in a real-time machine, as shown in Appendix Fig 4, and this was 
confirmed by running a selection of random wells on an agarose gel after 
amplification in real-time PCR machine (Fig 4.1B). In a representative 
experiment, it can be clearly seen that all the mouse and human Tspan genes 
are expressed in J774.2 and A549 cells, respectively (Fig 4.1C). We used two 
negative controls: 1) RNA samples without reverse transcriptase enzyme 
(NRT), and 2) reverse transcriptase enzyme without RNA sample (NRNA) 
(shown in Appendix Table 1). The qPCR data showed that all 31 murine 
Tspan genes are expressed by J774.2 as shown in Fig 4.2, while the qPCR 
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results showed that all 33 human Tspan genes are expressed by A549 cells 
as shown in Fig 4.3. 
 
   
 
Figure 4.1 Validation of qPCR ( RNA integrity and primers specificity). 
A: Gel electrophoresis of RNA.The 18S and 28S rRNA bands are clearly visible in the intact 
RNA samples. NI: non-infected cells, E264: Infected J774.2 cells with environmental strain 
and CDC272: Infected J774.2 cells with clinical strain. B: Gel electrophoresis of a selection of 
random wells after amplification in real-time PCR machine. Bands showing ~150bp PCR 
products of CD9 and Tspan-2. C: qPCR output of a typical experiment, showing the increase 
of SYBR Green fluorescence with qPCR cycle number. The point at which the curve 
intersects the threshold (horizontal green line) is the Ct value; failure to reach the threshold 
indicates non-expression of that gene. D: The plot shows how PCR product fluorescence 
changes with temperature. A single peak on the melting curve analysis indicates a single 

































































































































































Figure 4.2 Tspan genes expression at the mRNA level in J774.2 cells. 
All data have been calculated with a suitable housekeeping gene (RpL13α), and the relative 
ΔCt levels of Tspans are presented in the Y-axis. The results are the means (± SEM) of 3 






































































































































































Figure 4.3 Tspan genes expression at the mRNA level in A549 cells. 
All data have been calculated with a suitable housekeeping gene (GAPDH), and the relative 
ΔCt levels of Tspans are presented in the Y-axis. The results are the means (± SEM) of 3 
independent experiments each performed in 2 technical replicates. 
4.3.2 Changes in Tspan genes expression at the mRNA level after 
infection of A549 and J774.2 cells 
To analyse which gene expression levels are changed during B. thailandensis 
infection, qPCR was used. Tspan genes expression changes were analysed 
in both cell lines in response to infection by B. thailandensis mutant and wild 
type. The fold change was calculated using the equation 2^ (-ΔΔCt). In brief, 
RNA was extracted and treated with DNaseI to avoid genomic DNA 
contamination. cDNA was prepared using a reverse transcriptase kit. The 
primer specificity was checked using melting curves as an extra step in a real-
time PCR machine (Fig 4.1D). Amplification was performed on cDNA samples 
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using reverse and forward primers for Tspans (human and mouse) using a 
real-time PCR machine. All 33 Tspans of A549 cells and 31 Tspans of J774.2 
cells had detectable mRNA levels in uninfected cells but the mRNA levels of 
10 Tspans were found to change 18hr post-infection, as shown in Appendix 
Fig 5. However, only 5 Tspans met the criteria for specific involvement in 
fusion rather than infection (namely, changes in both host cell types, both 
bacterial strains but no change with B. thailandensis E264-ΔtssK mutant 
strain) and so these were selected as candidates for further study as 








































































































Figure 4.4 Changes in Tspan genes expression at mRNA level in response to 
both B. thailandensis fusogenic strains. 
Tspan genes expression were measured by qPCR after 18hr infection with B. thailandensis 
CDC272 or E264 and non-fusogenic mutant (E264-ΔtssK). Expression of Tspans was 
calculated using the 2-ΔΔCt method relative to the results to the housekeeping genes RpL13α 
and GAPDH. 5 Tspans showed consistent changes in both host cell types and no change 
with non-fusogenic mutant (E264-ΔtssK). The significance of differences were tested by one-
way ANOVA, where * p<0.05; ** p<0.01; *** p<0.001 significant (vs. control-uninfected cells). 




4.3.3 Tspan genes expression in A549 and J774 cells over time 
To further analyse the 5 differentially expressed genes associated with MGC 
formation, we performed an expression analysis over 5 time points during 
bacterial infection. To do this, QIAGEN RNeasy Mini Kits were used to extract 
mRNA from J774.2 and A549 cells before and after infection by B. 
thailandensis. TURBO DNase kit was used according to the manufacturer’s 
instructions to remove the genomic DNA. A High-Capacity cDNA Reverse 
Transcription Kit was used to make complementary DNA (cDNA) for all 
samples over 5-time points. The SYBR green method was used to quantify 
the DNA product formed, as demonstrated in section 2.2.4. In order to 
normalise the qPCR data, the ΔCt was used to analyse the data. Also, the fold 
change was calculated using equation 2-ΔΔCt for all genes. 
The expression of genes was normalised to the GAPDH and RpL13α levels in 
all samples at 0, 2, 4, 10, and 18hr. The melting curve analysis (at 65-95°C) 
was performed at the end of each experiment to determine the primers’ 
specificity. As shown in Fig 4.4, Tspan-2, Tspan-13, Tspan-5, CD81 and CD9 
mRNA levels appeared to correlate closely with the onset of fusion in both cell 
types. Significant induction of Tspan-2 and Tspan-13 mRNA was observed 
between 6 and 18hr (p ≤ 0.001) in both cell lines, while CD9 and CD81 mRNA 
was reduced at 18hr (p ≤ 0.01). The results also show that Tspan-5 mRNA 
was increased at 6hr (p ≤ 0.001) but reduced at 18hr (p ≤ 0.01) in both cell 
lines. It is apparent that Tspan-2 and Tspan-13 gene expression increased 
relative to uninfected controls during early time points after infection (highest 
at 6hr), and CD9 and CD81 gene expression reduced during infection, as 


















































































































































































































































































































































Figure 4.5 Time-courses of Tspan genes expression during B. thailandensis 
infection in J774.2 and A549 cells. 
Samples of infected and uninfected cells were taken at 0, 2, 4, 6, 10 and 18hr from the initial 
infection. Gene transcripts were determined by qPCR. The significance of differences were 
tested by one-way ANOVA, where * p<0.05; ** p<0.01; *** p<0.001 significant; ns=non-
significant using one-way ANOVA (vs. control-uninfected cells). Blue colour indicates cells 
infected by E264, and black colour indicates cells infected by CDC272. The results are the 
means (± SEM) of 3 independent experiments each performed in 2 technical replicates. 
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4.3.4 Tspan-partner genes expression at the mRNA level in A549 
and J774.2 cells 
The main feature of Tspan molecules is their interaction capability with other 
transmembrane molecules such as integrins, ADAM10, CD47, CD98, CD206 
and DC-STAMP, thereby acting as molecular coordinators to modulate the 
functional clustering of proteins in TEM (Levy and Shoham, 2005). This study 
used the qPCR method to measure the mRNA level of Tspan-partner genes. 
To do this, RNA was extracted and treated with DNaseI to avoid genomic 
DNA contamination. cDNA was prepared using a thermocycler machine. 
cDNA samples and all reverse and forward primers for Tspan-partners 
(human and mouse) were prepared and tested in a real-time PCR machine. 
The primer specificity was checked using melting curves as an extra step in a 
real-time machine. GAPDH was used as a housekeeping gene for Tspan 
genes expression in human A549 cells and RpL13α for mouse J774.2 cells. 
β-actin has been reported as a suitable housekeeping gene for both human 
as well as mouse (Patil et al., 2015, Eissa et al., 2016, Palacz-Wrobel et al., 
2017). GAPDH and RpL13α were tested by qPCR and were consistent with β-
actin (data not shown). Therefore, we decided to use only β-actin instead of 
using two different housekeeping genes to calculate the relative expression of 
Tspan-partners mRNA for both mouse J774.2 and human A549 cells. It was 
observed that all of the selected Tspan-partner genes were highly expressed 
by both cells types. The relative gene expression of CD98, integrins, ADAM10 
and CD172α genes were more highly expressed than other Tspan-partner 

































































































































































Figure 4.6 Tspan-partner genes expression at the mRNA level in J774.2 and 
A549 cells. 
All data have been calculated relative to a suitable housekeeping gene (β-actin). Bars show 
the mRNA level of Tspan-partner proteins by J774.2 (A) and A549 (B) cells. The results are 
the means (± SEM) of 3 independent experiments each performed in the 2 technical 
replicates. 
4.3.5 Tspan-partner genes expression at the mRNA level in A549 
and J774.2 cells after infection by B. thailandensis 
This study used the qPCR method to measure the changes of Tspan-partner 
genes in response to bacterial infection. In order to normalise the qPCR data, 
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the ΔCt was used to analyse the data. Also, the fold change was calculated 
using equation 2-ΔΔCt for all genes. As shown in Fig 4.7 and Appendix Fig 6, 
12 Tspan-partner genes had detectable mRNA levels in uninfected cells and 5 
Tspan-partner genes were found to change 18hr post-infection. However, only 
3 Tspan-partner genes showed consistent changes in expression in both host 
cell types and both bacterial strains but not with non-fusogenic mutant (E264-









































































Figure 4.7 Tspan-partner genes expression changed in response to B. 
thailandensis infection. 
Tspan-partner genes expression were measured by qPCR after 18hr infection with B. 
thailandensis CDC272 or E264 and non-fusogenic mutant (E264-ΔtssK). Expression of Tspan 
-partner proteins was calculated using the 2-ΔΔCt method relative to the results to the 
housekeeping gene β-actin. Five Tspan-partner proteins were found to change 18hr post-
infection. 3 Tspan-partner proteins showed consistent changes in both host cell types and no 
change with non-fusogenic mutant (E264-ΔtssK). The significance of differences was tested 
by one-way ANOVA, where * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 significant (vs. 
control-uninfected cells). The results are the means (± SEM) of 3 independent experiments 
performed each in 2 technical replicates. 
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4.3.6 Innate immune molecules and cell signalling genes following 
infection with B. thailandensis 
This experiment was performed to investigate if innate immune or cell 
signalling molecules are involved in MGC formation and/or bacterial infection. 
It is known that several innate immune molecules have a role in bacterial 
infection in many cell types. In particular, signalling molecules SOCS3 and 
iNOS are involved in B. pseudomallei infection (Ekchariyawat et al., 2005). It 
is also known that this bacterium induces expression of suppressor of 
cytokine signalling 3 (SOCS3) which inhibits concomitant iNOS activation 
(Ekchariyawat et al., 2005). The gene expression of these molecules was 
measured in response to B. thailandensis infection in both cell types using 
qPCR. Data shows gene expression of signalling molecules and 3 innate 
immune molecules were changed in both host cell types and were also 
changed with non-fusogenic mutant (E264-ΔtssK). It seems that they may 
have a regulatory role in bacterial infection, but not in MGC formation. SOCS3 
was upregulated more than 10 fold after 18hr infection, while iNOS was 
switched off during bacterial infection. 3 factors that have a role in apoptosis 
were also tested: caspase-1 and p53 were up-regulated after infection, while 
caspase-3 was not different 18hr post-infection. One main signalling protein 
p38 was also tested. However, it was not changed with fusogenic or non-











































































































Figure 4.8 Innate immune molecules and cell signalling genes in MGC 
formation and/or bacterial infection. 
p38, p53, iNOS, SOCS3, caspase-3, and caspase-1 expression was measured by qPCR after 
18hr infection with B. thailandensis CDC272 or E264 and non-fusogenic mutant (E264-
ΔtssK). Expression of these markers in uninfected and infected J774.2 and A549 cells was 
calculated using the 2-ΔΔCt method following the estimation of the house-keeping gene β-actin. 
p53, SOCS3 and caspase-1 showed changes in both host cell types and showed changes 
with non-fusogenic mutant (E264-ΔtssK). The significance of differences was tested by one-
way ANOVA, where * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 significant; ns=non-
significant (vs. control-uninfected cells). The results are the means (± SEM) of 3 independent 
experiments each performed in 2 technical replicates. 
4.3.7 Tspan proteins expression on the cell surface of A549 cells  
Currently, monoclonal or polyclonal antibodies to human Tspan molecules are 
not available for all proteins. Only the level of Tspan-2, Tspan-11, Tspan-13, 
Tspan-15, CD151, CD9, CD63 and CD81 proteins were tested on human lung 
cell lines A549 by flow cytometry. To do this, we used FACS analysis of the 
binding of these antibodies to live A549 cells. Cells were harvested using a 
non-enzymatic cell dissociation solution and stained, as described in section 
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2.2.3.2.1. A FITC-labelled secondary antibody was used at the manufacturer’s 
recommended concentration 1:250. The data are shown as median 
fluorescence intensity (MFI). The negative controls here were cells treated 
with the binding buffer BBN or irrelevant antibody with the same isotype. This 
study was not used to screen the level of Tspans protein expression on the 
J774.2 cells because this has already been done in a previous study 
(Elgawidi, 2016) in some cases or the anti-mouse antibodies are not 
available. The data showed that CD9, CD81, Tspan-2, Tspan-13, Tspan-15 
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Figure 4.9 Tspan proteins surface expression on the cell surface of A549 cells. 
The analysis was performed by flow cytometry on A549 cells. A: Dot plot showing the gated 
population (encircled) of A549 selected for analysis according to their side scatter (SSC) and 
forward (FCS) characteristics. B: The means of median fluorescence intensities relative to 
their isotypes. The results were the mean (± SEM) of 4 independent experiments each 
performed in 2 technical replicates.  
4.3.8 Tspan proteins expression following B. thailandensis 
infection 
This experiment was performed to investigate if the selected Tspan proteins 





Tspan-13, CD9 and CD81 proteins on the cell surface were investigated at 
18hr post-infection using flow cytometry. Interestingly, the results show an 
elevation in the levels of Tspan-2 and Tspan-13 during infection by B. 
thailandensis CDC272 and WT E264 compared with their levels during 
infection by mutant B. thailandensis E264-ΔtssK. However, the results show 
that the levels of CD9 and CD81 did not change during infection by B. 
thailandensis CDC272 or WT E264 and E264-ΔtssK, as shown in Fig 4.10. 
These data indicate that whilst Tspan-2 and Tspan-13 may have a role in 































































































































Figure 4.10 Tspan-2, Tspan-13 and CD9 proteins change in response to B. 
thailandensis infection on the surface of A549 cells. 
A549 cells were infected with fusogenic B. thailandensis CDC272 and WT E264 or non-
fusogenic mutant (E264-ΔtssK). A549 cells left uninfected were used as controls. After 18hr 
of infection, the cells were stained with primary anti-Tspan antibodies and labelled secondary 
antibodies and then analysed by flow cytometry. Expression of Tspan proteins after infection 
were normalized to the levels on uninfected cells (100%). The significance of differences was 
tested by one-way ANOVA, where ** p<0.01; *** p<0.001 significant; ns=non-significant. The 
results are the means (± SEM) of 3 independent experiments each performed in 2 technical 
replicates. 
4.3.9 Gating strategy to detect fused and/or infected cells using 
flow cytometric analysis. 
To determine if CD9 expression changed only on infected and/or fusing cells, 
we devised a strategy to measure levels only on these cells. It was expected 
that the fused or infected cells would be larger and located in lower right 
quadrant (Q3) of an SSC/FSC, as shown in Fig 4.11. The percentage of A549 
infected cells by B. thailandensis CDC272 was about 13.1%, while the 
percentage was 11.3% for A549 cells infected with B. thailandensis E264. 
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Furthermore, the percentage of A549 cells infected with E264-ΔtssK is about 
8%. However, it is possible that some MGC would be too large to flow through 
the cytometer nozzles and these would be excluded from this analysis. The 
data showed that there is a significant reduction of CD9 on A549 cells after 
18hr E264 infection but not CDC272 (Fig 4.12). Other Tspans did not show 




Figure 4.11 Gating strategy to detect fused or/and infected cells using flow 
cytometric analyses. 
The dot plots show A549 cells gated according to forward scatter (FSC), and side scatter, the 
Q3 gates show fused cells infected by B. thailandensis.The graphs represented for the means 
(± SEM) of 3 independent experiments each performed in 2 technical replicates. 
A: Uninfected cells  B: Infected cells+E264-ΔtssK 




















































Figure 4.12 CD9 expression changed in response to B. thailandensis infection 
on the surface of A549 cells after gating strategy. 
A549 cells were infected with either fusogenic B. thailandensis CDC272 or E264 and non-
fusogenic mutant (E264-ΔtssK) for 2hr. A549 cells left uninfected were used as controls. After 
16hr of kanamycin and amikacin treatment, cells were stained with primary anti-CD9 antibody 
and secondary antibody and then analysed by flow cytometry. Percentages of MFI of gated 
larger A549 cells from Q3 after infection were normalized to uninfected cells. The significance 
of differences was measured by unpaired t-test, where * p < 0.05 significant; ns=non-
significant. The results are the means (± SEM) of 3 independent experiments each performed 
in 2 technical replicates. 
4.3.10 Time-courses of downregulation or upregulation of selected 
Tspan proteins on the surface of A549 cells 
The levels of CD9, CD81, Tspan-2 and Tspan-13 proteins on the cell surface 
during the infection were also investigated at different time courses to try and 
correlate Tspan proteins expression with the onset of fusion. The 
quantification was performed using flow cytometry, as described in section 
2.2.3.5. Briefly, both infected and uninfected cells were harvested and washed 
with BBN. Appropriate primary antibodies were incubated with cells for 45min. 
A FITC-labelled secondary antibody was used at the recommended 
concentration. The negative controls here were cells treated with the binding 
buffer BBN or irrelevant antibody with the same isotype. The MFI was 
normalized to uninfected cell expression levels for all samples. The results 
show that Tspan-13 and Tspan-2 expression during bacterial infection did not 
change at 2 and 8hr after infection, but showed a significant increase after 
18hr infection, compared with uninfected cells. Expression of CD9 and CD81 
significantly increase after 8hr infection and then reduced at the later time 
points. Tspan-13 and Tspan-2 expression were correlated with mRNA levels 
at the same time points. CD9 and CD81 showed differences between mRNA 















































































































































































































































































































































Figure 4.13 Time-courses of Tspan proteins expression on the surface of A549 
cells in response to B. thailandensis infection. 
A549 cells were infected with either fusogenic B. thailandensis CDC272 or E264 and non-
fusogenic mutant (E264-ΔtssK). A549 cells left uninfected were used as controls. Samples 
were taken at 2, 8 and 18hr after the initial infection. Cells were stained with primary 
antibodies and analysed by flow cytometry at each time course of infection. The significance 
of differences was tested by one-way ANOVA, where * p<0.05; ** p<0.01 significant; ns=non-
significant (vs control uninfected cells). The results are the means (± SEM) of 3 independent 
experiments each performed in 2 technical replicates. 
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4.3.11 Tspan-partner proteins expression on the surface of A549 
cells 
Only ADAM10, CD98 and CD172α were measured on the surface of A549 
cells by flow cytometry as described in section 2.2.3.2.1. To do this, we used 
FACS analysis of the binding of these antibodies to live A549 cells. Cells were 
harvested using a non-enzymatic cell dissociation solution and stained, as 
described in section 2.2.3.2.1. A FITC-labelled secondary antibody was used 
at the manufacturer’s recommended concentration 1:250. The negative 
controls here were cells treated with the binding buffer BBN or irrelevant 
antibody with the same isotype control. The data showed that ADAM10, CD98 
and CD172α were expressed on the surface of A549 cells, with high levels of 























Figure 4.14 Tspan-partner proteins expression on the surface of A549 cells. 
The analysis was performed by flow cytometry on A549 cells. Primary anti-ADAM10, CD98 
and CD172α antibodies in BBN were used with non-specific mouse IGg1a as isotype control. 
Secondary antibodies were an anti-mouse IgG-FITC antibody for anti-ADAM10, while anti-
CD172α was a conjugated antibody A: Dot plot showing the gated population (encircled) of 
A549 selected for analysis according to their side scatter (SSC) and forward (FCS) 
characteristics. B: The means of median fluorescence intensities relative to their isotypes. 




Non-stained cells  Isotype – cells   Stained cells  
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4.3.12 Tspan-partner proteins expression following B. 
thailandensis infection 
The expression of Tspan-partner proteins was investigated to determine if a 
change occurs in response to infection with the WT strain, but remains 
unchanged with the mutant strain. Briefly, both infected and uninfected cells 
were harvested and washed with BBN. Appropriate primary antibodies were 
incubated with cells for 45min. A FITC-labelled secondary antibody was used 
at the recommended concentration. The negative controls here were cells 
treated with the binding buffer BBN or irrelevant antibody with the same 
isotype. Interestingly, the results show that there is no change in the level of 
ADAM10, and CD98 did not change in response to both WT and E264-ΔtssK 
infection. However, CD172α was observed to significantly decrease after 
infection by B. thailandensis CDC272 and E264 compared with the level of 














































































































Figure 4.15 Tspan-partner proteins expression in response to B. thailandensis 
infection of A549 cells. 
A549 cells were infected with either fusogenic B. thailandensis CDC272 and WT E264 or non-
fusogenic E264 ΔtssK. A549 cells left uninfected were used as controls. After the 16hr of 
kanamycin and amikacin treatment, cells were stained with primary antibodies and analysed 
by flow cytometry. Expression of Tspan-partner proteins after infection was normalized to the 
expression on uninfected cells. The significance of differences to ΔtssK was measured by t-
test, where * p<0.05 significant. The results are the means (± SEM) of 3 independent 
experiments each performed in 2 technical replicates. 
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4.3.13 Time-courses of Tspan-partner proteins expression 
following B. thailandensis infection on A549 cells 
The levels of Tspan-partner proteins were measured over time during 
bacterial infection. These molecules might have a role in the MGC formation 
as negative or positive regulators. ADAM10 expression during bacterial 
infection was increased significantly after 8hr and then reduced compared 
with uninfected cells, while CD98 was only increased significantly during 8hr 
infection compared with infected cells by E264-ΔtssK (Fig 4.16). However, 
CD172α did not change after 2hr and 8hr infection but was significantly 
decreased after 18hr infection compared with uninfected cells and infected 
cells by E264-ΔtssK. It seems that there is no correlation between mRNA and 
protein expression for either ADAM10 and CD98. It is also apparent that 
CD172α was decreased in response to bacterial infection and that there are 






















































































































































































































































Figure 4.16 Time-courses of Tspan-partner proteins expression on the surface 
of A549 cells in response to B. thailandensis infection. 
A549 cells were infected with either fusogenic B. thailandensis CDC272 or E264 and non-
fusogenic mutant (E264-ΔtssK). A549 cells left uninfected were used as controls. Samples 
were taken at 2, 8 and 18hr from the initial infection. Cells were stained with primary 
antibodies and analysed by flow cytometry at each time point. The significance of differences 
was tested by one-way ANOVA, where * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 
significant; ns=non-significant. The results are the means (± SEM) of 3 independent 





This chapter focused on Tspans expression at the mRNA and the protein 
levels in J774.2 and A549 cells. In addition, some innate immunity and cell 
signalling genes were also examined. The hypothesis behind this work was 
conceived following previous reports that Tspans and Tspan-associated 
proteins have a role in MGC formation and/or B. thailandensis infection of 
these two cell lines.  
4.4.1 Tspans expression change at the mRNA and protein levels 
following B. thailandensis infection 
The main aim was to detect which Tspan molecules are changed during B. 
thailandensis infection and/or MGC formation. Here, all 33 human and 31 
mouse Tspans had detectable at mRNA in uninfected A549 and J774.2 cells; 
10 Tspans were found to change post-infection but only 5 Tspans showed 
consistent changes in both host cell types and no change with E264-ΔtssK 
(Tspan-2, Tspan-5, Tspan-13, CD81 and CD9) (Fig 4.4). The mRNA levels of 
Tspan-2 and Tspan-13 increased but mRNA levels of Tspan-5, CD81 and 
CD9 decreased. It would be predicted that there might be an essential role for 
these proteins primarily in MGC formation rather than a bacterial infection. To 
our knowledge, there is no other study that has systematically measured 
Tspan genes expression during bacterially-induced MGC formation. 
In sections 4.3.3 and 4.3.10, these 5 Tspans were selected for further study 
using 2-18hr time courses. All of these appeared to correlate quite closely 
with the onset of fusion in both cell types. Expression of Tspan-2, Tspan-5 
and Tspan-13 at the mRNA level in the earlier stages of infection increased 
rapidly, perhaps indicating that the cells increased gene expression to 
improve their ability to engulf bacteria. However, Tspan-5 decreased in the 
later stages of infection. It seems that Tspan-5 has a different role during 
bacterial infection, while Tspan-2 and Tspan-13 might promote bacterial 
infection and might also induce MGC formation. Flow cytometry confirmed 
changes at the protein level for only 2 Tspans (Tspan-2 and Tspan-13). CD9 
and CD81 mRNA were reduced during the later stages of the fusogenic 
bacterial infection but reductions were not seen at the protein level (Figs 4.5 
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and 4.13). That does not mean that CD9 and CD81 have no role in MGC 
formation because larger fusing cells with reduced protein levels may not be 
detectable by flow cytometry as MGC could be too large to flow through the 
cytometer nozzles. There are only a limited number of publications on Tspan 
functions in MGC formation. For example, Iwai et al. have tested CD9 at the 
mRNA level in RAW264 cells and found that CD9 expression increases during 
osteoclastogenesis (Iwai et al., 2007). These results were different from our 
finding that expression of CD9 in both J774.2 and A549 cells was decreased 
during MGC formation. In addition, we attempted to analyse the results on the 
principles of flow cytometric analysis, which are the larger cells would be in 
the same location in plotting (Fig 4.11). It was observed that only CD9 in 
infected cells was reduced compared with uninfected cells (Fig 4.12). Our 
finding here was supported by Takeda et al. who found that CD9 has a 
negative role in MGC (Takeda et al., 2003). 
Iwai et al. also observed that the expression of Tspan-13 decreased and 
Tspan-5 increased during osteoclastogenesis (Iwai et al., 2007). Our findings 
suggest that Tspan-13 and Tspan-5 may have different roles in Burkholderia-
induced MGC formation. Zhou et al. also found that Tspan-5 was upregulated 
in RAW264 cells during osteoclastogenesis (Zhou et al., 2014). This result 
also did not correlate with ours in regards to Tspan-5. It seems that Tspan-5 
and Tspan-13 play different roles during fusion, depending on the types of 
inducers.  
4.4.2 Tspan-partners expression change at the mRNA and protein 
levels following B. thailandensis infection 
There are studies that report that Tspan-partner proteins, including CD98, 
CD44, CD47 and DC-STAMP, are important in macrophage fusion (Ozge et 
al., 2009, Yagi et al., 2005, Martinez et al., 2009, Weiguo et al., 2006). Here, 
we investigated 12 Tspan-partners after 18hr of infection with B. 
thailandensis. The expression of 5 Tspan-partners at the mRNA level was 
found to change post-infection, but only 3 showed consistent changes in both 
host cell types and no change with E264-ΔtssK (ADAM10, CD172α and 
CD98) (Fig 4.7). We observed that ADAM10 and CD172α decreased at the 
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mRNA level, whereas CD98 significantly increased. Interestingly, flow 
cytometry confirmed changes at the protein level at 18hr only for CD172α (Fig 
4.15). That does not mean there is no role for ADAM10 and CD98 in MGC 
formation induced by B. thailandensis because a large MGC cannot flow 
through the cytometer nozzles and some expression changes at the later 
stages of fusion may have been missed.  
These findings were not in agreement with Gautam and Acharya who found 
that CD172α and CD47 gene expression were increased in cells stimulated by 
Hsp70–peptide complex to form MGC (Gautam and Acharya, 2014). 
However, Verrier et al. observed that ADAM10, 17 and 15 decreased during 
osteoclastogenesis (Verrier et al., 2004). This finding is in agreement with our 
data that shows ADAM10 decreases during MGC formation. We found that 
CD98 gene expression at 18hr increased in response to bacterial infection, 
but CD98 protein expression significantly increased only at 8hr infection (Fig 
4.16). This finding is supported by Suparak et al. who showed that CD98 
increased after B. pseudomallei infection (Suparak et al., 2011). Paola et al. 
have shown that CD98 has a role in MGC formation by activating integrin in a 
human placental trophoblast cell line (BeWo) (Paola et al., 2007). Yoshiki and 
Boyd have also demonstrated the positive role of CD98 in MGC formation 
(Yoshiki and Boyd, 2004). It seems that CD98 may also have a role in MGC 
formation and/or bacterial infection. 
4.4.3 Innate immune molecules and cell signalling genes following 
infection with B. thailandensis in A549 and J774.2 cells 
It is known that some innate immune molecules and cell signalling genes 
have a role in bacterial infection with many cell types. It is also known that this 
bacterium induces expression of SOCS3, which inhibits concomitant iNOS 
activation (Ekchariyawat et al., 2005).  
Changes in gene expression of p53, caspase-1 and SOCS3 genes were 
detected in response to B. thailandensis infection in both cell types. However, 
they were also changed after infection with the non-fusogenic mutant (E264-
ΔtssK), suggesting that these are primarily involved in infection rather than 
fusion (Fig 4.8). These data were partly supported by Ekchariyawat et al who 
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observed that B. pseudomallei can increase expression of SOCS3 
(Ekchariyawat et al., 2005). A study has also shown that three factors (p53, 
caspase-1 and caspase-3) were involved in apoptosis and pyroptosis 
(Crighton et al., 2007). Kang et al. have found that caspase-1 was up-
regulated in response to infection with both B. pseudomallei (Kang et al., 
2016). Polyak et al. demonstrated that p53 could induce apoptosis via the 
generation of reactive oxygen species that damage mitochondria (Polyak et 
al., 1997). It could be suggested that infected cells were ready to undergo 




Chapter 5 Distinct roles for Tspans and Tspan-
partner proteins in MGC formation during B. 
thailandensis infection 
5.1 Introduction 
It has been widely shown that B. thailandensis and B. pseudomallei can 
induce MGC formation by bacterial effectors (Toesca et al., 2014, Schwarz et 
al., 2014). It is possible that the bacteria can regulate this process by affecting 
the expression of host cell membrane molecules, including Tspan members. It 
has been found that anti-CD9 antibody and recombinant soluble forms of the 
extracellular domain (EC2) of CD9 have a negative effect on bacterial 
adhesion to epithelial cells, including adhesion of E. coli, S. aureus and N. 
meningitides (Green et al., 2011). Furthermore, Hassuna has shown that CD9 
is implicated in S. typhimurium infection of monocyte-derived macrophages at 
different stages (Hassuna, 2010). Furthermore, our research team have 
observed that using antibodies against mouse CD9, CD81 and CD63 
enhances MGC formation in J774.2 and RAW264 mouse macrophages cell 
lines infected with B. thailandensis (Elgawidi, 2016). 
In this chapter, we investigated the roles of the Tspans and partner proteins 
identified in chapter 4, using antibodies, recombinant proteins and a peptide 
derived from CD9EC2. This may give clues about the mechanism of infection 
and MGC formation. 
5.2 Aims 
To investigate the effects on bacterial infection and MGC formation of A549 
cells of: 
1) anti-human antibodies against CD9, CD81, Tspan-2, Tspan-13, 
ADAM10, CD98 and CD172α; 
2) over-expressed proteins, recombinant GST-CD9EC2 and CD9EC2-
derived peptide. 
The possible co-localization of B. thailandensis with CD9GFP in the mouse 




5.3.1 Role of CD9 in infection and MGC formation 
5.3.1.1 The effect of anti-CD9 antibody on bacterial infection in A549 cells 
This experiment was to investigate if there is any role for CD9 in B. 
thailandensis infection, in particular, the total bacterial infection and 
internalisation in A549 cells after 2hr infection. The infection assay was 
performed as described in section 2.2.5. In brief, A549 cells were seeded in 
96 well plates and some treated for 1hr with the anti-CD9 antibody. Both 
treated and untreated cells were infected with B. thailandensis CDC272 and 
E264. To count the total bacterial infection, the wells were washed 3x with 
HBSS and lysed by the addition of 100μl of 1% TritonX-100 for 15min. To 
count only internalised bacteria, the cells were cultured with DMEM containing 
antibiotics, washed, and lysed using TritonX-100. The lysis mixture was 
serially diluted before 10μl of each dilution was pipetted onto LB agar plates. 
After 48hr of incubation at 37oC, colonies were counted and used to calculate 
CFU per well. Data showed that anti-CD9 antibody has no effect on the total 
bacterial infection associated with cells or internalisation when compared with 
the effect of isotype antibody control on both B. thailandensis strains (Fig 5.1). 























































































































































Figure 5.1 Effect of anti-CD9 antibody on total B. thailandensis infection. 
A549 cells were pre-treated with isotype control (JC1) and anti-CD9 antibody before infection, 
as described in section 2.2.7. Bars total number of bacteria and/or internalised bacteria per 
10000 cells for A549 cells infected by two bacterial strains, CDC272 and E264. The effects of 
anti-CD9 treatments were tested against the isotype control by unpaired t-test, where ns=non-
significant. The results were the mean for 3 independent experiments each performed in 4 
technical replicates. 
5.3.1.2 The effect of anti-CD9 and anti-CD81 antibodies on MGC formation 
induced by B. thailandensis in A549 cells 
This experiment was performed using anti-human antibodies against CD9 and 
CD81, as described in section 2.2.8. To do this, A549 cells were seeded in 
96 well plates and treated for 1hr with anti-CD9 and anti-CD81 antibodies. 
Then the cells were infected with B. thailandensis CDC272 and E264 for 2hr 
and then changed the medium to DMEM containing antibiotics for 16hr. The 
fusion index was quantified relative to unfused cells per field of view. MGCs 
were defined as cells containing 3 or more nuclei. Data shows that anti-CD9 
and anti-CD81 antibodies enhanced MGC formation when compared with the 
effect of isotype control in both bacteria strains, and increased the nuclei per 
MGC, as shown in Fig 5.2. Effect of anti-CD81 antibody on bacterial infection 
was tested, as shown in section 5.3.2.1. It might be that CD9 and CD81 may 

















































































































































Figure 5.2 Effect of anti-CD9 and CD81 antibodies on MGC formation induced 
by both B. thailandensis CDC272 and E264. 
A549 cells were pre-treated with isotype control and anti-CD9 and CD81 antibodies before B. 
thailandensis infection, as described in section 2.2.7. Bars show the fusion index and nuclei 
per MGC for A549 cells infected with both strains of B. thailandensis. The effects of different 
treatments were tested by unpaired t-test, where * p<0.05; ** p<0.01 significant. The results 
were the mean for 3 independent experiments each performed in 4 technical replicates. 
5.3.1.3 Effect of CD9 over-expression on the total bacterial infection and 
internalised bacteria in J774.2 cells 
This study aimed to compare the total bacterial infection at 2hr and 
internalised bacteria at 18hr in WT J774.2 and cells over expressing GFP 
(GFPJ774.2) or mouse CD9GFP (CD9GFPJ774.2). Transfected and non-
transfected J774.2 cells were seeded in 96 well plates and infected with either 
CDC272 or E264 strains for 2 and 18hr. The results show that there are no 
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differences between WT J774.2, GFPJ774.2 and CD9GFPJ774.2 cell lines for 









































































Figure 5.3 Comparison of total number of bacteria and internalised bacteria at 
2 and 18hr in J774.2 cells expressing GFP or CD9GFP. 
WT, GFP and CD9GFPJ774.2 cells were washed two times before infection, as described in 
section 2.2.7. A: Bars show total number of bacteria after 2hr per 10000 cells for J774.2 cells 
infected by both B. thailandensis strains, CDC272 and E264. B: Bars show internalised 
bacteria after 18hr per 10000 cells for J774.2 cells infected by two B. thailandensis strains, 
CDC272 and E264. The effects of different treatments were tested by unpaired t-test, where 
ns=non-significant. The results are the means (± SEM) of 3 independent experiments each 
performed in 4 technical replicates. 
5.3.1.4 Effect of CD9 over-expression on MGC formation induced by B. 
thailandensis 
B. thailandensis CDC272 and E264 have the ability to cause similar levels of 
MGC formation in GFP, CD9GFP and WT J774.2 cells following infection 
when compared with uninfected cells, as shown in section 3.3.2.1. The GFP, 
CD9GFP and WT J774.2 cells were infected at MOI 0.5, 1 and 3 for 2hr, and 
then the medium was changed to DMEM containing amikacin and kanamycin 
for 16hr. The cells were fixed and stained to count the fusion index. 
Interestingly, the fusion index in CD9GFPJ774.2 cells infected at these MOI 
values was significantly lower than the fusion index of GFPJ774.2 cells for 
both bacterial strains (Fig 5.4). This may be evidence to support the previous 

























































            Figure 5.4 Effect of CD9 over-expression on MGC formation induced by both B. 
thailandensis strains. 
GFP, CD9GFP and WT J774.2 cells were infected as described in section 2.2.8. Bars show 
fusion index in J774.2 cells infected by two B. thailandensis strains, CDC272 and E264. Black 
bars show the fusion index for WT J774.2; black bars with green border show the fusion index 
for GFPJ774.2; green bars show the fusion index for CD9GFPJ774.2 at MOI 0.5, 1 and 3. 
The effects of different treatments were tested by two-way ANOVA, where * p<0.05; ** p<0.01 
significant; ns=non-significant. The results are means (± SEM) of 3 independent experiments 
each performed in 8 technical replicates. 
5.3.1.5 Co-localisation of B. thailandensis and CD9GFP 
The above data showed that the over-expression of CD9GFP has a negative 
effect on MGC induction by B. thailandensis. This work was to investigate if 
CD9 may have co-localisation with attached or internalised B. thailandensis 
CDC272 or E264 using fluorescence microscopy. In this study, bacteria were 
transfected with plasmids encoding mCherry fluorescent proteins as 
described in section 2.2.3. The CD9GFPJ774.2 cells were infected by 
bacteria for 2hr. Then the cells were treated with DMEM containing antibiotics 
for 3hr, and cells were fixed with PFA 2%. Coverslips were mounted using 
Vectashield (with DAPI) and sealed onto slides, in darkness. The finding 
shows that there is only a slight co-localization of CD9 with the CDC272 strain 
while finding shows that there is no co-localisation between CD9 and the 




Figure 5.5 Fluorescent micrographs of CD9GFPJ774.2 cells infected by both B. 
thailandensis strains. 
CD9GFPJ774.2 cells were infected for 2hr, washed by HBSS 2x and incubated with media 
containing 500μg/ml kanamycin and amikacin to kill all extracellular bacteria. Then, infected 
cells were incubated for 2hr, washed 2x and fixed for 10min, then stained. The blue colour 
indicates nuclei were stained with DAPI, the green colour indicates CD9GFP, and the red 
colour means bacteria labelled with mCherry. The images are representative of several fields 
of view from a single experiment. 
5.3.1.6 CD9-derived peptide 8005 and CD9EC2 functional studies on MGC 
formation and bacterial infection 
The EC2 is variable in length and amino acid sequence among Tspans. This 
region is thought to be important for Tspan-partner interactions, and 
consequently, it facilitates Tspan functions (Takeda et al., 2003, 
Parthasarathy et al., 2009, Yáñez-Mó et al., 2001). Recombinant protein 
corresponding to EC2 of Tspans is an alternative tool to mAbs that are used 
in determining Tspans functions. This protein is expressed in E. coli as fusion 
protein with glutathione S-transferase (GST). This GST fusion protein is 
soluble and stable, so it can be purified using non-denaturing procedures 
(Smith and Johnson, 1988). Previous work in the laboratory has shown that a 
peptide (8005; 40 amino acids) directly derived from the sequence of the EC2 
of CD9 has potent anti-adhesive effects against S. aureus (unpublished data, 
Rahaf Issa) and P. aeruginosa in epithelial cell lines (Alrahimi, 2017). In 
addition these peptides have no adverse effects on bacterial metabolism 
(unpublished data, Rahaf Issa) and may be an important new class of 
antibacterial agents. 
E264-mCherry-infected CD9GFPJ774.2 cells 
50μm 50μm 
CDC272 mCherry-infected CD9GFP J774.2 cells 
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5.3.1.6.1 CD9-derived peptide 8005 effects on B. thailandensis growth 
The effects of 8005 peptides on the growth of B. thailandensis in LB broth is 
shown in Fig 5.6. 500nM peptide 8005 and SCR peptide were added to LB 
media, and then the bacteria were inoculated. Data showed that there is no 
effect of 8005 or SCR growth at any time point.  


































Figure 5.6 Effect of CD9-derived peptide 8005 on B. thailandensis growth. 
B. thailandensis was cultured in LB media with normal saline, control (SCR) or 8005 peptides. 
Both strains of bacteria were incubated in a shaking incubator, and OD600 was measured at 
different time points. Data are means (± SEM) of 2 independent experiments each performed 
in 2 technical replicates.  
5.3.1.6.2 CD9-derived peptide 8005 effects on infection of A549 cells with B. 
thailandensis  
The effects of 8005 peptides on the total bacterial infection and internalised B. 
thailandensis of A549 cells are shown in Fig 5.7 and Fig 5.8. The infection 
assay was performed and the cells were treated with 8005 and SCR peptide 
for 1hr. The cells were washed and infected with B. thailandensis for 2 and 
18hr. To count the total number of bacteria after 2hr, the wells were washed 
3x with HBSS and lysed by the addition 1% TritonX-100 for 15min. To count 
internalisation after 2hr and bacterial replication after 18hr, the cells were 
cultured with DMEM containing antibiotics, washed, and lysed after 2 and 
18hr using TritonX-100. The lysis mixture was serially diluted and plated onto 
LB agar plates. After 48hr of incubation at 37oC, colonies were counted and 
used to calculate CFU per well. Pre-treatment of cells with 8005 and SCR 
peptides at a concentration of 25, 50, 100 and 200nM significantly reduced B. 
thailandensis infection, in terms of the number of infected cells at 2hr 
compared to untreated and control peptide treatment. The results also 
showed that there is a reduction in the number of intracellular bacteria after 2 
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or 18hr with 8005 peptide compared with SCR and untreated A549 cells, 
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Figure 5.7 CD9-derived peptide 8005 reduces total B. thailandensis infection of 
A549 cells. 
Cells were treated with different concentrations of CD9 peptide 8005 or SCR control for 
60min, and then infected with bacteria for 2hr. They were then washed 2x and lysed with 
TritonX-100 and bacteria quantified by CFU to count the bacterial infection (bacteria per 
10000 A549 cells). The treated cells were infected for 2hr, they were then washed 2x and 
treated with amikacin and kanamycin for 1hr, and then infected cells were lysed with TritonX-
100 to quantify the internalised bacteria effects of different treatments. The effects of different 
treatments were tested by unpaired t-test where * p<0.05 significant; ns=non-significant. The 
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Figure 5.8 Effect CD9-derived peptide 8005 reduces B. thailandensis internalisation 
at 2 and 18hr in A549 cells. 
Cells were treated with different concentrations of CD9 peptide 8005 or SCR control for 
60min, then infected with bacteria for 2hr. They were then washed 2x, treated with amikacin 
and kanamycin, and incubated for a further 16hr to count internalised bacteria. The total 
bacterial infection was at MOI 5 per 10000 A549 cells. The effects of different treatments 
were tested by unpaired t-test where * p<0.05; ** p<0.01 significant; ns=non-significant. The 
results are the means (± SEM) of 3 independent experiments each preformed in 3 technical 
replicates. 
5.3.1.6.3 Effect of CD9-derived peptide 8005 on MGC formation induced 
by both B. thailandensis strains 
The effects of 8005 peptides on MGC induced by B. thailandensis was 
investigated. To do this, the fusion assay was conducted. The cells were 
treated with 8005 peptides and SCR after and before infection to determine if 
the effects of peptide related primarily to bacterial infection or fusion. After 
treatment with peptide for 1hr, cells were infected for 2hr and then incubated 
for 18hr with DMEM containing amikacin and kanamycin. The fusion index 
was quantified as described in 2.2.6. Pre-treatment of A549 cells with 8005 at 
concentrations of 25, 50, 100 and 200nM significantly reduced MGC formation 
induced by B. thailandensis infection. Data also showed that GST-CD9EC2 
treated cells showed no reduction in MGC formation (Fig 5.9A). However, 
there was no reduction in MGC formation when the cells were infected for 2hr 
and then treated with 8005 or SCR (Fig 5.9B). This suggests that 8005 has a 
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Figure 5.9 Effect of CD9-derived peptide 8005 and GST-CD9EC2 on MGC 
formation induced by both B. thailandensis in A549 cells. 
A: Cells were pre-treated with different concentrations of peptide 8005, GST-CD9EC2 or 
control scrambled peptide for 60min, and then infected with bacteria for 2hr. B: Cells were 
infected for 2hr and then pre-treated with peptide 8005 or control scrambled peptide for 
60min. The effects of different treatments were tested by unpaired t-test where * p<0.05 ** 
p<0.01 *** p<0.001 significant. The results are the means (± SEM) of 4 independent 
experiments each preformed in 3 technical replicates. 
5.3.2 Role of Tspan-2 and Tspan-13 in B. thailandensis infection 
and MGC formation in A549 cells 
The anti-Tspan-2 antibody and cells over-expressing Tspan-2 were provided 
by Ibrahim Yasseen, and all experiments to investigate the role of Tspan-2 on 
A549 cell infected by B. thailandensis CDC272 were performed by me with a 
previous PhD student from University of Sheffield, Yaseen (Yaseen, 2017). 
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5.3.2.1 Effect of anti-CD81, anti-Tspan-2 and anti-Tspan-13 antibodies on 
bacterial infection of A549 cells 
The present study was conducted to investigate the possible roles of CD81, 
Tspan-13 and Tspan-2 in the bacterial infection and MGC formation in A549 
cells. For infection, A549 cells were seeded in 96 well plates and some 
treated for 1hr with anti-CD81, anti-Tspan-2 and anti-Tspan-13 antibodies, or 
the relevant isotype controls. The treated and untreated cells were infected for 
2hr with B. thailandensis CDC272 and E264. To count the total bacterial 
infection, the cells were washed 3x with HBSS and lysed by the addition of 
100μl of 1% TritonX-100 for 15min. To count only internalised bacteria, the 
cells were cultured with DMEM containing antibiotics for 1hr, washed, and 
lysed using TritonX-100. The lysis mixture was serially diluted and plated onto 
LB agar plates for CFU counting. The results show that antibodies against 
Tspan-2 and Tspan-13 could significantly reduce B. thailandensis infection 
and internalisation compared with isotype control, while anti-CD81 antibody 
reduces internalisation compared with isotype control but not the total 
bacterial infection, as shown Fig 5.10. It seems that both Tspans play a role in 





























































































































































































































Figure 5.10 Effect of anti-Tspan-2, anti-Tspan-13 and anti-CD81 antibodies on 
B. thailandensis infection. 
A549 cells were pre-treated with isotype control (JC1, IgM), anti-CD81, anti-Tspan-2 and anti-
Tspan-13 antibodies before infection as described in section 2.2.7. Bars show total bacterial 
infection per 10000 cells for A549 cells infected by two bacterial strains. The effects of 
different treatments were tested one-way ANOVA, where * p<0.05; ** p<0.01 significant; 
ns=non-significant. The results are the means (± SEM) of 3 independent experiments each 
performed in 4 technical replicates. 
5.3.2.2 Effect of anti-Tspan-2 and anti-Tspan-13 antibodies on MGC formation 
induced by both B. thailandensis in A549 cells 
This experiment was performed to investigate the effect of anti-Tspan 
antibodies (anti-Tspan-2 and anti-Tspan-13) on MGC formation induced by B. 
thailandensis in A549 cells. Both treated and untreated cells were infected for 
2hr with both strains of WT bacteria and then cultured with media containing 
antibiotics for 16hr. The fusion index was quantified relative to uninfected cells 
per field of view. MGCs were defined as cells containing 3 or more nuclei. 
Data showed that antibodies against Tspan-2 and Tspan-13 significantly 
reduced the fusion index. Anti-Tspan-2 antibody-treated cells have a fusion 
index reduced by more than 40% compared with isotype control, and anti-
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Tspan-13 antibody showed more than 50% reduction compared with isotype 
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Figure 5.11 Effect of anti-Tspan-2 and anti-Tspan-13 antibodies on MGC 
formation induced by both B. thailandensis strains. 
A549 cells were treated with isotype or anti-Tspan-2 and anti-Tspan-13 antibodies after B. 
thailandensis infection for 2hr, as described in section 2.2.7. Bars show the fusion index for 
A549 cells infected by two types of strains. The effects of different treatments were tested by 
t-test, where * p<0.05; ** p<0.01 significant. The results are the means (± SEM) of 3 
independent experiments each performed in 4 technical replicates. 
5.3.2.3 Effect of Tspan-2 over-expression on bacterial infection 
This study aimed to compare total number of bacteria and internalised 
bacteria after 18hr in GFP, Tspan-2GFP and WT A549 cells. Our results have 
demonstrated that over-expression of Tspan-2GFP in A549 cells slightly 
increases the total number of bacteria by E264 but not CDC272 at 2hr 
compared with GFPA549 infected cells. However, there was no difference in 
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Figure 5.12 Over-expression of Tspan-2 increases B. thailandensis CDC272 
and E264 infection. 
GFP, Tspan-2GFP and WT A549 cells were infected as described in section 2.2.8. Bars 
show total number of bacteria after 2hr and internalised bacteria post 18hr of B. thailandensis 
strains, CDC272 and E264. Black bars show A549 infected with bacteria; black bars with 
green borders show Tspan-2GFPA549 cells infected with bacteria; green bars show GFP 
A549 cells infected with bacteria at MOI 5. The effects of different treatments were tested by 
one-way ANOVA, where * p<0.05 significant; ns=non-significant. The results are the means 
(± SEM) of 3 independent experiments each performed in 3 technical replicates. 
5.3.2.4 Effect of Tspan-2GFP expression on MGC formation induced by B. 
thailandensis 
The aim of this experiment was to determine if over-expression of Tspan 2-
GFP in A549 cells affects MGC formation induced by B. thailandensis. The 
GFP, Tspan-2GFP and WT A549 cells were infected by both B. thailandensis 
CDC272 and E264. Interestingly, the fusion index in Tspan-2GFPA549 cells 
was significantly increased compared with GFPA549 cells for both B. 
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Figure 5.13 Over-expression of Tspan-2 promotes MGC formation induced by 
both B. thailandensis strains. 
GFP, Tspan-2GFP and WT A549 cells were infected as described in section 2.2.8. Bars 
show fusion index and the number of nuclei per MGC in A549 cells infected by both B. 
thailandensis strains, CDC272 and E264. Black bars show the WT A549 cells; black bars with 
green borders show the GFPA549 cells; green bars show the Tspan-2GFPA549 cells infected 
at MOI 5. The effects of different treatments were tested by one-way ANOVA, where * 
p<0.05; ** p<0.01 significant. The fusion index is the means (± SEM) of 5 experiments 
preformed in 4 technical replicates. 
5.3.3 Role of Tspan-partner proteins ADAM10, CD98 and CD172α 
in B. thailandensis infection and MGC formation in A549 cells 
5.3.3.1 Role of ADAM10, CD98 and CD172α in B. thailandensis infection 
This experiment was to investigate if there is a role for ADAM10, CD98 and 
CD172α in B. thailandensis infection, using antibodies against these host 
surface proteins. Briefly, the cells were treated with antibodies or isotype 
controls for 1hr and washed 2x with HBSS to remove all nonspecific binding. 
They were then infected with B. thailandensis for 2hr. The infected cells were 
washed 2x and lysed using TritonX-100. The lysis mixture was serially diluted 
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and plated onto LB agar plates for CFU counting. The results show that anti-
ADAM10, CD98 and CD172α antibodies have no effect on total bacterial 
infection and/or internalisation when compared with isotype control antibodies 
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Figure 5.14 Effect of anti-ADAM10, anti-CD98 and anti-CD172α antibodies on B. 
thailandensis CDC272 and E264 infection of A549 cells. 
A549 cells were pre-treated with isotype control (JC1, IgG1 and IgG2) and anti-ADAM10, 
CD172α and CD98 antibodies before infection. Bars show the total number of bacteria and/or 
internalised bacteria per 10000 cells for A549 cells infected by two bacterial strains, CDC272 
and E264. The effects of different treatments were tested by one-way ANOVA, where 
ns=non-significant. The results are the means (± SEM) of 3 independent experiments each 
performed in 4 technical replicates. 
5.3.3.2 Roles of ADAM10, CD98 and CD172α in MGC formation 
ADAM10, CD98 and CD172α are known to be involved in the cell fusion 
process (Gautam and Acharya, 2014, Ohgimoto et al., 1995, Verrier et al., 
2004). It was also observed that the level of these 3 Tspan-partner proteins 
consistently changed in response to fusogenic B. thailandensis strains, with 
no change for the non-fusogenic mutant at both gene and protein levels as 
described in section 4.3.5 and section 4.3.12. The aim of this experiment 
was to investigate if antibodies against these proteins could affect MGC 
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formation after B. thailandensis infection. The cells were treated with anti-
ADAM10, anti-CD98 and anti-CD172α antibodies or isotype controls for 1hr 
and then washed. They were infected for 2hr and incubated with DMEM 
containing antibiotics for 16hr. The fusion index was quantified relative 
uninfected cells per field of view. MGCs were defined as cells containing 3 or 
more nuclei. Data shows that ADAM10 antibody enhanced MGC formation, 
and anti-CD172α antibody reduced MGC formation significantly when 
compared with isotype treatment for one fusogenic bacterial strain CDC272 
but not for E264. In contrast, the results show that there is no effect of 







































































































Figure 5.15 Anti-ADAM10, anti-CD98 and anti-CD172α antibodies reduce or 
enhance MGC formation induced by both B. thailandensis strains. 
A549 cells were pre-treated with isotype or anti-ADAM10, CD98 and CD172α antibodies 
before B. thailandensis infection, as described in section 2.2.7. Bars show the fusion index 
for A549 cells infected by both fusogenic strains. The effects of different treatments were 
tested by one-way ANOVA, where ** p<0.01; *** p<0.001 significant; ns= non-significant. The 
fusion index are the means (± SEM) of 3 independent experiments each performed in 4 
technical replicates. 
5.4 Discussion 
In this chapter, we investigated the roles of 4 Tspans (CD9, CD81, Tspan-2, 
and Tspan-13) and 3 Tspan-partner proteins (CD98, ADAM10 and CD172α). 
These were identified in chapter 4 as proteins that may have a role in either 
infection or/and MGC formation. 
5.4.1 CD9 may be a negative regulator of MGC formation 
The first aim of this study was to detect if CD9 plays a role in B. thailandensis 
infection. In section 5.3.1.1, the results showed that there is no effect of anti-
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CD9 antibody on the bacteria infection and internalisation for both bacterial 
strains in A549 cells (Fig 5.1). In section 5.3.1.4, the results also showed that 
over-expression of CD9 in J774.2 cells also has no effect on total bacterial 
infection after 2hr and internalised bacteria after 18hr. These results are in 
agreement with other data from our group. For example, Elgawidi found that 
anti-CD9 antibody has no effect on B. thailandensis infection of J774.2 and 
RAW264 mouse macrophages (Elgawidi, 2016). In contrast, anti-CD9 
antibody could decrease Salmonella infection of J774.2 cells and U937 
human macrophages (Hassuna et al., 2017). Furthermore, CD9 reduced the 
infection of N. meningitides (Green et al., 2011). Our team also observed that 
anti-CD9 antibody significantly reduced the infection of P. aeruginosa of U937 
and HaCaT cell lines (Alrahimi, 2017). 
The second aim of this study was to determine if CD9 plays a role in MGC 
formation induced by fusogenic strains of B. thailandensis. In section 5.3.1.2, 
data clearly showed that anti-CD9 antibody treatment enhances the MGC 
formation compared with isotype control (Fig 5.2). In addition, over-
expression of CD9GFP in J774.2 cells reduced MGC formation when 
compared with GFP and WT controls (Fig 5.4). These results are in 
agreement with findings of Takeda et al. who showed that anti-CD9 antibody 
enhances MGC formation (Takeda et al., 2003). Parthasarathy et al. have 
also demonstrated that anti-CD9 antibody promotes MGC formation 
(Parthasarathy et al., 2009). 
5.4.2 CD9-derived peptides and CD9EC2 reduce B. thailandensis 
infection and may inhibit MGC formation 
This work aimed to demonstrate if recombinant GST-CD9EC2 or a peptide 
derived from CD9EC2 could reduce the MGC formation and/or B. 
thailandensis infection of A549 cells. In section 5.3.1.5, we showed that pre-
treatment with peptide could decrease the total number of bacteria and/or 
internalised bacteria after 2 and 18hr in A549 cells. It has also been shown 
that these peptides can affect MGC formation (Figs 5.5, 5.6 and 5.7). 
However, we attempted to differentiate between treating cells before and after 
infection. The results showed that there is no effect on MGC formation if the 
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cells treated after infection. This suggests that the primary effect of these 
reagents is the inhibition of infection, rather than a direct effect on fusion.  
We compared these results with other findings. For example, a reduction is 
found in MGC formation using GST-CD9EC2, but there was no effect of a 
shorter human CD9EC2-derived peptide on MGC formation and bacterial 
infection of J774.2 mouse macrophages (Elgawidi, 2016). It has been 
observed that GST-CD9EC2 could reduce MGC formation stimulated by Con-
A (Parthasarathy et al., 2009). The effect of these peptides was seen with 
other bacteria such as P. aeruginosa by a previous PhD student from 
University of Sheffield (Alrahimi, 2017). In her work, it has been observed that 
peptide 8005 could reduce P. aeruginosa adhesion. Ventress et al. observed 
that the adhesion of S. aureus could be reduced using a range of shorter 
peptides derived from GST-CD9EC2 (Ventress et al., 2016).  
5.4.3 Tspan-2 and Tspan-13 are positive regulators of MGC 
formation and B. thailandensis infection 
Tspan-2 was investigated using anti-Tspan-2 antibody treatment and over-
expression of Tspan-2GFPA549 cells. Anti-Tspan-2 antibody reduced both 
MGC formation and total bacterial infection significantly compared with 
isotype antibody control. However, there were no differences between treated 
and non-treated infected cells in terms of bacterial internalisation. Tspan-2 
over-expression significantly promoted MGC formation and the total bacterial 
infection. Tspan-2 has been implicated in both bacterial infection and MGC 
formation. We attempted to differentiate between the two possibilities by 
treating cells both before and after infection. The results showed significantly 
reduced MGC formation. 
Tspan-2 has a similar sequence to CD81 and CD9 (Yaseen et al., 2017), both 
known to affect MGC formation in a range of systems (Takeda et al., 2003, 
Elgawidi, 2016, Hulme et al., 2014, Parthasarathy et al., 2009). It has been 
shown that Tspan-2 over-expression increases the size and number of 
cellular protrusions in host cells (Grossmann et al., 2015). It has also been 
shown that these cellular protrusions are implicated in MGC formation by 
myoblasts induced by B. thailandensis E264 (French et al., 2011). In addition, 
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Tspan-2 is known to play a proapoptotic role in B-cells by induction of JNK 
pathway (Hwang et al., 2016).  
Following treatment with an anti-Tspan-13 antibody before and after infection, 
the internalised bacteria or total bacterial infection reduced significantly, and 
the fusion index was decreased by more than 15% compared with control. We 
also attempted to differentiate between the two possibilities by treating cells 
before or after infection. The results showed significantly reduced MGC 
formation in both cases (Fig 5.14 and Fig 5.15). There are no previous 
studies on the role of Tspan-13 in bacterial infection. However, Tspan-13 has 
a negative role in osteoclast formation. For example, Iwai et al. have shown 
that Tspan-13 has negative effects on osteoclast formation stimulated by 
RANKL (Iwai et al., 2007).  
5.4.4 ADAM10, CD98 and CD172α have little effect on bacterial 
infection but CD172α may have a role in MGC formation in 
response to B. thailandensis infection 
Here, we investigated the potential role of these Tspan-partners on MGC 
formation and bacterial infection by pre-treating A549 cells with antibodies 
against ADAM10, CD98 and CD172α. As Fig 5.14 shows, all antibodies had 
no effect on bacterial infection. In contrast, it has been reported that anti-
ADAM10 antibody reduced the total bacterial infection of P. aeruginosa 
infecting lung cells (Antonelli et al., 2017). ADAM10 also has a positive role in 
S. aureus infection (Von et al., 2016). ADAM10 is also known as the receptor 
of α toxin of S. aureus (Otto, 2014, DuMont and Torres, 2014). Li et al. have 
shown that CD172αKO increased the Salmonella infection of the spleen in 
mice (Li et al., 2012). That would suggest CD172α has a negative role in 
Salmonella infection. Baral and Utaisincharoen reported that CD172α has a 
negative role on TLR signalling and it is a negative regulator of iNOS 
expression in B. pseudomallei-infected macrophages, which has an important 
role in B. pseudomallei killing (Baral and Utaisincharoen, 2012). However, 
there is no study to show the role of CD98 in other bacterial infection.  
In section 5.3.3, the antibody against ADAM10 had a large effect on fusion 
induced by B. thailandensis. The potential role of ADAM10 in MGC formation 
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is unknown. It was shown that ADAM10 can be regulated by TspanC8, which 
are important in many cell functions, in particular, cell fusion (Matthews et al., 
2017). Tspan-5 is a member of the TspanC8 family and is implicated in cell 
fusion of osteoclasts (Iwai et al., 2007).   
Here, it was shown that anti-CD172α antibody has no effect on MGC 
formation in A549 cells induced by B. thailandensis (Fig 5.15). This result was 
different from previous findings. For example, Suparak et al. showed that anti-
CD172α could partially suppress MGC formation induced by B. pseudomallei 
(Suparak et al., 2011). Furthermore, several studies have also reported that 
CD47 and CD172α can regulate macrophages fusion induced by LPS. 
CD172α is implicated in the cell fusion of macrophages (Yagi et al., 2005, Han 
et al., 2000, Suparak et al., 2011). It is possible that there is a different role for 
CD172α in different cells and different inducers.  
The anti-CD98 antibody also appears to promote the MGC formation induced 
by B. thailandensis (Fig 5.15). This result was in agreement with Suparak et 
al. who found that anti-CD98 could suppress MGC formation after infection 
with B. pseudomallei (Suparak et al., 2011). Interestingly, CD98 could 
modulate integrin β1, which is regulated by CD9 and CD81 (Cai et al., 2005). 
It is known that CD9 and CD81 are involved in the MGC formation (Takeda et 
al., 2003,Takeda et al., 2008).  
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Chapter 6 Effect of manipulating the gene 
expression of 3 Tspans and ADAM10 on B. 
thailandensis infection and MGC formation 
6.1 Introduction 
Many studies examined the effects of knockout of Tspan genes to investigate 
their roles in cell function. For example, CD9 has an essential role in 
fertilisation, as CD9 knockout mouse females have defects in sperm-egg 
fusion (Kaji et al., 2000). CD81 deletion from mice could affect the regulation 
of cell proliferation (Geisert Jr et al., 2002). The deletion of CD81 also could 
reduce fertility in female mice, and the double knockout of CD9/CD81 leads to 
complete female infertility (Rubinstein et al., 2006). However, the lack of CD9 
from bone marrow cells enhances MGC formation compared to those of WT 
(Takeda et al., 2003). CD9 and CD81 are involved in the formation of 
myofibrils. Furthermore, Takeda et al. (2003) have observed that double 
knockout of CD9/CD81 causes spontaneous cell fusion and increased 
osteoclastogenesis. Interestingly, our research team have previously 
observed that CD9 and CD82 knockout enhance MGC formation in mouse 
bone marrow-derived macrophages infected with B. thailandensis (Elgawidi, 
2016). 
Tspan-2 is a member of the Tspans family that has high sequence identity 
with CD9 and CD81, which have roles in cell fusion (Hemler, 2008, Yaseen et 
al., 2017). Tspan-13 is also implicated in many cell functions, for example, in 
the progress of cell fusion, and metastasis of breast cancer (Iwai et al., 2007, 
Arencibia et al., 2009). CD9 is a cell membrane coordinator protein and it can 
interact with other Tspans and other partner molecules (Hemler, 2003, 
Hemler, 2008). ADAM10 is a partner protein for several Tspans which has 
many cell functions, including the proteolytic release of many cell-surface 
proteins (Seipold and Saftig, 2016). ADAM10 also can be regulated by Tspan-
15 (Haining et al., 2012, Jouannet et al., 2016). 
Potential roles for Tspan-2, Tspan-13, CD81, CD9 and ADAM10 proteins in 
MGC formation and B. thailandensis infection were identified in chapter 4 and 
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chapter 5. To examine their roles in these processes, gene expression was 
disrupted. We tested 3 Tspans and ADAM10, however, we did not test CD81 
because it has a similar negative effect on MGC formation to CD9 and the 
sequence of CD81 is very similar to CD9. Furthermore, as Tspan-15 has a 
large effect on ADAM10 expression (Haining et al., 2012, Jouannet et al., 
2016), we also investigated Tspan-15 knockout (KO) in A549 cells whether it 
could affect the MGC formation and infection by B. thailandensis. ADAM10KO 
and Tspan-15KO A549 cells were provided by Dr Mike Tomlinson, University 
of Birmingham (UK) (Szyroka, 2019). CD9KO A549 cells were provided by Dr 
David Blake, Fort Lewis College (USA) (Blake et al., 2018). Tspan-15 is a 
member of the TspanC8 subfamily (Tspan-5, Tspan-10, Tspan-14, Tspan-15, 
Tspan-17 and Tspan-33). Interestingly, Haining et al. have described that 
ADAM10 expression reduced by around 50% in Tspan-15KO A549 cells when 
compared with WT A549 cells (Haining et al., 2012, Jouannet et al., 2016).  
6.2 Aims 
The aims of this chapter are to investigate the roles in bacterial infection and 
MGC formation of: a) Tspan-2, Tspan-13, CD9 and ADAM10 using 
knockdown (KD), and b) CD9, Tspan-15 and ADAM10 using KO. The KD 
cells lines were made using siRNA transfection of A549 cells, and KO cell 
lines were obtained from collaborators as detailed in chapter 2 (section 
2.4.1.3).  
6.3 Results 
6.3.1 Transfection of A549 cells with Smart Pool siRNA 
6.3.1.1 Delivery efficiency of Smart Pool siRNA 
Firstly, we needed to demonstrate that the Smart Pool siRNA transfection 
reagents could penetrate A549 cells. The efficiency of penetration was tested 
by both fluorescence microscopy and flow cytometry. To do this, 6mm 
coverslips were placed in 24 well plates and seeded with 1x105 cells/ml, and 
the fluorescently labelled non-targeting control reagent was added to the cells 
according to the manufacturer’s instructions. Secondly, to identify the 
optimum concentration, 25 or 100nM of Smart Pool siRNA or fluorescently 
labelled non-targeting reagents was added to 700µl serum free-DMEM, and 
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incubated for 24hr. Fluorescence microscopy was used to estimate the 
percentage of transfection by counting cells expressing the fluorescent control 
reagent. For flow cytometry, cells were grown and transfected in 24 well 
plates and washed 2x. Untreated and treated cells were analysed using flow 
cytometry as described in section 2.2.10. The results using 100nM of 
fluorescently labelled non-targeting siRNA showed that siRNA reagents KD 
penetrated more than 99% of A549 cells by flow cytometry, and fluorescence 
microscopy confirmed this (Fig 6.1). It seems that these reagents were 






































Figure 6.1 Determination of in vitro transfection efficiency by fluorescence 
microscopy and flow cytometry. 
A: A549 cells were pre-treated with control siRNA examination reagent for 24hr, and uptake 
maintained by fluorescence microscopy. B: A549 cells ratios transfected with control siRNA 
materials, and uptake maintained by flow cytometry. Abbreviation NT=non-transfected cells, 
Non-TM=cells treated with non-targeting control materials, and Fluor non-TM=cells treated 
with fluorescently labelled non-targeting control materials. The results are the mean for 2 
independent experiments each performed in 2 technical replicates.  






6.3.1.2 Expression of CD9, Tspan-13 and ADAM10 on A549 cells after 
treatment with siRNA KD reagents 
The A549 cells were treated with 100nM Smart Pool siRNA reagents to 
demonstrate the percentage of target knockdown after treatment with siRNA 
reagent using real-time qPCR and flow cytometry. The results show that when 
A549 cells were treated with appropriate siRNA materials, CD9 expression at 
total mRNA and protein levels was reduced by more than 70% compared with 
control non-targeting reagents. Data also shows that Tspan-13 also reduced 
more than 80% compared with the cells treated with non-targeting KD 
reagents. In addition, ADAM10 expression reduced more than 75% at the 
mRNA level, but only by 50% at the protein level on the cell surface 
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Figure 6.2 CD9, Tspan-13 and ADAM10KD at mRNA and protein levels in A549 
cells after 48hr treatment with Smart Pool siRNA and non-targeting KD 
materials. 
A549 were pre-treated with siRNA and then prepared to measure the mRNA and protein 
levels as described in section 2.2.8.1 and section 2.2.9. The effects of different treatments 
were tested by unpaired t-test, where * p<0.05; ** p<0.01 significant. Non-TM=cells treated 
with non-targeting control materials. The results are the means (± SEM) of 3 independent 
experiments each performed in 2 technical replicates. 
6.3.1.3 Expression of Tspan-2 on A549 wild type cells and Tspan-2KD cells 
by real-time qPCR and flow cytometry 
This work was performed jointly with a previous PhD student from University 
of Sheffield, Ibrahim Yaseen (Yaseen, 2017). Briefly, cells were grown 
overnight to reach 70-90% confluency prior to transfection. For one well of a 
6-well plate, separate solutions of 10µl of 100nM siRNA in 190µl DMEM-
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serum free and 5µl DharmaFECT reagent in 195µl DMEM-serum free were 
mixed and incubated for 5min at room temperature. The mixture was added in 
a dropwise fashion. After 24hr transfection, growth media were changed with 
fresh media. Cells were inspected for the gene KD after a further 48hr using 
qPCR or flow cytometry. The results show that there is a 40% reduction of 
Tspan-2 expression at the mRNA and protein levels compared with A549 cells 
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Figure 6.3 Effect of Tspan-2KD at mRNA and protein levels in A549 cells after 
72hr treatment with siRNA or non-targeting materials. 
A549 cells were transfected with DharmaFECT reagent and then were treated with 100nM 
siRNA or non-targeting materials, and then were prepared to measure the mRNA and protein 
levels as described in section 2.2.9 and section 2.2.10. The effects of different treatments 
were tested by unpaired t-test, where * p<0.05 significant. Non-TM=cells treated with non-
targeting control materials. The results are the means (± SEM) of 3 independent experiments 
each performed in 2 technical replicates. 
6.3.2 Effect of KD in B. thailandensis infection and MGC formation 
6.3.2.1 Effect of CD9KD on B. thailandensis infection and internalisation 
CD9KD Smart Pool siRNA-treated A549 cells were used 48hr post-
transfection. CD9KD and cells treated with non-targeting siRNA were infected 
for 2hr with B. thailandensis CDC272 and E264. Cells were washed 2x with 
HBSS and lysed to count the total number of bacteria by the addition of 100μl 
of 1% TritonX-100 for 15min. To count only internalised bacteria, the cells 
were incubated with DMEM containing antibiotics, washed and lysed using 
TritonX-100. The lysis mixture was serially diluted before 10μl of each dilution 
was plated onto LB agar plates for CFU counts. CFU was counted after 36hr 
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of incubation. The findings show that there is no significant difference 
between CD9KD cells or control cells treated with non-targeting reagents on 
the total bacterial infection or internalisation of both B. thailandensis strains, 
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Figure 6.4 Effect of CD9KD on B. thailandensis infection. 
A549 cells were pre-treated with KD reagents for CD9 before infection, as described in 
section 2.2.8. Bars show total number of bacteria and/or internalised bacteria per 10000 cells 
for A549 cells infected by both bacterial strains. The effects of different treatments were 
tested by unpaired t-test, where ns=non-significant. The results are the means (± SEM) of 3 
independent experiments each performed in 4 technical replicates. 
6.3.2.2 Effect of CD9KD reagents on MGC formation induced by B. 
thailandensis 
The aim was to investigate if the CD9KD could also affect MGC formation 
induced by B. thailandensis. To do this, we treated the cells with Smart Pool 
siRNA reagent for 48hr. The control and KD A549 cells were infected by 
bacteria for 2hr and then washed and incubated with DMEM containing 
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amikacin and kanamycin antibiotics for 16hr. The fusion index was quantified 
relative to uninfected cells per field of view. MGCs were defined as cells 
containing 3 or more nuclei. Only B. thailandensis CDC272 strain, MGC 
formation and the number of nuclei per MGC were increased significantly in 
CD9KD A549 cells compared with A549 cells treated with non-targeting KD 






















































































































Figure 6.5 Effect of CD9KD on MGC formation induced by both B. thailandensis 
strains. 
A549 cells were pre-treated CD9 siRNA KD reagents for 48hr and were infected B. 
thailandensis as described in section 2.2.8. Bars show the fusion index and the number of 
nuclei per MGC in A549 cells infected by both fusogenic strains. The effects of different 
treatments were tested by unpaired t-test, where * p<0.05; *** p<0.001 significant, where 
ns=non-significant. The results are the means (± SEM) of 3 independent experiments each 
performed in 4 technical replicates. 
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6.3.2.3 Effect of Tspan-13KD on total B. thailandensis infection and 
internalisation 
The effect of Tspan-13KD on B. thailandensis infection was investigated to 
support further data acquired using anti-Tspan-13 antibody. Briefly, we treated 
the cells with Smart Pool siRNA reagent for 48hr. Control and Tspan-13KD 
A549 cells were infected with B. thailandensis CDC272 and E264 for 2hr. To 
count total number of bacteria, the wells were lysed using 1% TritonX-100 for 
15min. To count only internalised bacteria, the cells were incubated with 
DMEM containing antibiotics, washed and then lysed using TritonX-100. The 
lysis mixture was serially diluted and then plated onto LB agar plates. After 
36hr of incubation at 37oC, CFU was determined. Data showed that the total 
number of bacteria per 10000 cells was decreased when compared with cells 
treated with non-targeting materials (Fig 6.6). Findings also showed that the 
internalisation of bacteria was decreased significantly when compared with 
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Figure 6.6 Effect of Tspan-13KD on B. thailandensis infection. 
A549 cells were pre-treated with KD reagents for Tspan-13 before infection as described in 
section 2.2.8. Bars show the total number of bacteria and/or internalised bacteria per 10000 
cells for both B. thailandensis strains, CDC272 and E264. The effects of different treatments 
were tested by unpaired t-test, where * p<0.05; ** p<0.01 significant. The results are the 
means (± SEM) of 3 independent experiments each performed in 4 technical replicates. 
6.3.2.4 Effect of Tspan-13KD on MGC induced by B. thailandensis 
The effect of Tspan-13KD on MGC formation was investigated to confirm our 
findings that acquired using anti-Tspan-13 antibody. Briefly, we treated the 
cells with Smart Pool siRNA for 48hr. Control and Tspan-13KD A549 cells 
were infected with B. thailandensis for 2hr and then washed and incubated 
with DMEM containing amikacin and kanamycin antibiotics for 16hr. The 
fusion index was quantified relative to uninfected cells per field of view. MGCs 
were defined as cells containing 3 or more nuclei. The fusion index and the 
number of nuclei per MGC were decreased significantly in infected Tspan-




































































































































Figure 6.7 Effect of Tspan-13KD on MGC formation induced by both B. 
thailandensis strains. 
A549 cells were pre-treated with Tspan-13 siRNA KD or non-targeting reagents for 48hr and 
were infected with B. thailandensis, as described in section 2.2.8. Bars show the fusion index 
and the nuclei per MGC in A549 cells infected by two strains. The effects of different 
treatments were tested by unpaired t-test, where * p<0.05; ** p<0.01 significant. The results 
are the means (± SEM) of 3 independent experiments each performed in 4 technical 
replicates. 
6.3.2.5 Effect of Tspan-2KD on total B. thailandensis infection and MGC 
formation 
Infection experiments were performed by myself, using Tspan-2KD A549 cells 
produced by another laboratory member (Yaseen, 2017). This work was 
performed only with one strain of B. thailandensis, (CDC272) because there 
was not enough KD material to screen two strains. Briefly, we treated the cells 
with DharmaFECT siRNA for 72hr. Control and Tspan-2KD A549 cells were 
infected with B. thailandensis CDC272 and E264 for 2hr. To count total 
number of bacteria, the wells were lysed using 1% TritonX-100 for 15min. To 
count only internalised bacteria, the cells were incubated with DMEM 
containing antibiotics, washed and then lysed using TritonX-100. The lysis 
mixture was serially diluted and then plated onto LB agar plates. After 36hr of 
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incubation at 37oC, CFU was determined. The total number of bacteria and 
internalised bacteria was reduced in the Tspan-2KD A549 cells when 
compared with cells treated with non-targeting reagents (Fig 6.8A).  
To investigate the role of Tspan-2 in MGC formation, control and Tspan-2KD 
A549 cells were infected with B. thailandensis for 2hr and then washed and 
incubated with DMEM containing amikacin and kanamycin antibiotics for 16hr. 
The fusion index was quantified relative to uninfected cells per field of view. 
MGCs were defined as cells containing 3 or more nuclei. The fusion index and 
the number of nuclei per MGC were decreased significantly in infected Tspan-
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Figure 6.8 Effect of Tspan-2KD on MGC formation and B. thailandensis 
infection. 
A: The upper panels show that A549 cells were pre-treated with KD reagents for Tspan-2 
before infection as described in section 2.2.8. Bars show the total number of bacteria and/or 
internalised bacteria per 10000 cells for A549 cells infected by B. thailandensis CDC272. 
B:The lower panels show that A549 cells were pre-treated Tspan-2KD reagents for 72hr and 
infected B. thailandensis as described in section 2.2.8. Bars show the fusion index and the 
number of nuclei per MGC in A549 cells infected by B. thailandensis CDC272. The effects of 
different treatments were tested by unpaired t-test, where * p<0.05; ** p<0.01; *** p<0.001 
significant. The results are the means (± SEM) of 3 independent experiments each performed 
in 4 technical replicates. 
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6.3.2.6 Effect of ADAM10KD on total B. thailandensis infection and 
internalisation 
To validate the results using anti-ADAM10 antibody, we studied the effect of 
ADAM10KD on B. thailandensis infection. Briefly, the cells were treated with 
ADAM10 targeting and non-targeting Smart Pool siRNA for 48hr. Control and 
ADAM10KD cells were infected for 2hr with B. thailandensis CDC272 and 
E264. To count the total number of bacteria, the cells were lysed by the 
addition of 1% TritonX-100 for 15min. To count only internalised bacteria, the 
cells were incubated with DMEM containing antibiotics, washed and lysed 
using TritonX-100. The lysis mixture was diluted and then was plated onto LB 
agar plates. CFU was counted after 36hr of incubation. The findings showed 
that ADAM10KD has no effect on the total number of bacteria and/or 
internalisation when compared with cells treated with non-targeting materials 
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Figure 6.9 Effect of ADAM10KD on B. thailandensis infection 
A549 cells were pre-treated with KD reagents for ADAM10 before infection as described in 
section 2.2.8. Bars show the total number of bacteria and/or internalised bacteria per 10000 
cells for A549 cells infected by two B. thailandensis, CDC272 and E264. The effects of 
different treatments were tested by unpaired t-test, where ns: non-significant. The results are 
the means (± SEM) of 3 independent experiments each performed in 4 technical replicates. 
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6.3.2.7 Effect of ADAM10KD on MGC formation induced by B. thailandensis 
To validate the results using anti-ADAM10 antibody, we studied the effect of 
ADAM10KD on MGC formation. Briefly, the cells were treated with ADAM10 
targeting and non-targeting Smart Pool siRNA for 48hr. Control and 
ADAM10KD cells were infected with B. thailandensis for 2hr and then washed 
and incubated with DMEM containing amikacin and kanamycin antibiotics for 
16hr. The fusion index was quantified relative to uninfected cells per field of 
view. MGCs were defined as cells containing 3 or more nuclei. The fusion 
index and nuclei per MGC were increased significantly in A549 cells with 






































































































































Figure 6.10 Effect of ADAM10KD on MGC formation induced by both B. 
thailandensis strains. 
A549 cells were pre-treated with ADAM10 siRNA KD reagents for 48hr and were infected with 
B. thailandensis as described in section 2.2.8. Bars show the fusion index and the number of 
nuclei per MGC in A549 cells infected by two types of strains. The effects of different 
treatments were tested by unpaired t-test, where * p<0.05 significant; ns is non-significant. 




6.3.3 CD9 expression in CD9KO A549 cells 
The CD9KO A549 cells were produced by Dr. David J. Blake (Blake et al., 
2018) and the WT control cells obtained from the in-house cell bank. CD9KO 
and WT A549 cells were checked for CD9 expression using flow cytometry. 
Cells were harvested using non-enzymatic cell dissociation solution and 
stained with primary anti-CD9 antibody or isotype control for 45min, and then 
washed 2x with BBN. A FITC-labelled secondary antibody was used at the 
recommended concentration 1:250 for 45min. The negative controls here 
were cells treated with the binding buffer BBN or irrelevant antibody with the 
same isotype. The results show that ~82% of the WT A549 cells express 
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Figure 6.11 Measurement of CD9 expression on WT and CD9KO A549 cells by 
flow cytometry. 
Cells were tested using anti-human CD9, isotype control (JC1) and secondary anti-mouse 
IgG-FITC. A: The upper panel shows the cell expressing CD9 on WT and KO A549 cells, 
respectively. B:The lower panel shows the median fluorescence intensity of CD9 on WT and 
CD9KO cells. The significance of differences between uninfected and infected cells was 
measured by t-test, where ** p<0.01 significant. The results are the means (± SEM) of 3 





6.3.3.1 Tspan-15 and ADAM10 expression in CD9KO A549 cells 
CD9KO may affect the expression of other cell surface proteins. These 
experiments were performed to investigate the possible effect of CD9KO on 
the expression of Tspan-15 and ADAM10. However, mock-treated A549 cells 
from the Blake laboratory were not available for this study and WT A549 cells 
from University of Sheffield stocks were used instead. The levels of 
expression were measured using flow cytometric analysis, as described in 
section 2.2.8. The results show that the level of ADAM10 was slightly 
increased with CD9KO compared with WT A549, but not significantly. Tspan-
15 expression was not changed on the surface of CD9KO cells compared to 
WT A549 cells, as shown in Fig 6.12. It seems that CD9KO has no effect on 








































Figure 6.12 Cell surface protein expression on WT and CD9KO A549 cells. 
Flow cytometry analysis was performed as described in section 2.2.9. The significance of 
differences between uninfected and infected cells was measured by t-test, where *** p<0.001 
significant; ns=non-significant. The results are the means (± SEM) of 3 independent 
experiments each performed in 2 technical replicates. 
6.3.3.2 Effect of CD9KO on total B. thailandensis infection and internalisation 
The ability of B. thailandensis to infect CD9KO and WT A549 cell lines were 
investigated. The total bacterial infection for both strains of B. thailandensis 
was assessed in WT and CD9KO A549 cell lines after 2hr of infection. Briefly, 
both WT and CD9KO cells were infected for 2hr with B. thailandensis 
CDC272 and E264. Cells were washed 2x with HBSS and lysed to count the 
total number of bacteria by the addition of 100μl of 1% TritonX-100 for 15min. 
To count only internalised bacteria, the cells were incubated with DMEM 
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containing antibiotics, washed and lysed using TritonX-100. The lysis mixture 
was serially diluted before 10μl of each dilution was plated onto LB agar 
plates for CFU counts. It was observed that the infection after 2hr of B. 
thailandensis was very similar in both CD9KO and WT A549 cells for both 
strains of B. thailandensis, as demonstrated in Fig 6.13. These confirmed the 
KD results that CD9 has no role in the adhesion and uptake of B. 
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Figure 6.13 Effect of CD9KO in A549 cells on B. thailandensis infection. 
A549 cells were infected by B. thailandensis, as described in section 2.2.8. Bars show the 
total number of bacteria and/or internalised bacteria per 10000 cells for A549 cells infected by 
two bacterial strains, CDC272 and E264. The effects of different treatments were tested by 
unpaired t-test, ns=non-significant. The results are the means (± SEM) of 3 independent 
experiments each performed in 4 technical replicates. 
6.3.3.3 Effect of CD9KO on MGC formation induced by B. thailandensis 
These investigations were to confirm our results with CD9KD on MGC 
formation induced by B. thailandensis infection. To do this, the WT and KO 
A549 cells were infected with bacteria for 2hr and then washed and incubated 
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with DMEM containing amikacin and kanamycin antibiotics for 16hr. The 
fusion index was quantified relative to uninfected cells per field of view. MGCs 
were defined as cells containing 3 or more nuclei. Fusion index was 
significantly increased in CD9KO A549 cells when compared with WT A549 
cells infected by both B. thailandensis strains, but only CDC272-infected cells 
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Figure 6.14 Effect of CD9KO on MGC formation induced by both B. 
thailandensis strains. 
A549 cells were infected by B. thailandensis, as described in section 2.2.8. Bars show the 
fusion index and the number of nuclei per MGC in A549 cells infected by two strains. The 
effects of different treatments were tested by unpaired t-test, where ** p<0.01 significant; 
ns=non-significant. The results are the means (± SEM) of 3 independent experiments each 
performed in 4 technical replicates. 
6.3.4 ADAM10 expression in ADAM10KO and WT A549 cells 
ADAM10KO and WT control A549 cells were obtained from Dr Mike 
Tomlinson (University of Birmingham) (Szyroka, 2019). ADAM10 expression 
was measured using flow cytometry to confirm that the cells do not express 
this protein. Briefly, cells were harvested using non-enzymatic cell 
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dissociation solution and stained with primary anti-ADAM10 antibody and 
isotype control for 45min, and then washed 2x with BBN. A FITC-labelled 
secondary antibody was used at the recommended concentration 1:250 for 
45min. The negative controls here were cells treated with the binding buffer 
BBN or irrelevant antibody with the same isotype. The results show that the 
percentage of cells that express ADAM10 on WT A549 cells was ~96%, but 



























Figure 6.15 ADAM10 expression on WT and ADAM10KO A549 cells by flow 
cytometry. 
Cells were tested using primary anti-human ADAM10, isotype control (JC1) and secondary 
anti-mouse IgG-FITC. A: The upper panel shows the fluorescence intensity of ADAM10 on 
WT and KO A549 cells, respectively. B: The lower panel shows the median fluorescence 
intensity of ADAM10 on WT and ADAM10KO cells. The significance of differences between 
uninfected and infected cells was measured by t-test, where ** p<0.01 significant. The results 






6.3.4.1 CD9 and Tspan-15 expression in ADAM10KO and WT A549 cells 
Flow cytometric analysis was used to measure the levels of protein 
expression on the cell surface as described in section 2.2.9. The findings 
show that CD9 and Tspan-15 were normally expressed on ADAM10KO A549 
when compared to WT A549 cells. It is apparent that there are no effects of 









































Figure 6.16 Cell surface molecule expression on ADAM10KO and WT A549 
cells. 
Flow cytometry analysis was performed as described in section 2.2.9. The significance of 
differences between uninfected and infected cells was measured by t-test, where **** 
p<0.0001 significant; ns=non-significant. The results are the means (± SEM) of 3 independent 
experiments each performed in 3 technical replicates. 
6.3.4.2 Effect of ADAM10KO on total B. thailandensis infection and 
internalisation 
These investigations were to confirm our results with ADAM10KD on B. 
thailandensis infection, in particular for the total number of bacteria and 
internalised bacteria after 2hr of infection. In brief, both ADAM10KO and WT 
A549 cells were seeded in 96 well plates. Both ADAM10WT and ADAM10KO 
cells were infected for 2hr with B. thailandensis CDC272 and E264. A549 
cells were washed 2x with HBSS and lysed to count the total number of 
bacteria by the addition of 100μl of 1% TritonX-100 for 15min. To count only 
internalised bacteria, the cells were incubated with DMEM containing 
antibiotics, washed and lysed using TritonX-100. The lysis mixture was 
serially diluted before 10μl of each dilution was plated onto LB agar plates for 
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CFU counts. The results show there is no effect of ADAM10KO on the total 
number of bacteria and internalised bacteria. B. thailandensis infection of 
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Figure 6.17 Effect of ADAM10KO in A549 cells on total B. thailandensis 
infection. 
A549 cells were infected by B. thailandensis, as described in section 2.2.8. Bars show total 
number of bacteria and/or internalised bacteria per 10000 cells for A549 cells infected by two 
B. thailandensis strains, CDC272 and E264. The effects of different treatments were tested by 
unpaired t-test, ns=non-significant. The results are the means (± SEM) of 3 independent 
experiments each performed in 4 technical replicates. 
6.3.4.3 Effect of ADAM10KO on MGC induced by B. thailandensis 
These experiments were performed to confirm our findings with ADAM10KD. 
To do this, the WT and KO A549 cells were infected by bacteria for 2hr and 
then washed and incubated with DMEM containing amikacin and kanamycin 
antibiotics for 16hr. The fusion index was quantified relative to uninfected cells 
per field of view. MGCs were defined as cells containing 3 or more nuclei. The 
data did not correlate with our findings with ADAM10KD A549 cells. 
ADAM10KO has no effect on fusion index compared with WT A549 cells 
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infected by both B. thailandensis strains, and has no effect on the number of 














































































































Figure 6.18 Effect of ADAM10KO on MGC formation induced by both B. 
thailandensis strains. 
A549 cells were infected by B. thailandensis, as described in section 2.2.8. Bars show the 
fusion index and the number of nuclei per MGC in A549 cells infected by two types of B. 
thailandensis strains. The effects of different treatments were tested by unpaired t-test, where 
ns=non-significant. The results are the means (± SEM) of 7 independent experiments each 
performed in 4 technical replicates. 
6.3.5 Tspan-15 expression in Tspan-15KO and WT A549 cells 
Tspan-15KO and WT control A549 cells were obtained from Dr Mike 
Tomlinson (University of Birmingham) (Szyroka, 2019). Tspan-15KO and WT 
A549 cells were checked for Tspan-15 expression using flow cytometry. Cells 
were harvested using non-enzymatic cell dissociation solution and stained 
with primary anti-CD9 antibody and isotype control for 45min, and then 
washed 2x with BBN. A FITC-labelled secondary antibody was used at the 
recommended concentration 1:250 for 45min. The negative controls here 
were cells treated with the binding buffer BBN or irrelevant antibody with the 
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same isotype. The results show that the percentage of cells that express 
Tspan-15 on WT A549 cells was ~75%, but only ~6% of Tspan-15KO cells 
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Figure 6.19 Tspan-15 expression on WT and Tspan-15KO A549 cells by flow 
cytometry. 
Cells were tested using primary anti-human Tspan-15, isotype control (JC1) and secondary 
anti-mouse IgG-FITC. A: The upper panel shows the population expressing Tspan-15 on WT 
and KO A549 cells, respectively. B: The lower panel shows the median fluorescence intensity 
of Tspan-15 on WT and Tspan-15KO cells. The significance of differences between 
uninfected and infected cells was measured by t-test, where * p<0.05 significant. The results 
are the means (± SEM) of 3 independent experiments each performed in 2 technical 
replicates. 
6.3.5.1 CD9 and ADAM10 expression on Tspan-15KO and WT A549 cells 
Tspan-15KO may affect the expression of other cell surface proteins. These 
experiments were performed to investigate the possible effect of Tspan-15KO 





ADAM10 were measured using flow cytometric analysis. The findings show 
that ADAM10 was reduced by more than 50% on the surface of KO A549 
compared to WT, and the level of CD9 was also reduced significantly. It 
seems that Tspan-15KO can regulate ADAM10 and CD9 expression in A549 







































Figure 6.20 Cell surface molecules expression on WT and Tspan-15KO A549 
cells. 
Flow cytometry analysis was performed as described in section 2.2.9. The significance of 
differences between uninfected and infected cells was measured by t-test, where * p<0.05; 
**** p<0.0001 significant. The results are the means (± SEM) of 3 independent experiments 
each performed in 3 technical replicates.  
6.3.5.2 Tspan15 expression after infection with B. thailandensis 
This experiment was performed to investigate if Tspan-15 is changed in 
response to 18hr of B. thailandensis infection using flow cytometry. The 
results show that there is no change in the levels of Tspan-15 during the 
infection by B. thailandensis CDC272 and E264 or by B. thailandensis E264-
ΔtssK, as described in Fig 6.21. These indicated that Tspan-15 is not 




































Figure 6.21 Tspan-15 protein expression after infection on the surface of A549 
cells. 
A549 cells were infected with either fusogenic B. thailandensis CDC272 or E264 or non-
fusogenic mutant E264 ΔtssK. A549 cells left uninfected were used as controls. After 16hr of 
kanamycin and amikacin treatment, cells were stained with primary anti-Tspan-15 antibody 
for 45min, and then analysed by flow cytometry. The significance of differences between 
uninfected and infected cells was measured by one-way ANOVA, where ns=non-significant. 
The results are the means (± SEM) of 2 independent experiments each performed in 2 
technical replicates. 
6.3.5.3 Role of Tspan-15 on B. thailandensis infection 
The effect of Tspan-15KO and antibody on bacterial infection was 
investigated. In brief, the WT and Tspan-15KO A549 cells were seeded in 96 
wells plates. 8 wells of WT A549 cells were treated with the anti-Tspan-15 
antibody or isotype control for 1hr, and then the cells were washed. Both cell 
types were infected for 2hr with B. thailandensis CDC272 and E264. A549 
cells were washed 2x with HBSS and lysed to count the total number of 
bacteria by the addition of 100μl of 1% TritonX-100 for 15min. To count only 
internalised bacteria, the cells were incubated with DMEM containing 
antibiotics, washed and lysed using TritonX-100. The lysis mixture was 
serially diluted before 10μl of each dilution was plated onto LB agar plates for 
CFU counts. It was observed that Tspan-15KO has a slight effect on B. 
thailandensis infection but was not significantly different when compared with 
WT A549 cells. Data also showed that anti-Tspan-15 antibody has no effect 
on total number of bacteria or internalised bacteria when compared with 
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Figure 6.22 Effect of Tspan-15KO and anti-Tspan-15 antibody on B. 
thailandensis infection in A549 cells. 
A549 cells were pre-treated with anti-Tspan-15 and JC1 for 1hr, and then WT, Tspan-15KO 
and A549 treated with antibody were infected for 2hr, as described in section 2.2.8. Bars 
show the total bacterial infection and/or internalised bacteria per 10000 cells for A549 cells 
infected by two bacterial strains, CDC272 and E264. The effects of different treatments were 
tested by unpaired t-test, where ns=non-significant. The results are the means (± SEM) of 3 
independent experiments each performed in 4 technical replicates.  
6.3.5.4 Role of Tspan-15 on MGC formation induced by B. thailandensis 
These experiments were performed to investigate the effect of anti-Tspan-15 
antibody and Tspan-15KO on MGC formation and the number of nuclei per 
MGC. To do this, the WT and Tspan-15KO A549 cells were seeded in 96 
wells plates. Some WT A549 cells were treated with the anti-Tspan-15 
antibody for 1hr, and then the cells were washed. The WT and Tspan-15KO 
A549 cells were infected with bacteria for 2hr, and then washed and 
incubated with DMEM containing amikacin and kanamycin antibiotics for 16hr. 
The fusion index was quantified relative to uninfected cells per field of view. 
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MGCs were defined as cells containing 3 or more nuclei. MGC formation and 
nuclei per MGC were significantly increased with Tspan-15KO A549 cells 
when compared with WT A549 cells infected by both B. thailandensis strains 
(Fig 6.23). Data also showed that anti-Tspan-15 antibody has no effect on 
MGC formation in WT A549 cells when compared with isotype control for both 
B. thailandensis strains, and has no effect on the number of nuclei per MGC 























































































































































Figure 6.23 Effect of Tspan-15KO and anti-Tspan-15 antibody on MGC 
formation induced by both B. thailandensis strains. 
A549 cells were infected by B. thailandensis, as described in section 2.2.8. Bars show the 
fusion index and the number of nuclei per MGC in A549 cells infected by two B. thailandensis 
strains. The significance of differences between uninfected and infected cells was measured 
by t-test where ** p<0.01; *** p<0.001; **** p<0.0001 significant; ns=non-significant. The 






6.4.1 CD9 negatively regulates MGC formation in response to B. 
thailandensis infection 
This section aimed to confirm that CD9 has no effect on the total number of 
bacteria or internalised bacteria, and has a negative role in MGC formation 
induced by B. thailandensis. Results showed that CD9KD and KO have no 
effect on infection with both strains of B. thailandensis (Fig 6.3 and Fig 6.13). 
These findings are in agreement with other data from members in our 
laboratory: CD9KO in mouse macrophages had no effect on B. thailandensis 
infection (Elgawidi, 2016). In contrast, a previous PhD student from University 
of Sheffield has shown that CD9KO in mouse macrophages has an important 
effect on Salmonella infection (Ali, 2016). Furthermore, it has been observed 
that CD9 is involved in adhesion of several types of bacteria to human 
epithelial cell lines (Green et al., 2011). It seems that CD9 may have no effect 
on B. thailandensis infection, but could contribute to other bacterial infections.   
Both KD and KO of CD9 in A549 cells increased the fusion index compared 
with WT A549 and increased the number of nuclei per MGC induced by B. 
thailandensis CDC272, but not E264 (Fig 6.4 and Fig 6.14). It seems that 
CD9 has a negative effect on MGC formation and the number of nuclei per 
MGC. Our data were supported by a member of our laboratory (Elgawidi, 
2016) who also found that B. thailandensis increased MCG formation in the 
mouse CD9KO bone marrow-derived macrophages when compared to WT. 
6.4.2 Tspan-2 and Tspan-13 play a role in MGC formation and B. 
thailandensis infection 
The aim of this section was to investigate the effects of Tspan-2KD and 
Tspan-13KD on B. thailandensis infection. In sections 6.3.2.3 and section 
6.3.2.5, data showed that Tspan-2KD and Tspan-13KD could reduce B. 
thailandensis infection of A549 cells (Fig 6.6 and Fig 6.8). In section 5.5.4.2 
and section 5.5.4.4, data indicated that anti-Tspan-13 and anti-Tspan-2 
antibodies decreased the total bacterial infection of B. thailandensis and 
internalised bacteria after 2hr of infection. To the best of our knowledge, this 
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study is the first to observe that these two Tspans are implicated in B. 
thailandensis infection.  
We observed that Tspan-2 also positively regulates MGC formation induced 
by B. thailandensis (Fig 6.8). Tspan-2 has a similar sequence to CD9 and 
CD81, which are involved in MGC formation (Yaseen et al., 2017). It has been 
found that Tspan-2 could interact with CD44, which has a positive role in cell 
fusion (Sterling et al., 1998). Tspan-2 is also a partner protein of MT1-MMP 
(Sterling et al., 1998). This interaction could cause the cell membrane of 
neighbour macrophages to fuse (Weiguo et al., 2006). In addition, Arndt et al. 
found that Tspan-2 could induce the formation of cellular protrusions in 
epithelial cells (Arndt et al., 2015). These protrusions could be involved in 
cellular fusion (Sung and Weaver, 2011).  
There are only a limited number of publications on Tspan-13 function. It is 
hard to clarify the specific role of Tspan-13 in MGC formation induced by B. 
thailandensis infection. However, Iwai et al. observed that Tspan-13 is 
involved in cell fusion in bone marrow induced by RANKL (Iwai et al., 2007). 
Subsequently, the same scientific team also described that Tspan-13KD could 
induce osteoclastogenesis and MGC formation in RAW264 mouse 
macrophages (Iwai et al., 2007). These findings might be inconsistent with our 
findings regarding the role of Tspan-13 in MGC formation. However, Iwai et al. 
used different stimulation factors and cell lines.  
6.4.3 Effect of ADAM10KD and KO on B. thailandensis infection 
and MGC formation in A549 cells 
ADAM10 has several functions: the regulation of cell development, cell 
adhesion, cell fusion and bacterial infection (Dreymueller et al., 2012, 
Matthews et al., 2017). In this section, the aim was to investigate if ADAM10 
has a role in B. thailandensis infection or MGC formation.  
In section 6.3.2.6 and section 6.3.4.1, data shows that ADAM10KD and KO 
have no effect on B. thailandensis infection. It seems that ADAM10 is not 
required for B. thailandensis infection but is required for other bacteria 
species. For example, it has been observed that ADAM10 is implicated in S. 
aureus and P. aeruginosa infection (Hassan and Nelson, 2002).  
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In section 6.3.2.7 and section 6.3.4.2, findings show that ADAM10KD in 
A549 cells significantly increased MGC formation, while ADAM10KO had no 
effect on MGC formation and number of nuclei. These results might be 
explained by the minor role of ADAM10 with no direct impact on MGC 
formation. It has been observed that ADAM10 interacts with Tspan-5, known 
to be involved in MGC formation (Reyat et al., 2017). Furthermore, 
ADAM10KO might cause a reduction or enhancement of the expression of 
other Tspans, which are involved in MGC formation. Other proteins might 
compensate for ADAM10 when it is absent from the cells for many passages 
(KO) but this might not occur when the protein is only temporarily 
downregulated (KD). 
6.4.4 Tspan-15KO enhances MGC formation 
Tspan-15 is a member of an evolutionarily conserved sub-family of Tspans, 
the TspanC8 which includes Tspan-5, Tspan-10, Tspan-14, Tspan-15, Tspan-
17, and Tspan-33. ADAM10 can interact with the TspanC8 sub-family and can 
be regulated in particular by Tspan-15. Tspan-15 can regulate many Tspans 
and Tspan-partner proteins (Haining et al., 2012, Jouannet et al., 2016). 
Here, we investigated the roles of Tspan-15 in infection with B. thailandensis 
and the resulting MGC formation in lung epithelial cells. Here, I have shown 
that the protein level of Tspan-15 did not change after infection with either the 
fusogenic or the non-fusogenic strain E264-ΔtssK (Fig 6.21). We also 
observed that anti-Tspan-15 antibody has no effect on B. thailandensis 
infection and MGC formation (Figs 6.22 and 6.23). In section 6.3.5.1, data 
shows that Tspan-15KO can reduce the surface expression of ADAM10 and 
CD9 (Fig 6.20). Interestingly, we found that Tspan-15KO increased MGC 
formation, and had a slight effect on B. thailandensis infection. These findings 
could suggest that Tspan-15 has no direct role in MGC formation or B. 
thailandensis infection. However, other effects of Tspan-15KO, such as a 
negative effect on cell surface expression of other proteins or activation of 
some proinflammatory responses, could affect MGC formation and B. 
thailandensis infection. These findings are supported by Jouannet et al. who 
have shown the negative effect of Tspan-15KO on ADAM10 cell surface 
expression (Jouannet et al., 2016). For example, Weiss found that ADAM10 
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mediated shedding of some cell surface proteins, which could be promoted by 
Tspan-15 (Weiss, 2018). They also found Tspan-15 could activate nuclear 
factor-κB (NF-κB). It is known that NF-κB is important in proinflammatory 
responses to B. thailandensis infection (Wiersinga, 2017). However, these 




Chapter 7 General discussion 
7.1 Summary 
Melioidosis is a serious infectious disease caused by B. pseudomallei. This 
bacterium is closely related to B. thailandensis (Christoph et al., 2009). They 
provoke the same immune responses and have the same mechanism of 
infection (Chen et al., 2006, Reginsson et al., 2012, Lertpatanasuwan et al., 
1999, Brett et al., 1997). Recently, it was observed that B. thailandensis E555 
is a very good surrogate for B. pseudomallei because it has similar responses 
to the intracellular environment during the infection of the J774.1 mouse 
macrophage cell line (Kovacs-Simon et al., 2019). MGC formation is a 
histopathological feature of melioidosis (Wong et al., 1995, Hsu, 2012). MGC 
formation appears to aid bacterial spreading to other cells while minimizing 
exposure to the host immune system (Wong et al., 1995). However, the 
specific role of MGC formation in bacterial pathogenesis is still not fully 
understood.  
As explained in chapter 1, Tspan molecules are a superfamily of membrane 
proteins that coordinate several membrane-associated functions such as 
trafficking, adhesion and bacterial infection (Monk and Partridge, 2012). 
Tspans have also been implicated in many cell fusion processes, including 
myoblast fusion (Charrin et al., 2013, Hemler, 2001), virus-induced cell fusion 
(Fukudome et al., 1992, Gordón-Alonso et al., 2006, Menelaos et al., 2014), 
sperm-egg fusion (Le Naour et al., 2000, Rubinstein et al., 2006, Jankovičová 
et al., 2015), and macrophage and monocyte fusion during MGC formation 
(Takeda et al., 2003, Ishii et al., 2006, Parthasarathy et al., 2009, Hulme et 
al., 2014). Another role of Tspans is in bacterial infection. For example, 
Hassuna et al. have demonstrated the role of CD9 and CD81 in Salmonella 
infection (Hassuna et al., 2017). Ventress et al. have demonstrated that CD9 
has a role in S. aureus infection in keratinocyte cells (Ventress et al., 2016). 
Green et al. have also described a role for CD9, CD151 and CD63 in the 
infection of human epithelial cells by several types of bacteria, including 
Neisseria sp, E. coli and Streptococcus pneumoniae (Green et al., 2011). Our 
research team have observed that the CD9KO can affect the early stages of 
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bacterial infection (30min to 60min) by B. thailandensis (Elgawidi, 2016). 
However, antibodies that bind Tspans have no effect on B. thailandensis 
infection in RAW264 and J774.2 cells after 2hr of infection.  
In chapter 3, it was shown that a fusogenic strain of B. thailandensis could 
induce not only a mouse macrophage cell line but also A549 cells to form 
MGC. These results were in agreement with other researchers who have 
shown that B. thailandensis can induce different cell lines to form MGC 
(Boddey et al., 2007, Schwarz et al., 2014, Chiang et al., 2015, Michevaviteva 
et al., 2017). GFP and mCherry tags on MGC formation have no effect on 
MGC when expressed in B. thailandensis. A previous PhD student from 
University of Sheffield has shown that a mutant (E264-ΔtssK) of B. 
thailandensis cannot promote infected cells to form MGC in RAW264 cells 
(Hall, 2016). Here, it was also found that a mutant of E264-ΔtssK, cannot 
induce MGC in either A549 or J774.2 cells despite causing a similar bacterial 
infection to the WT bacteria. It seems that mutant E264-ΔtssK is a suitable 
choice as a way of discriminating between changes in host cells caused by 
infection and changes that lead to MGC formation.  
In chapter 4, it was hypothesised that Tspans and Tspan-partner proteins 
would have altered expression levels in response to B. thailandensis infection 
in J774.2 and A549 cells. It was also hypothesized that the expression of 
some innate immunity and cell signalling genes would also alter in response 
to bacterial infection. I found that most Tspans and Tspan-partners are highly 
expressed at the mRNA level in J774.2 and A549 cells. These findings are 
similar to many published studies. For example, Iwai and co-workers detected 
the expression of all 12 Tspan genes studied in the mouse macrophage cell 
line RAW264 (Iwai et al., 2007). Haining and colleagues also tested A549 
cells and found all of the TspanC8 subfamily were expressed (Haining et al., 
2012). Mélanie et al has also detected CD151 expression in A549 cells 
(Mélanie et al., 2010). The next step was to investigate changes in all Tspans 
at the mRNA level in response to infection by both B. thailandensis strains in 
both cell lines. To select which Tspans are involved in MGC formation and not 
simply in B. thailandensis infection, both cell lines were infected by fusogenic 
WT and non-fusogenic B. thailandensis E264-ΔtssK. After 18 hours of 
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infection it was observed that mRNA levels of Tspan-2 and Tspan-13 
increased significantly with WT fusogenic strains but not with E264-ΔtssK, 
while Tspan-5, CD81, CD9 decreased significantly only with WT. 
The changes to 4 candidate Tspans in MGC formation were further examined 
at the protein level using flow cytometry to detect protein expression 
(antibodies to Tspan-5 are not currently available). Data showed that 
expression of Tspan-2 and Tspan-13 increased in response to fusogenic B. 
thailandensis strains compared with E264-ΔtssK, while CD9 and CD81 were 
not changed at protein level after 18hr infection compared with the non-
fusogenic strain. Theoretically, the size of fused cells could be too large to 
flow through the cytometer nozzles, and so these cells would be absent from 
the analysis. An alternative method for quantifying protein expression in cells 
could involve the use of western blotting. Another explanation is that the 
wrong time points were chosen. Ideally, more experiments would be 
performed to investigate other earlier or later time-points. Only cell surface 
protein levels were investigated and so we could use permeabilisation to 
detect intracellular proteins in flow cytometry, or western blot to detect total 
protein expression. 
Tspan-partner proteins expression were also examined using the same 
criteria. Our findings showed that only 3 Tspan-partners changed mRNA 
levels following WT B. thailandensis infection with WT but not with the mutant. 
CD172α and ADAM10 decreased, and CD98 increased in expression. Studies 
have reported that several Tspan-partner proteins are involved in MGC 
formation and bacterial infection including CD98, CD44 and DC-STAMP 
(Ozge et al., 2009, Yagi et al., 2005, Martinez et al., 2009, Weiguo et al., 
2006). These studies were in agreement with our findings, suggesting no role 
of CD44 or DC-STAMP and a positive role of CD98 in MGC formation. Our 
data are also supported by Paola et al who have shown that CD98 experssion 
is increased by activating integrin during fusion of the human placental 
trophoblast cell line BeWo (Paola et al., 2007). Furthermore, our data is in 
agreement with Verrier et al who observed that ADAM10 is involved in cell 
fusion in the MG63 osteosarcoma cell line (Verrier et al., 2004). Interestingly, 
our results were not supported by Acharya and co-workers who found that 
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CD172α expression at the mRNA level increased during fusion of malignant 
cells (Gautam and Acharya, 2014).  
In chapter 5, it was shown that binding of antibodies to cell surface CD9 and 
ADAM10 can enhance MGC formation, whereas antibodies against Tspan-2 
and Tspan-13 can inhibit MGC formation. CD98 antibodies also reduced 
formation of MGC. Many studies are in agreement with these findings, for 
example, Suparak and co-researchers have shown that using anti-CD98 
antibody can affect cell fusion in U937 human macrophages (Suparak et al., 
2011), while a previous PhD student from University of Sheffield has shown 
that anti-CD9 and anti-CD81 antibodies enhance MGC formation induced by 
B. thailandensis in J774.2 mouse macrophages (Elgawidi, 2016). 
Furthermore, 8005 peptide from CD9EC2 was tested. The results showed that 
peptide 8005 reduces B. thailandensis infection of A549 cells. This peptide 
has the same effect on other bacterial infections, such as S. aureus and P. 
aeruginosa (unpublished data Rahaf Issa) (Alrahimi, 2017). Anti-Tspan-2 and 
Tspan-13 antibody treatment before and after infection can inhibit MGC 
formation, as well as reduce the total bacterial infection. To the best of our 
knowledge, there are no preivous studies that agree or disagree with these 
findings.  
As shown in chapter 4, there were no significant differences in protein levels 
of ADAM10, CD172α and CD98 following B. thailandensis infection of A549 
cells, relative to uninfected cells. However, antibodies against ADAM10 and 
CD98 molecules were shown to affect MGC formation. The progression or 
suppression of MGC formation may not be dependent on simply the 
expression levels of these surface molecules. To the best of our knowledge, 
this is the first investigation to notice that host surface molecules play a role in 
MGC formation induced by B. thailandensis in A549 cells. It is possible that 
Tspans and Tspan-partner proteins could facilitate the attachment of cells to 
each other, bringing their membrane into close contact, during infection with 
B. thailandensis. It also seems that B. thailandensis could favour MGC 




In chapter 6, KD of Tspan-2 and Tspan-13 confirmed the positive role of 
these Tspans in MGC formation. The KD and KO of CD9 and ADAM10 
confirmed their negative roles in MGC formation induced by B. thailandensis. 
In addition, Tspan-15KO A549 cells have been used in this study. The 
findings showed that the KO of Tspan-15 in A549 cells increased MGC 
formation induced by B. thailandensis, which could be due to changes in CD9 
and ADAM10.  
Tspan-2 is a partner to CD9 and CD81 (Terada et al., 2002, Yaseen et al., 
2017), which are both involved in MGC formation, and is also a partner to 
CD44 (Otsubo et al., 2014). CD44 is important in intracellular replication of L. 
monocytogenes in bone marrow-derived macrophages (Eriksson et al., 2003). 
This close association of Tspan-2 with CD9 may have promoted B. 
thailandensis uptake, perhaps by a cooperative role of Tspan-2 with CD44, 
which is up-regulated upon infection (Eriksson et al., 2003).  
We observed that Tspan-13 has a role in both infection and MGC formation. 
There are only limited publications that describe the role of Tspan-13 in MGC 
formation, so it is hard to explain the specific positive role of Tspan-13 in MGC 
formation. However, Iwai et al. have described a negative role of Tspan-13 in 
osteoclastogenesis induced by RANKL pathway in RAW264. In contrast, a 
study has described Tspan-13 as being involved positively in apoptosis in 
hTERT from human osteosarcoma cells (Jaiswal et al., 2018).  
Similar to the results presented here, CD9KO has previously been shown to 
enhance MGC formation (Takeda et al., 2003). Similarly, one of our lab 
members found that CD9KO caused enhancement of MGC formation in 
mouse bone marrow-derived macrophages infected with B. thailandensis 
(Elgawidi, 2016). However, Miyado et al. made different findings. They found 
CD9KO in mice eggs prevented fusion with sperm (Miyado et al., 2000). Thus, 
CD9 might be involved in several different processes with different functions.  
It is known that ADAM10 is a partner to several Tspans, including CD9 and 
CD81 (Haining et al., 2012). ADAM10KO appeared not to significantly 
enhance fusion, whereas ADAM10KD and antibody treatment appeared to 
cause enhancement of MGC formation induced by B. thailandensis. In 
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addition, as we found in chapter 6, Tspan-15KO causes an enhancement of 
MGC formation and reduces ADAM10 expression at the cell surface by 50%. 
That could explain the minor role of ADAM10 in MGC formation induced by B. 
thailandensis. However, these enhancements need further experiments. 
Moreover, a study has shown the interaction of ADAM10 with Tspan-5, which 
is involved in cell fusion (Iwai et al., 2007, Reyat et al., 2017). It was supposed 
that ADAM10 might play a minor role in MGC formation. No study has yet 
described a role for ADAM10 in B. thailandensis infection, but there is 
evidence of involvement in other bacterial infections. For example, ADAM10 
acts as a receptor for S. aureus and P. aeruginosa (Hassan and Nelson, 
2002, Ichiro et al., 2011, Wang et al., 2012). 
7.2 Limitations 
There are several limitations to this study, partly due to limited funding and 
time. Not all anti-Tspan antibodies are commercially available, and Tspan-5 
could not be investigated fully. The other point is that only surface protein 
expression was examined instead of total cellular protein expression, which is 
a problem because some Tspans act intracellularly (e.g. CD63, CD9 and 
CD81) (Monk and Partridge, 2012). Moreover, the cells that underwent 
KO/KD approaches had not been investigated in regard to other functional 
activity such as migration, adhesion, trafficking and cell proliferation which 
could help to explain another role of Tspan molecules in MGC formation. The 
KO/KD approach was carried out for selected Tspans/Tspan-partners not for 
all candidates because of limited time and funding. No in vivo studies were 
included, that would be useful to fully understand the role of these proteins in 
MGC formation in response to bacterial infection using antibodies and 
peptides. However, it might be addressed in future work. Finally, the main 
pathogen of melioidosis, which is B. pseudomallei, could not be used in this 
study, because itis classified as hazard group 3 and we have no permission to 






It can be concluded from this work that:  
• CD9 and CD81 are negative regulators of MGC formation 
• 8005 peptide from EC2 of CD9 can significantly reduce B. 
thailandensis infection. 
• Tspan-5 may also act as a negative regulator of fusion 
• Tspan-2 and Tspan-13 are required for total bacterial infection and may 
also act as positive regulators of MGC formation 
• Tspan partner proteins ADAM10 and CD98 may act as regulators of 
fusion. 
7.4 Future work 
Ultimately, it is highly recommended to investigate the role of selected Tspans 
and Tspan-partners in vivo, to test whether they have some responses to B. 
thailandensis infection, and the main causative agent of melioidosis, B. 
pseudomallei. It is also recommended to investigate these selected Tspans 
with other bacterial and fungal infections. Furthermore, we highly 
recommended testing peptide 8005 on B. pseudomallei infections of different 
types of cell lines and in vivo. In addition, we can synthesise other peptides 
from other selected Tspans or its partners and examine them with B. 
thailandensis or other bacterial infections. Finally, we can advise the use of 
peptides or antibodies against these selected Tspans and partner as 
treatments to avoid the B. pseudomallei infection in its endemic area. 
However, it needs more experimental investigations for further validation and 
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Appendix Figure 1 Maps of pBBR-MCS1, pBBR-MCS1-GFP and pBBR-MCS1-
mCherry plasmids.  
A: Parental pBBR-MCS-1 plasmid. B: pBBR-MCS-1 mCherry plasmid constructed by 
transferring the smaller fragment generated from the digestion of ptetmCherry-prey with 
HindIII and XhoI into pBBR-MCS-1, digested with the same enzymes. C: pBBR-MCS-1-GFP 
plasmid constructed by transferring the smaller fragment generated from the digestion of 







Appendix Figure 2 Flow cytometry of transfected GFP and Tspan-2GFPA549 
cells. 
Dot plots from FACS analysis of the transfected and sorted cells compared with the 
untransfected A549 control; the percentage GFP+ve population is shown on diagram. SSC-A 
denotes side-angle-scatter, Blue 530-30-A for the relative intensity of GFP (detector supplied 
with 530/30 filter type). 
  





Appendix Figure 3 Flow cytometry of transfected GFP and CD9GFPJ774.2 
cells. 
Dot plots from FACS analysis of the transfected and sorted cells compared with the 
untransfected J774.2 control; the percentage GFP+ve population is shown on diagram. SSC-
A denotes side-angle-scatter, Blue 530-30-A for the relative intensity of GFP (detector 
supplied with 530/30 filter type). 
  




     
Appendix Figure 4 Validation of qPCR primer specificity. 
A single peak on the melting curve analysis indicates a single PCR product. These 
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Appendix Figure 5A Changes in Tspan genes expression in response to both 
B. thailandensis fusogenic and non- fusogenic strains. 
Tspan genes expression were measured by qPCR after 18hr infection with B. thailandensis 
CDC272 and E264. Expression of Tspan was calculated using the 2-ΔΔCt method relative to 
the results to the house keeping genes RpL13α. 8 Tspan showed changes in both host cell 
types.The significance of differences was tested by one-way ANOVA, where * p<0.05; ** 
p<0.01; *** p<0.001 significant; ns=non-significant. The results are the means (± SEM) of 3 





















































































































































































































































































































































Appendix Figure 5B Changes in Tspan genes expression in response to both 
B. thailandensis fusogenic and non- fusogenic strains.  
Tspan genes expression were measured by qPCR after 18hr infection with B. thailandensis 
CDC272 and E264. Expression of Tspan was calculated using the 2-ΔΔCt method relative to 
the results to the house keeping genes GAPDH. 10 Tspan showed changes in both host cell 
types.The significance of differences was tested by one-way ANOVA, where * p<0.05; ** 
p<0.01; *** p<0.001 significant; ns=non-significant. The results are the means (± SEM) of 3 























































































































































Appendix Figure 5C Changes in Tspan genes expression in response to both 
B. thailandensis fusogenic and non- fusogenic strains.  
Tspan genes expression were measured by qPCR after 18hr infection with B. thailandensis 
CDC272 or E264 and non-fusogenic mutant (E264-ΔtssK). Expression of Tspan was 
calculated using the 2-ΔΔCt method relative to the results to the house keeping genes RpL13α 
and GAPDH. 5 Tspan showed consistent changes in both host cell types, and no change with 
non-fusogenic mutant (E264-ΔtssK). The significance of differences was tested by one-way 
ANOVA, where * p<0.05; ** p<0.01; *** p<0.001 significant; ns=non-significant. The results 















































































































































































































































































































Appendix Figure 6 Changes in Tspan-partner genes expression in response to 
both B. thailandensis fusogenic and non-fusogenic strains.  
Tspan-partner genes expression were measured by qPCR after 18hr infection with B. 
thailandensis CDC272 or E264 and non-fusogenic mutant (E264-ΔtssK). Expression of Tspan 
partners was calculated using the 2-ΔΔCt method relative to the housekeeping gene β-actin. 3 
Tspans showed consistent changes in both host cell types, and no change with non-fusogenic 
mutant (E264-ΔtssK). The significance of differences was tested by one-way ANOVA, where * 
p<0.05; ** p<0.01; *** p<0.001 significant; ns=non-significant. The results are the means (± 






(No- reverse transcriptase) 
NRNA  
(No-RNA sample) 
GAPDH 39.931763 35.14805 Undetermined Undetermined 
Tspan-1 28.99355 29.73428 Undetermined 35.46973 
Tspan-2 32.01488 31.457602 Undetermined 34.31121 
Tspan-3 33.28066 35.41695 36.942593 34.817585 
Tspan-4 27.331385 27.61647 Undetermined Undetermined 
Tspan-5 Undetermined Undetermined Undetermined Undetermined 
Tspan-6 Undetermined Undetermined Undetermined Undetermined 
Tspan-7 25.130657 28.451052 Undetermined Undetermined 
Tspan-8 34.979122 Undetermined 36.744892 38.351868 
Tspan-9 31.989952 31.60617 35.661633 34.85089 
Tspan-10 30.511805 30.511805 34.821 36.603764 
Tspan-11 29.11388 28.41412 Undetermined Undetermined 
Tspan-12 31.194061 31.194061 39.931763 39.931763 
Tspan-13 Undetermined 34.31121 33.13016 34.456974 
Tspan-14 Undetermined 28.910097 34.415993 37.634903 
Tspan-15 33.479237 Undetermined 38.000103 39.757984 
Tspan-16  29.215239 28.62408 30.595415 30.595415 
Tspan-17 33.788227 33.788227 34.462414 35.136116 
Tspan-18 34.896137 33.360744 35.109177 35.109177 
Tspan-19 Undetermined Undetermined Undetermined Undetermined 
Tspan-20 32.667362 Undetermined 32.377937 33.257576 
Tspan-21 Undetermined Undetermined 34.837246 39.627895 
Tspan-22 Undetermined Undetermined Undetermined Undetermined 
Tspan-23 Undetermined Undetermined Undetermined Undetermined 
CD151 Undetermined Undetermined Undetermined Undetermined 
CD53 Undetermined Undetermined Undetermined Undetermined 
CD37 Undetermined 34.190094 Undetermined 34.11498 
CD81 Undetermined Undetermined Undetermined 36.527473 
CD82 Undetermined Undetermined Undetermined Undetermined 
CD9 37.008453 Undetermined 36.35095 37.497417 
CD63 33.03921 37.261692 34.586628 33.99199 
Tspan-31 32.29289 32.29289 34.21766 33.61503 
Tspan-32 29.951612 29.951612 30.593681 30.593681 
Tspan-33 34.121746 33.715054 34.817585 34.817585 
 
Appendix Table 1 Representative data from a single qPCR experiment. 
Two negative controls were used to validate the data of real time-qPCR which were no RNA 
sample (NRNA) and no reverse transcriptase enzyme to RNA sample (NRT) in the first step 
of cDNA synthesis. The data shows the raw Ct values of a representative single experiment; 2 
technical replicates. Undetermined means no SYBR fluorescent signal. 
 
